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Abstract 
Interferon-inducible PYHIN protein family includes the DNA-binding proteins, 
AIM2 and IFI16, which form ASC-caspase 1 dependent inflammasomes, important in immunity 
against cytosolic bacteria, DNA viruses and HIV. The role of other members of this family in 
the recognition of DNA and/or regulation of immune responses is unclear. We identified an 
immune regulatory function of p205, another member of the PYHIN family, in the 
transcriptional control of immune genes. Knockdown of p205 in macrophages revealed that 
inflammasome activation due to dsDNA and ligands that engage the NLRP3 inflammasome 
were severely compromised. Detailed mechanistic analysis showed that loss of p205 was 
associated with a decrease in Asc mRNA and protein levels. p205 knockdown resulted in 
reduced RNA Polymerase II-mediated endogenous Asc gene transcription and mRNA 
processing, suggesting a co-transcriptional control of Asc gene expression. Ectopically 
expressed p205 induced expression of an Asc gene-luciferase reporter and collaborated with 
other transcription factors, such as c/EBPβ, p65/RelA, to further enhance expression. p205 
knockdown also affected the expression of the immune genes Cd86, Cox2, Cxcl2, Il1α, Il10, 
Il12α, Il6 and Ifnα in LPS-stimulated macrophages. Together these findings suggest that p205 
regulates inflammation through control of Asc gene expression, and other immune genes. 
Fungal infections activate both caspase 1-dependent and -independent 
inflammasomes.  In an independent study, we show that Paracoccidioides brasiliensis fungal 
infection also induces caspase 8-dependent non-canonical inflammasome. Caspase 8-dependent 
IL-1β processing required dectin-1, Syk and Asc. Rip3-/- Casp8-/- mice infected with P. 
brasiliensis displayed increased fungal load and showed worse disease progression compared to 
wild type and Rip3-/- mice. These results revealed the importance of caspase 8 in activating and 
regulating inflammasome responses during fungal infection in vivo. 
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1.1 What is Innate Immunity? 
 The innate immune system consists of genetically coded receptors that 
present an impressive ‘first line of defense’ to threats from outside or within the host 
system. These receptors known as the pattern recognition receptors (PRR) recognize 
foreign particles that are associated with pathogens such as bacteria, virus, fungus or 
protozoa called Pathogen-associated Molecular Patterns (PAMP) as well as self-derived 
molecules that may pose dangerous and harmful to the host called Danger-associated 
Molecular Patterns (DAMP) (1). Upon recognition and engagement by these molecules 
resulting from pathogenic infection or cellular damage, the receptors initiate a rapid 
immune response that triggers the production of cytokines and chemokines to contain and 
eliminate the threats, before the slower adaptive immune system kicks in to eradicate 
them and form a long-term memory response. These cytokines and chemokines also act 
as a herald that informs the system of imminent intrinsic or extrinsic danger, which is 
initiated within the infected cells to attract immune cells, also turns to protect the 
surrounding cells from being infected. Cells like macrophages, dendritic cells, fibroblasts, 
mast cells, monocytes, neutrophils and natural killer (NK) cells express these PRR and 
are the sentinels for the host immune system, while the adaptive immune system that is 
engaged by the innate immune system, consists primarily of B-cells and T-cells.  
 The innate immune system is evolutionarily the original host defense 
system, which is the dominant immune system in plants, fungi, insects and primitive 
multicellular organisms. The primary functions of the innate immunity include immune 
cells recruitment to sites of infection and cellular damage, activation of the complement 
cascade to identify pathogens and clear antibody complexes or dead cells, identification 
	 17	
and removal of foreign particles present in organs, tissues, blood and lymph, activating 
the adaptive immune system by antigen presenting cells (APC) and acting as a physical 
and chemical barrier to infectious agents. 
	 18	
 
Figure 1.1: Pattern Recognition Receptors and Innate Immune 
pathways. Innate immunity consists of genetically coded receptors called 
Pattern Recognition Receptors (PRR) such as Toll-like receptors (TLR), RIG-I 
like receptors (RLR), NOD-like receptor (NLR) proteins, AIM2-like receptors 
(ALR) and cGAS. Upon binding their cognate pathogen-derived or danger-
associated molecules, the PRRs activates multiple immune pathways through 
adapter proteins and transcription factors leading to immune responses including 
NF-κB, Interferons and Inflammasome pathways.  
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1.2 Pattern Recognition Receptors and Their Ligands 
The Pattern Recognition Receptors or PRRs are classified into different 
families principally according to their structures as well as by ligand-specificity and the 
signaling pathways that they activate upon stimulation.  
 
1.2.1 Toll-like receptors (TLR) 
 Toll-like receptors or TLR are the most comprehensively studied innate 
immune receptors that recognize a wide range of PAMP and DAMP. Initially, Toll was 
described in Drosophila melanogaster as a protein involved in embryonic development. 
It was later discovered to function in fungal pathogen detection and response (2). TLRs 
are type-I transmembrane (TM) proteins, found in the cell membrane or in the 
endosomes, primarily composed of multiple extracellular N-terminal leucine-rich repeats 
(LRR), followed by a cysteine-rich region, a TM domain and an intracellular Toll/IL-1 R 
(TIR) motif (3, 4). The LRR domain is responsible for ligand binding and detecting 
foreign particles while signal transduction occurs through the TIR domain that is capable 
of protein-protein interactions. Bacterial cell wall components in the extracellular 
compartment are detected by TLR present in the plasma membrane. TLR2 forms 
heterodimers with TLR1, TLR6 and possibly human TLR10 to detect triacylated or 
diacylated lipopeptides, peptidoglycans, lipoglycans, lipoteichoic acid (LTA) present in 
the cell walls of both Gram-positive and Gram-negative bacteria, while TLR5 recognizes 
the bacterial flagellin. Human TLR8 and mouse TLR13 respond to viral and bacterial 
RNA. TLR11 and TLR12, found only in mouse, recognize profilin from Toxoplasma 
gondii. TLR4, with the help of MD2 and CD14, shuttle between the plasma membrane 
	 20	
and the endosome, and recognizes lipoglycans like lipopolysaccharide (LPS) derived 
from Gram-negative bacteria (5). In contrast, the endosomal TLRs sense bacterial or viral 
nucleic acids within the cytosol – TLR3 senses double-stranded (ds) RNA (6), TLR7/8 
sense single-stranded (ss) RNA (7) and TLR9 recognizes unmethylated CpG DNA (8). 
Upon activation, the TLR dimerize and stimulate MAPK, IFN or NF-κB pathways by 
recruiting the adapters myeloid differentiation primary response protein 88 (MyD88) or 
TIR-domain containing adapter inducing IFN (TRIF; also known as TICAM1) to induce 
proinflammatory cytokine production (9, 10). The downstream signaling proceeds 
through distinct pathways, and deletion of both MyD88 and TRIF completely blocks 
TLR signaling. 
 
1.2.2 RIG-I like receptors (RLR) 
  RIG-I or retinoic acid inducible gene-1 encoded by the gene DDX58 was 
the first DExD/H box RNA helicase to be identified as an intracellular receptor for RNA 
(11). The other members of this RIG-I like receptors or RLR superfamily include 
melanoma differentiation-associated gene 5 (MDA5) and laboratory of genetics and 
physiology 2 (LGP-2) (12). These proteins contain a DExD/H box RNA helicase domain 
(DEAD domain) with ATPase activity and a C-terminal repressor domain (CTD). RIG-I 
and MDA5 also contain two tandem N-terminal caspase activation and recruitment 
domains (CARDs) that are absent in LGP-2. Although RIG-I and MDA-5 share similar 
domain structure, they recognize distinct RNA ligands in a sequence-independent, length-
dependent manner as established by their crystal structures. RIG-I detects smaller 5’ 
triphosphate RNA molecules and ssRNA. MDA5 preferentially binds to the 
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phosphodiester backbone of longer dsRNA and oligomerizes to form filamentous 
structures on the RNA. RIG-I is involved in sensing Sendai Virus (SeV), Influenza A 
(IAV) and B (IBV) Virus, Hepatitis C Virus (HCV), Vesicular Stomatitis Virus (VSV) 
and Respiratory Syncytial Virus (RSV) (11). MDA-5 recognizes encephalomyocarditis 
virus (EMCV), coxsackie B virus (CBV) and Polio as well as the transfected synthetic 
viral RNA-mimic, polyinosinic:polycytidylic (poly I:C) (13). Upon detection of viral 
RNA particles, RIG-I and MDA5 oligomerize and activate type-I interferon (IFN) 
production via adapter protein mitochondrial antiviral signaling (MAVS) protein and 
transcription factors, Interferon Regulatory Factor (IRF) 3 and 7 (Pathway described in 
more detail in Section 1.3.1). Since 5’-triphosphate modified RNA are predominantly 
found in certain viral genomes, and not in mammalian system, a highly specific and 
strong immune response is initiated upon RIG-I and/or MDA5 induction upon RNA virus 
infection. The other member of the RLR family, LPG-2 was initially shown to negatively 
regulate RLR activity (14) as the LGP-2 overexpression decreased the capacity of RNA 
virus to induce type I IFNs. However, later Satoh et al. showed that LGP-2 deficient mice 
had increased interferon signaling upon infection contrary to its suggested function as a 
negative regulator (15). The RNA-binding PRRs are described in more detail in Section 
1.5. 
 
1.2.3 NOD-like receptors (NLR) 
  Multiple PAMP (e.g. Salmonella sp. type-III secretion, bacterial toxins, 
bacteria-derived RNA:DNA Hybrids etc) system as well as DAMP (e.g. mitochondrial 
damage, β-amyloids, K+ efflux, alum etc) activate the intracellular nucleotide 
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oligomerization domain-like receptors (NLR). In contrast to other receptor family 
members, the NLRs have not been shown to definitively bind or receive any specific 
microbial product. The NLR family includes NLRP1, NLRP3, NLRC4, NLRP6 and 
NLRP12 that activate the inflammasomes to regulate caspase activity and induce an 
inflammatory response.  There are 22 human and 34 mouse NLRs that have a common 
central nucleotide binding and oligomerization (NACHT) domain and a C-terminal 
leucine-rich repeat (LRR) responsible for immune activities of the NLR (16). (More 
details about NLR Inflammasomes in Section 1.4.1) 
  The NOD1 and NOD2 proteins were the first NLRs found to regulate NF-
κB and MAPK pathways. Another NLR, NLRC5, expressed widely in various tissues and 
cell types in both human and mouse, acts as a negative regulator in both NF-κB and type 
I IFN signaling pathways (171). NLRX1 is specifically located at the mitochondria and 
interacts with the MAVS to activate the transcription factors IRF3 and NF-κB signaling 
pathways, leading to the production of IFNα/β and proinflammatory cytokines. RIG-I-
MAVS interaction is impeded by NLRX1, thus negatively regulating of IFN-α/β 
induction during RNA virus infection. In contrast, NOD2 uses MAVS to activate an anti-
viral IRF3 response, leading to enhanced IFN-α/β induction (175). 
 
1.2.4 C-type lectin receptors (CLR) 
  The CLR family includes the receptors DC-SIGN, dectin-1, dectin-2, 
Mincle. They are soluble or transmembrane proteins, containing a distinct C-type lectin-
like domain (Carbohydrate Recognition Domain or CRD), that detect various fungal, 
bacterial and viral sugar-based derivatives such as zymosan, β-glucan, N-linked mannan, 
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a-mannose etc (17) The CLR activates NF-κB signaling pathway via a kinase, Syk 
(spleen tyrosine kinase) through direct interaction with the immunoreceptor tyrosine 
based activation (ITAM) motif present in their intracellular region (e.g. Dectin-1, DC-
SIGN) or indirectly through other molecules containing the ITAM motif (e.g. Dectin-2 or 
Mincle via FcRγ), and regulates TLR-induced gene transcription as well.  
 
1.2.5 AIM-2 like receptors (ALR) and cGAS 
  Of all the ALRs, so far, only absent in melanoma (AIM) 2 and Interferon 
Gamma Inducible protein (IFI) 16 have been characterized as PRRs. cGAS (cytosolic 
GAMP synthase; also known as MB21D1) is an enzyme that belongs to the 
nucleotidyltransferase family (18-20). AIM2 and cGAS localize in the cytoplasm and 
senses DNA in a sequence-independent manner to activate ASC-dependent 
inflammasome and STING-dependent type-I IFN respectively. IFI16 is a nuclear protein, 
which shuttles to the cytoplasm as well on post-translational modification or during 
specific infections, and activates the inflammasome upon Kaposi's sarcoma-associated 
herpesvirus (KSHV) infection, and also in CD4+ T-cells during Human 
Immunodeficiency Virus (HIV) infection (21, 22). The nucleic acid sensors AIM2 and 
IFI16 belong to the family of proteins called PYHIN proteins or as AIM2-like receptors 
(or ALRs) and are described in detail in Section 1.6. Other DNA sensors include 
DAI/ZBP1, MRE11, DDX41, LRRFIP1 and RNA Polymerase III that are described in 
detail in Section 1.5. 
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1.3 Innate Immune Signaling pathways 
  Activation of the PRRs upon detection of DAMPs and PAMPs within the 
host system triggers multiple distinct and parallel downstream signaling pathways that 
control the cellular processes, e.g. inflammation, autophagy, apoptosis, necrosis, cell 
survival and proliferation, that determines the fate of the infected or damaged host cells 
as well as that of the neighboring bystander cells. The Type-I Interferon pathway elicits 
the synthesis and secretion of IFN-α and IFN-β that initiates another cascade of antiviral 
and anti-tumor gene expression. The NF-κB/MAPK pathway, also known as the MyD88-
dependent pathway, activates multiple proinflammatory cytokine genes, including tumor 
necrosis factor (TNF) α, IL-6 and pro-IL-1β. Inflammasome activation causes a robust 
pro-inflammatory response through secreted cytokines such as IL-1β, IL-18 and leads to 
an inflammatory cell death. 
 
1.3.1 The Complement System 
  The complement system is comprised of a subset of proteins circulating in 
the blood that enhances the ability of antibodies and phagocytic cells to clear microbial 
pathogens and damaged cells, promotes opsonization and disrupts the plasma membrane 
of microbes (membrane attack complex or MAC) to kill the organism. The distinct 
biochemical pathways that activate the complement system are (i) the classical 
complement pathway, (ii) the alternative complement pathway and (iii) the lectin 
pathway (23). These reactions amplify the innate anti-microbial mechanisms, recruit 
leukocytes, initiate phagocytosis of pathogens and clear immune complexes. While un-
opsonized pathogens are eventually sensed and phagocytosed by other PRRs, 
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opsonization by complement provides an immediate and effective mechanism of 
pathogen clearance. 
  The classical pathway is triggered by activation of the C1-complex 
composed of C1q, C1r and C1s (C1qr2s2), when C1q binds to IgM or IgG antibodies 
bound to antigens. The complex is also activated when C1q binds directly to the surface 
of the pathogen. The C1r2s2 is a serine protease complex that cleaves C4 and then C2, 
producing C4a, C4b, C2a, and C2b. C4b and C2b bind to form the classical pathway C3-
convertase (C4b2b complex), which promotes cleavage of C3 into C3a and C3b. C3b 
later joins with C4b2b to make C5 convertase (C4b2b3b complex). It initiates the later 
events of complement activation comprising of a sequence of polymerization reactions in 
which the terminal complement components, C6, 7, 8 and 9 interact to form a membrane-
attack complex, which creates pores in the plasma membranes of pathogens leading to 
their death. 
  In the alternative pathway, a similar C3 convertase is formed from 
membrane-bound C3b complexed with Bb, from the component Factor B. The alternative 
pathway can act as an amplification loop for all three pathways, as it is initiated by the 
binding of C3b, and spontaneous C3 hydrolysis due to the breakdown of the internal 
thioester bond. The lectin pathway is similar to the classical pathway, except that it is 
initiated by mannose-binding lectin (MBL) instead of C1q. It is activated by the binding 
of MBL to mannose residues on microbial surfaces, which activates the MBL-associated 
serine proteases, MASP-1, and MASP-2 (similar to C1r and C1s in the classical 
pathway). 
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1.3.2 Type-I & Type-II Interferons  
  The type-I Interferon family consists of multiple cytokines including IFN-
α (13 human subtypes, 14 mouse subtypes), IFN-β and other less characterized cytokines 
such as IFN-ε, IFN-τ, IFN-κ, IFN-ω, IFN-δ and IFN-ζ. IFN-α/β are the most well 
defined, broadly expressed type-I IFN that can induce an anti-pathogenic state via 
changes in host gene transcription in infected as well as surrounding uninfected cells 
(24). Dependent on infections, different conditions arise that determine how type-I IFN 
are induced as well as the downstream signaling pathways that are initiated through type I 
IFN receptor (IFNAR), which trigger IFN-stimulated genes (ISG) activation or 
repression. The primary ligands that can activate type-I IFN are lipopolysaccharides 
(LPS), RNA and DNA. Hence, among the TLRs, TLR4 on the cell surface and TLR 
3/7/8/9 in the endosomes are potent activators of IFN. Similarly, the RNA helicases, 
RIG-I, MDA5 and the DNA sensors, cGAS, IFI16 can activate the type-I IFN pathways.  
 The multiple receptor signaling pathways converge upon the recruitment 
of the cytosolic TIR domain activating the tank binding kinase 1 (TBK1) complex that 
phosphorylates the transcription factors, IRF3 and IRF7 leading to their dimerization. 
The IRF3 and IRF7 homodimers translocate to the nucleus and activates downstream 
type-I IFN pathway including IFNα/β and other ISGs. 
 Upon activation, the receptors employ different adapter proteins to initiate 
IFN signaling. TLR3 activates TRIF to recruit TRAF3, IKKι and NAK-associated protein 
(NAP) 1 to activate TBK1 kinase activity while the other TLRs recruit MyD88 and IL-1 
receptor associated kinases (IRAK) to activate type-I IFN. TLR4 dimers use Myd88 and 
IRAKs as well as TRIF and TRIF-related adapter molecule (TRAM) to activate IRF3. 
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The RNA helicases, upon detection of viral RNA, signal through the adapter, MAVS also 
known as VISA (virus-induced signaling adapter), IPS-1 and Cardiff located on the outer 
membrane of mitochondria and peroxisomes via homotypic interactions between their 
CARD (Caspase-recruitment domains) domains. On binding of activated RIG-I or MDA-
5 filaments, MAVS aggregates on the on the surface of the mitochondria and recruits 
TNF receptor associated factor (TRAF) 3 and 6, caspase-8, RIP1, FAS-associated death 
domain (FADD), and TNF receptor-associated death domain (TRADD) are recruited to 
activated MAVS, forming a signaling complex for activation of the kinases IKKα/β and 
TBK1, resulting in downstream NF-κB and IRF3/7-dependent transcription of antiviral 
genes (Kawasaki et al., 2011). The cytosolic DNA sensors initiate IFN signaling through 
yet another adapter protein, STING. Overexpression of STING drives IFN expression. 
STING localizes to the outer membrane of the endoplasmic reticulum (ER) but 
relocalizes, upon activation, to the Golgi forming large aggregates (Ishikawa et al., 2009). 
The activated STING complex recruits TBK-1 that leads to the phosphorylation and 
dimerization of IRF3 and IRF7.  
 IFNα/β activates a second wave of IFN-dependent gene expression by 
engaging its extracellular receptor, IFNAR. Binding of IFNα/β, IFNAR1 and IFNAR2 
recruits the tyrosine phosphorylases, JAK1 and TYK2 that phosphorylates and activates 
STAT1, STAT2 and STAT3 that form STAT1 or STAT3 homodimers and/or STAT1/2 
heterodimers. These dimers translocate to the nucleus, bind the chromatin (ISRE; IFN-
Stimulatory Response Element) and activate transcription of several ISGs (e.g. IRF7, 
IRF9, Cxcl10, Cxcl9, RANTES, Viperin) in the damaged cell (autocrine) as well as in the 
surrounding cells (paracrine). 
	 28	
  Type II interferon or IFN-γ is mainly secreted by T cells, natural 
killer (NK) cells and macrophages. IFN-γ is c ritical for innate antiviral and anti-tumor 
immunity. While mice lacking IFN-γ or its receptor, IFNGR1 are able to manage the viral 
burden during VSV or Semliki Forest virus (SFV) infections, they are more susceptible to 
Vaccinia Virus (VACV) or lymphocytic choriomeningitis virus (LCMV) infections (14, 
19, 20). Interestingly, mice lacking both Ifnar1 and Ifngr1 gene expression show higher 
mortality rate to VV and LCMV (21), which suggests that the two IFN types are often 
complementary with respect to immune resistance to different viral pathogens. 
 IFN-γ–activated macrophages are better equipped to kill bacterial or 
protozoan pathogens. IFN-γ activates the factors, NADPH oxidase subunits, NOS2, 
lysosomal enzymes, and tryptophan-metabolizing enzymes that kill of microbes by 
reactive oxygen species (ROS), NO radicals, degradation, and tryptophan depletion 
respectively. Some of these factors are also regulated by STAT1. Additionally, IFN-γ 
enhances the synthesis of cytokines (e.g. IL-12 p40 subunit) that enhance antimicrobial 
immunity in vivo. IFN-γ is particularly effective against pathogens within the cells such 
as Listeria, Mycobacterium, Salmonella, Chlamydia, and Leishmania. Treatment with 
recombinant IFN-γ or genetic depletion of IFN-γ demonstrates the efficacy of IFN-γ as 
factor regulating pathogen survival or clearance. 
 
 
1.3.2 NF-κB and MAPK  
 The NF-κB (Nuclear Factor- κB) and MAPK (Mitogen-activated protein 
kinase) or ERK (extracellular protein kinase) pathways are the downstream signaling 
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pathways of most PRRs and are crucial for immune responses to cellular stress and 
infection. In mammals, the NF-κB family consists of five members, NF-κB1 (p105/p50), 
NF-κB2 (p100/p52), RelA (p65), RelB and c-Rel while the MAPK family contains 14 
kinases, of which extracellular signal-regulated kinase 1 (ERK1), ERK2, p38α, Jun N-
terminal kinase 1 (JNK1) and JNK2 have been studied extensively in innate immunity 
(25, 26). 
 All the TLRs induce a NF-κB dependent inflammatory gene signature in 
the host cells. Most of the TLRs signal through MyD88, with the exceptions of TLR3 that 
uses TRIF, and TLR4 that uses both MYD88 and TRIF. Activated TLRs bind MyD88 
and TIR domain containing adaptor protein (TIRAP) in the cytosol, which recruits 
IRAK-1, IRAK-4 and TRAF-6. IRAK-4 and TRAF6, in turn, associate with another 
complex consisting of transforming growth factor (TGF)-β-activated kinase (TAK1; also 
called MAP3K7) and TAK1-binding proteins (TAB) 1 and 2 that activates TAK1 and 
consequently, the transcription factors NF-κB through the IκB kinase (IKK) complex and 
activator protein 1 (AP-1) through the MAPK pathway. The TLR3-mediated NF-κB is 
activated through the homotypic binding of Receptor-interacting protein (RIP1) to the 
Rip motif in TRIF C-terminus and cooperative binding of TRAF6 to the N-terminus of 
TRIF. Although NF-κB pathway, upon TLR3 activation, in TRAF6-deficient fibroblasts 
is impaired, TRAF6 is not necessary for NF-κB activation in macrophages. Similar to 
TLR3, TLR4 can also activate TRIF/RIP1/TRAF6 dependent NF-κB signaling. Cells 
deficient for TRAF6 and MyD88 can activate NF-κB in response to LPS suggesting that 
TRIF could activate the pathway in TRAF6-independent RIP-1-dependent manner. The 
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NF-κB pathway remains active in LPS-stimulated, RIP1-deficient cells, but LPS-
stimulation in cells deficient for both MyD88 and RIP1 show no NF-κB activation.  
Various PRRs that can activate the MAPK pathway include the TLRs among 
others. MAPK activation in innate immune cells has been mostly studied in the context of 
TLR agonists. Following ligand binding to TLRs, IRAK4 is recruited to MYD88to form 
a complex with the related kinases IRAK1 and IRAK2, TRAF6 and the E2 ubiquitin-
conjugating enzyme 13 (UBC13; also known as UBE2N). TRAF6 and UBC13 catalyzes 
K63-linked polyubiquitination on TRAF6 and IRAK1, which leads to the activation of 
the MAPK pathway. TRAF3 is also recruited to MYD88 and its degradation by IAPs 
(inhibitor of apoptosis proteins) is required for the activation of MAPKs and for the 
induction of pro-inflammatory cytokines, but not for TLR-dependent of type I IFN 
production. The activated MAP3K TAK1 directly activates the MAPK kinases (MAP2K, 
MAPK) for both p38 and JNK that induce AP1-mediated gene activation. However, 
depending on the stimuli (e.g. TNF or IL-1) TAK1 can induce parallel pathways that may 
or may not require regulation by TAB1 and TAB2.  
  
 
1.3.3 Inflammasomes 
 Cellular stress, bacterial, fungal or viral infections also trigger a distinct 
set of sensors that activates the inflammasome complex. The receptors that activate the 
inflammasome are the NLRs and AIM2, IFI16 (ALRs). The inflammasome is a large 
multimeric complex consisting of the receptor, the adaptor protein Apoptosis-Associated 
Speck-Like Protein Containing a CARD domain (ASC; also known as PYCARD), and its 
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effector protein, caspase 1 (cysteine aspartate proteases 1) (27, 28) that cleave the 
inactive forms of IL-1β and IL18 to their mature, bioactive, secreted forms leading to a 
robust inflammatory response.  The Inflammasomes are described in more detail in the 
following Section 1.4. 
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1.4 What are Inflammasomes? 
 
 Inflammasomes are cytosolic multi-protein complexes that are assembled 
upon detection of pathogenic or self-derived danger molecules, and are responsible for 
the activation and induction of pro-inflammatory cytokines Interleukin-1β (IL-1β) and 
Interleukin-18 (IL-18), and an inflammatory form of programmed cell death known as 
pyroptosis via caspase 1 (27, 29) and Gasdermin-D (GSDMD) (30, 31). Inflammasomes 
are critical for resisting infection upon detection of pathogen-associated molecular 
patterns (PAMP) such as microbial nucleic acids, lipoproteins and carbohydrates by 
pattern recognition receptors (PRR). Similarly, inflammasomes also are activated upon 
recognition of endogenous triggers or danger-associated molecular patterns (DAMP) like 
mitochondrial damage, ionic imbalance, free ATP that are typical markers of injured or 
dying cells. Innate immune cells like macrophages, dendritic cells, fibroblasts, mast cells, 
monocytes and neutrophils express the PRRs that are responsible for launching 
inflammatory responses. However, deregulated inflammasome activation can lead to 
aggravated disease symptoms, autoimmune disorders and inflammatory diseases such as 
Alzheimer’s disease, atherosclerosis, diabetes and cancer. 
 Over the years, multiple distinct PRRs have been identified that can 
activate inflammasomes. The classical inflammasome complex contains a cytosolic 
receptor (e.g. a nucleotide-binding domain and leucine-rich-repeat containing protein or 
NLR or, an AIM2-like receptor or ALR) that gets activated upon microbial or 
endogenous insults and oligomerizes to recruit an adapter protein called ASC (apoptosis-
associated speck-like protein containing a CARD domain) and an effector, inflammatory 
cysteine aspartate protease, caspase to form a multimeric structure that promotes a 
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signaling cascade that elicits the maturation and production of inflammatory cytokines 
and chemokines as well as pyroptosis. 
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Figure 1.2: Structure of an Inflammasome. The inflammasome is a multimeric 
protein complex, which forms a speck-like structure, composed of a ligand-
activated receptor protein (e.g. NLRP3, NLRP1, AIM2), an adapter, ASC and an 
effector protease such as Caspase 1. The inflammasome is required for the 
maturation of inflammatory cytokines such as IL-1β and IL-18 as well as in 
promoting an inflammatory form of cell death called pyroptosis. 
Receptor Adapter Effector
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1.4.1 Caspase-1 dependent canonical inflammasomes 
  
  The term “inflammasomes” was initially coined to describe the multimeric 
complex composed of a receptor that recruits ASC, which enhances the nucleation and 
polymerization of the effector protease, caspase 1 that cleaves pro-IL-1β and pro-IL-18 
into their mature, secreted forms. Caspase 1 was initially called Interleukin-1 converting 
enzyme (ICE) owing to its role in converting the 31 kD pro-IL-1β into an active 17.5 kD 
fragment in 1989 (32, 33). In 1992, it was characterized as a heterodimeric cysteine 
protease composed of two subunits, p10 and p20 (34). The macromolecular protein 
complex comprising caspase 1, caspase 5, ASC and an NLR, NLRP1 was described in 
vitro for the first time in 2002 (27). The most well characterized caspase 1-dependent 
inflammasomes are NLRP1b, NLRP3, NLRC4 and AIM2. Other inflammasomes include 
NLRP12, NLRP6 and pyrin. 
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Figure 1.3: Canonical caspase 1-dependent inflammasomes. Canonical 
inflammasomes receptors include NLRC4 (activated by bacterial flagellin) 
NLRP1b (activated by anthrax lethal toxin), AIM2 (activated by cytosolic dsDNA) 
and NLRP3 (activated by a wide variety of signals e.g. pore-forming cytotoxins, 
ATP, ROS or reactive oxygen species). On activation, the receptors form an 
inflammasome complex with or without the adaptor, ASC, and recruit 
procaspase-1, which is subsequently cleaved into active caspase-1, which in turn 
cleaves pro-forms of IL-1b and IL-18 into their active forms as well as Gasdermin 
D (GsdmD) to induce cell death. (Adapted from Vanaja, Rathinam and Fitzgerald, 
Trends in Cell Biol., 2015) 
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NLR inflammasomes   
  NLRs are generally composed of three separate domains, all of which are 
found throughout metazoan evolution. At the N-terminus, NLRs either have a pyrin 
(PYD) domain, a caspase recruitment domain (CARD), or a baculovirus inhibitory repeat 
(BIR; also called IAP repeat) domain (2, 5). The central NBD (nucleotide-binding 
domain; also called NACHT, NAIP, CIITA, HET-E and TP1) domain is responsible for 
nucleoside-triphosphatase (NTPase) activity and oligomerization. The NBD, in the 
presence of nucleotides, especially ATP, is thought to maintain a ligand-receptive state. 
The C terminus of NLR proteins is composed of a manifold series of leucine-rich repeats 
(LRR). All these domains have been implicated in protein-protein interactions and 
downstream signal activation, through association with large macromolecular complexes 
called inflammasomes (28). 
 
NLRP1b   The first NLR that was shown to form an inflammasome 
complex was NLRP1. Humans only have one NLRP1 protein compared to the multiple 
paralogues found in mice, such as Nlrp1a, Nlrp1b and Nlrp1c. NLRP1 is expressed in 
adaptive immune cells and tissues as well as in non-hematopoietic tissues. Human 
NLRP1 is structurally unique among NLRs- it has an N-terminal CARD, central 
NACHT, LRR, function-to-find (FIIND) domains, and another C-terminal CARD.  
  Mouse Nlrp1b recognizes the anthrax lethal toxin (LeTx) from Bacillus 
anthracis in the cytoplasm to activate inflammasomes that is crucial for defense against 
B. anthracis spores in mice. The B. anthracis LeTx is a zinc metalloprotease lethal factor 
that enters the host cytosol and cleaves mitogen-activated protein kinase (MAPK) kinases 
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to block immune signaling. The LeTx also cleaves Nlrp1b close to its N-terminus that 
likely releases the receptor from its autoinhibitory state and/or induces structural changes 
that is more conducive to oligomerization. The lethal-toxin responsive Nlrp1b also 
undergoes an autoproteolytic processing in its FIIND domain, which is required for its 
function (35).  
  In vitro, NLRP1 interacts with caspases 1 and 5 to form a macromolecular 
complex that is necessary for IL-1β/IL-18 processing and pyroptosis. NLRP1 also 
interacts with caspases 2 and 9 to facilitate cell death via the apoptosome (36). 
Additionally, the Nlrp1b inflammasomes are functional independent of ASC, as caspase 
1 is activated via ubiquitination, and not cleavage, to induce IL-1β release and cell death.   
 
NLRP3    The NLRP3 (also called as cryopyrin and NALP3) 
inflammasome is the most well characterized inflammasome to date. NLRP3 is expressed 
by myeloid cells and is upregulated in response to the stimulation PAMPs (13). The gene 
encodes a pyrin domain, NBD and C-terminal LRR (14). NLRP3 lacks the CARD 
domain and thus, recruits procaspase-1 only in the presence of the adaptor molecule ASC 
through homophilic interactions between pyrin domains. It is triggered by various distinct 
DAMPs and PAMPs like K+ efflux, mitochondrial reactive oxygen species (ROS), 
mitochondrial or lysosomal damage, ATP, β-amyloids, hyaluronan, cholesterol crystals, 
crystalline particles (e.g. silica, alum), RNA:DNA hybrids, pore-forming toxins (e.g. 
hemolysin, pneumolysin) and several microbial pathogens. It is likely that NLRP3 is 
activated in response to a common cellular event (e.g. disruption in the cellular 
homoeostasis, pore formation in plasma membrane, lysosomal damage releasing 
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cathepsin B, ROS generation), which is downstream of all the aforementioned triggers. 
Activation of NLRP3 requires priming of the innate immune cells that induces NLRP3 
gene expression. NLRP3 activates IL-1β release via the classical ASC and caspase 1-
dependent inflammasome pathway. However, caspase 8 and FADD have also been 
implicated in NLRP3 inflammasomes in bacterial (e.g. Staphylococcus aureus (37), 
Listeria monocytogenes (38), Klebsiella pneumoniae, Neisseria gonorrhoeae, 
Escherichia coli, Porphyromonas gingivalis, Shigella flexneri and Chlamydia spp.), 
fungal (e.g. Paracoccidioides brasiliensis (39), Cryptococcus neoformans (40), 
Aspergillus fumigatus (41) Candida albicans (42)) and viral (e.g. adenovirus, IAV, SeV, 
VACV) infections, though the mechanism has not been entirely elucidated. 
  In addition, nucleic acids like bacterial RNA (43), mitochondrial DNA 
(44) as well as RNA:DNA hybrids (45) derived from bacterial replication intermediates 
also stimulate the NLRP3 inflammasomes. Although the nucleic acids co-localize with 
active NLRP3 inflammasome specks, it is unclear if they interact directly with NLRP3 or 
through an intermediate nucleic acid binding component. 
  It is not completely understood how NLRP3 gets activated though some 
recent insights have defined a role for NEK7 (NIMA-related protein kinase 7) that acts 
downstream of K+ efflux, binds to NLRP3 and controls NLRP3 oligomerization via its 
catalytic domain. HSP90 and SGT1 have been shown to interact with NLRP3 LRRs to 
maintain an inactive but stabilized structure (46). Further, deubiquitination of NLRP3 is 
required for its activity. So far there has been no direct evidence of ligand binding to 
NLRP3, which led to the general hypothesis that NLRP3 senses changes in the cellular 
milieu initiated by activators both self-derived and foreign.  
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  Genetic mutations that activate or predispose towards activation of the 
NLRP3 inflammasome are associated with cryopyrinopathies or cryopyrin-associated 
periodic fever syndromes (CAPS) such as FCAS (familial cold-induced 
autoinflammatory syndrome), MWS (Muckle-Wells syndrome), and NOMID/CINCA 
(neonatal onset multisystem inflammatory disorder or chronic infantile neurologic 
cutaneous and articular syndrome) (47). All these disorders are associated with periodic 
fevers and rashes, arthralgia, and conjunctivitis associated with neutrophil-dependent 
inflammation as well as neurological involvement, including aseptic meningitis and 
deafness as seen in NOMID/CINCA. 
 
NLRC4  NLRC4 is expressed predominantly in hematopoietic tissues and 
cells. The gene encodes a CARD, NBD and C-terminal LRRs. It can interact directly 
with procaspase-1 via homotypic CARD interactions as well as through the adapter ASC, 
which leads to the processing of caspase-1 (48). Intracellular flagellin is an activator of 
the NLRC4 inflammasome (49, 50). These responses to flagellin depend on an intact type 
III or IV secretion system (T3SS or T4SS) in the bacteria by which the flagellin enters the 
host cytosol (51). The rod proteins, which are the components of the bacterial secretion 
system, also act as activators of NLRC4 inflammasome (51). Using NLRC4-deficient 
system demonstrated that NLRC4 is critical for host defense against Salmonella, 
Shigella, Pseudomonas, and Legionella. Moreover, it has been shown that Salmonella 
and Legionella mutant lacking flagellin are incapable of activating the inflammasome. 
  Similar to NLRP3, there has been no direct evidence of a ligand-receptor 
relationship between NLRC4 and flagellin or rod proteins. NLRC4 also co-operates with 
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other NLRs such as NLRP3 in Salmonella, Shigella infections to activate the 
inflammasome (52, 53). In contrast to other inflammasomes, NLRC4 requires another 
NLR protein that functions as a co-receptor. There are four NAIP proteins in mice - 
NAIP1 binds to needle proteins of the T3SS, NAIP2 binds to the Salmonella SPI-1 basal 
rod component PrgJ and Shigella T3SS protein MxiI, and NAIP5/6 sense flagellin (54-
58). Humans express only one NAIP protein, which binds the Chromobacterium 
violaceum needle protein, Cprl (and not flagellin) (58). NAIP5 had been genetically 
linked to Legionella replication in mice (83) and humans (84) and was shown to sense an 
additional epitope found within flagellin (85, 86) which led to the discovery of 
association of NLRC4 with NAIP5 that restricts Legionella replication (87). 
 
NLRP12  Infection with the plague-causing bacteria, Yersinia pestis induces 
NLRP12 inflammasome activation leading to production of IL-18, which is critical for 
the pathogen clearance (59). Further, NLRP12-deficient mice are highly susceptible to Y. 
pestis infection. The NLRP12 as well as NLRP3 inflammasome complexes are also 
present in monocytes of malaria patients, suggesting that, together with the NLRP3 
inflammasome, the NLRP12 inflammasome may be important in IL-1β production and 
hypersensitivity to secondary bacterial infections in infected patients (60). However, the 
specific ligand that activates the NLRP12 inflammasome is not known, and further 
elucidation of the role of NLRP12 in infectious diseases is required. 
 
NLRP6   The NLRP6 inflammasome induces IL-1β and IL-18 
production and simultaneously regulates autophagosome formation that is required for 
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mucin granule exocytosis from the goblet cells in the intestine that maintains intestinal 
barrier integrity. NLRP6 depletion in mice alters the composition of colonic microbiota 
due to expansion of colitogenic bacteria, Bacterioidetes and TM7 (61-63). However, the 
mechanism of how NLRP6 modifies the intestinal microbiota, and the ligand that drives 
NLRP6 activation are still unknown. 
 
Pyrin inflammasomes  
 Pyrin (also called marenostrin and TRIM20) is a non-NLR protein 
expressed primarily in immune cells such as monocytes and dendritic cells (64). Encoded 
by the gene, MEFV, the protein contains an N-terminal pyrin, two B-box zinc-fingers, a 
coiled coil, and C-terminal B30.2 (also called SPRY) domains (65). Mutations in the 
MEFV gene cause an autoinflammatory disease, familial Mediterranean fever (FMF) 
(66). Pyrin had been shown to form an inflammasome complex with ASC and activate 
caspase-1 in in vitro reconstitution assays, but the biological relevance of this 
inflammasome had remained unknown for a while (65, 66). The physiological activation 
of pyrin inflammasome was only recently characterized in macrophages and DCs that 
occurred in response to bacterial toxins of Clostridium difficile Toxin B, of Clostridium 
botulinum C3 toxin as well as by effector proteins VopsS from Vibrio parahaemolyticus 
and IBpA from Histophilus somni (64). Intriguingly, pyrin is activated by pathogen-
mediated modifications of the host proteins, Rho GTPases. Rho glycosylation by C. 
difficile Toxin B, FIC-domain adenylylation by VopS and IbpA, ADP-ribosylation by C. 
botulinum C3 toxin, and deamination by Burkholderia cenocepacia act as ligands for 
pyrin and activate inflammasomes. Pertussis toxin also induces the pyrin inflammasome 
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through its ADP-ribosyltransferase activity (67). All of these inactivating modifications 
occur in the switch-I residue of RHOA proteins and inactivation of other members (e.g. 
RAC and CDC42) does not trigger pyrin inflammasomes. This indicates that pyrin may 
not directly interact with RHOA but senses a downstream event such as changes in 
cytoskeletal dynamics, since pyrin is known to interact with actin (68). Further, Wdr-/- 
mice that lacks a protein involved in actin depolymerization has been found to be 
susceptible to pyrin-dependent autoinflammation and thrombocytopenia (69). Taken 
together, the pyrin inflammasome represents a novel inflammatory pathway that detects 
pathogen-induced cellular changes to induce fitting immune responses. 
 
AIM2 and IFI16 inflammasomes     
  AIM2 detects cytosolic DNA derived from DNA viruses such as murine 
cytomegalovirus (MCMV) and Vaccinia Virus (VACV) as well as from cytosolic 
bacteria like Francisella tularensis and Listeria monocytogenes to induce an ASC-
caspase 1-dependent inflammasome that leads to IL-1β, IL-18 processing and cell death. 
IFI16, on the other hand, activates an ASC-dependent inflammasome in the nucleus in 
cells infected with KSHV. IFI16 also detects the RNA virus, HIV to initiate 
inflammasome activation. (Detailed descriptions of AIM2 and IFI16 in Sections 1.5 and 
1.6) 
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1.4.2 Caspase-11/Caspase-4/5 dependent non-canonical inflammasomes 
  The non-canonical inflammasome pathway involves the activation of 
mouse caspase 11 and the human caspases 4 and 5 in response to the Gram-negative 
bacterial endotoxin, LPS in the host cytoplasm (70-73). Unlike caspase 1, caspase 11, 4 
and 5 activation does not process IL-1β or IL18 (71) but initiates GSDMD-mediated 
pyroptotic cell death (30) and release of endogenous alarmin molecules such as HMGB-1 
in a caspase-1 independent manner (72). Activation of caspase-11 by intracellular LPS 
cleaves gasdermin D to release an active N-terminal fragment of gasdermin D that 
controls NLRP3-dependent activation of caspase-1 and cell death via pore formation in 
the plasma membrane that promotes pyroptosis. Again, in contrast, caspase 11 activation 
seems to progress independently of all known inflammasomes including NLRP3, NLRC4 
and NLRP6 (72).  
  In comparison to canonical inflammasomes, it was expected that a CARD-
containing upstream of caspase 11 should be responsible for intracellular LPS-mediated 
caspase 11-dependent inflammasome activation. However, interestingly, an alternative 
multiprotein complex assembly was proposed that suggests that caspase 11 (caspase 4/5 
in humans) itself may be acting as the direct receptor for cytosolic LPS. This conclusion 
was drawn from the observations that caspase 11 purifies from E. coli as an oligomer of 
higher order. Further, biochemical studies showed that caspase 11 bound directly to LPS 
through the positively-charged lysine residues in the caspase 11 CARD domain (73). 
Interestingly, this interaction was specific to caspase 11 as the closely related CARD 
domain of caspase 1 was unable to bind LPS (73). However, it still remains to be shown 
	 45	
whether there are other factors that facilitate the detection of cytosolic LPS, binding and 
subsequent activation of caspase 11. 
  Other studies have demonstrated the roles of TRIF and type-I IFN in 
causing pyroptosis and caspase 11- dependent caspase 1 activation in Gram-negative 
bacterial infections. Type-I IFN, via TLR3 and/or MAVS, induces caspase 11 expression 
through STAT1-IRF9 activation though it is partially upregulated by NF-κB as well. 
Furthermore, IFNα/β regulates caspase 11 pathway by inducing guanylate-binding 
proteins (GBPs) that are involved in host immunity and antimicrobial defenses (74, 75). 
The precise mechanism by which GBPs control caspase-11 remains unresolved. The 
GBPs are though to mediate optimal caspase 11 activation by disrupting the pathogen-
containing vacuoles that releases bacteria into the cytosol and thus activating caspase 11 
(74). Conversely, another study claims that instead of regulating the integrity of the 
bacteria-containing vacuole but the GBPs act downstream to activate caspase 11 (75).  
  Moreover, while it is known that caspase-11 synchronizes pyroptotic cell 
death and caspase 1 activation downstream of NLRP3 inflammasomes, the mechanism 
still remains unclear. While the assembly of NLRP3-ASC specks does not require 
caspase 11, caspase 11 does interact with caspase 1 during Gram-negative bacterial 
infections. However, the discovery that induction if caspase 11 by poly (I:C) (TLR3 
ligand) conferred Tlr4-/- mice susceptible to LPS-induced lethality indicates that caspase 
11 drives LPS- dependent endotoxemia (in contrast to TLR4 that only primes the cells in 
response to extracellular LPS) (70, 72). Thus, the host system has evolved with two 
distinct pathways that respond differentially to extracellular and intracellular Gram-
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negative bacteria. Together these findings establish the essential role of caspase 11 
dependent immune responses in controlling bacterial infections. 
  
1.4.3 Caspase-8 dependent non-canonical inflammasomes 
  Initially, the inflammasomes induction and processing of IL-1β was 
attributed solely to caspase 1 activity. However, recently it has come to light that there 
are alternative pathways, involving other caspases, which can process IL-1β release and 
regulate inflammatory responses. 
	 47	
  
Figure 1.4: Role of caspase 8 in fungal infection, cell death and regulation 
of inflammasomes. Caspase 8 activates IL-1β activation during fungal infections 
in dectin-1/Syk/MALT1/CARD9/Asc dependent manner. The dectin-1 complex 
also regulates pro-IL-1β gene expression. Signaling through CD95/Fas (e.g. LPS 
stimulation) or with TRAIL induces apoptosis by recruitment of FADD and 
caspase 8 homodimers, which is blocked by cFLIP-Caspase 8 heterodimers. 
Caspase 8 also controls the decision between apoptosis and necroptosis 
(through RIPK1, RIPK3 and MLKL) upon TNFα stimulation. Caspase 8 is also 
required for canonical and non-canonical NLRP3 inflammasome activation. 
Stimulation of TLR results in NF-κB activation and up-regulation of pro–IL-1β as 
well as NLRP3 mRNA that is partially dependent on caspase-8. Active caspase-8 
is required for activation of the canonical caspase 1 (e.g. LPS+ATP, 
LPS+nigericin) and non-canonical caspase 11 (e.g. C. rodentium, E. coli) 
inflammasome through assembly and activation of the NLRP3 complex. 
However, caspase 8 can also negatively regulate NLRP3 inflammasome 
activation in a RIPK1/RIPK3 dependent manner (not shown). 
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  Involvement of caspase 8 in cell death through mitochondrial apoptotic 
signaling is well characterized. Caspase 8 is expressed in its zymogen form that is 
activated by its autoactivation and proteolytic cleavage. Activation of death receptors 
(e.g. Fas, tumor necrosis factor receptor (TNFR) 1 and death receptor 3) promotes the 
association of the adapter protein Fas-associated death domain (FADD) with caspase 8. 
Activated caspase-8 propagates the apoptotic signal either by directly cleaving and 
activating downstream apoptotic caspases such caspase 3, or by cleaving the pro-
apoptotic proteins, BH3 Bcl2-interacting protein, which leads to the release of 
cytochrome c from mitochondria, that activates caspase-9, which promotes apoptosis.  
  Recent studies have shown that activated caspase 8 acts as a protease that 
can cleave IL-1β, independently or as a part of inflammasomes, at the Asp117 site, the 
same site that is targeted by caspase 1 but not by caspase 3, caspase 7, caspase 9 and 
catalytically inactive caspase 8 mutant (76-79). Caspase 8 is a critical protease that that 
activates pro-IL-1β during fungal pathogenesis such as Candida albicans and Aspergillus 
fumigatus infections (80).  The dectin-1 receptor signaling pathway is activated by fungal 
components such as β-glucans and induces a non-canonical inflammasome complex 
composed of Caspase recruitment domain-containing protein (CARD) 9, B-cell 
lymphoma/leukemia (BCL) 10 and Mucosa-associated lymphoid tissue lymphoma 
translocation protein (MALT) 1 that interact with ASC and caspase 8. The CARD9-
BCL10-MALT1 (CBM) complex activates the kinase, Syk that induces NF-κB-
dependent transcription of pro-IL-1β, through the phosphorylation and degradation of the 
IKK complex. The recruitment of ASC-caspase 8 to this complex activates caspase 8 that 
cleaves pro-IL-1β in a caspase 1 –independent manner. This mechanism of caspase 8-
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dependent IL-1β activation was is important during infections with Mycobacterium bovis 
and Mycobacterium leprae (80).  
Blocking or depletion of IAPs (inhibitors of apoptosis proteins) in 
macrophages resulted in LPS-induced IL-1β secretion that was dependent on both 
caspase 8 and caspase 1- NLRP3 inflammasome. Blocking of the IAPs, XIAP (X-linked 
IAP; also called BIRC4), cellular IAP (cIAP) 1 (also called BIRC2) and 2 (also called 
BIRC3), resulted in the release of receptor-interacting serine/threonine-protein kinase 
(RIPK) 3 that triggers the caspase 1 and/or caspase 8 dependent pathways (81, 82). 
Further, a later study confirmed that RIPK3 is required for LPS-induced caspase 1- or 
caspase 8-dependent secretion of IL-1β in dendritic cells. The caspase 8-containing pro-
IL-1β processing complex contains RIPK1, RIPK3 and FADD, and requires signaling 
through interaction with the C-terminal receptor-interacting protein homotypic interaction 
motif (RHIM) of TRIF (83).  
 Pro-apoptotic chemotherapeutic drugs (e.g. doxorubicin) that induce ER 
stress promotes caspase 8-TRIF dependent, caspase 1 independent secretion of IL-1β in 
LPS-primed macrophages or dendritic cells. It is hypothesized that the drugs dysregulate 
mitochondrial functions that induce the release of second mitochondrial-derived activator 
of caspases (SMAC), which inhibits IAPs, and thus averting IAP-mediated degradation 
of RIPK3 and inhibition of caspase 8-dependent processing of IL-1β (77, 84). 
  Another pathway employs TLR7-MyD88-primed FAS and FAS ligand 
(FASL; also called TNFSF6 and CD95L) interactions to drive caspase 8- and FADD- 
dependent release of IL-1β and IL-18, and is independent of RIPK3. 
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  Recent studies have implicated caspase 8 involvement in the activation of 
caspase 1 that leads to IL-1β maturation. Caspase 8 have been identified to co-localize 
with ASC or caspase 1 inflammasome specks in macrophages and DCs infected with S. 
typhimurium, F.novicida, C. rodentium and A. fumigatus. Recombinant caspase 8 has 
been shown to cleave and activate caspase 1 in vitro upon stimulation with LPS and ATP 
or infection with Yersinia pestis, Yersinia psuedotuberculosis, C. rodentium and A. 
fumigatus. Activation of caspase 1 by caspase 8 in Yersinia infection requires RIPK1 and 
FADD and partly dependent on RIPK3 and TRIF. This is in contrast to C. albicans 
infection where caspase 1 and caspase 8 regulate IL-1β maturation independently of each 
other. Also, a delayed pathway of caspase 8-dependent IL-1β release occurs in absence of 
caspase 1 upon prolonged stimulation with LPS or nigericin, or infection with S. 
typhimurium. Hence, the caspases 1 and 8 can act synergistically as well as independently 
dependent on the stimulations to activate canonical and non-canonical inflammasomes 
and further studies are required to tease apart the mechanics of this relationship. 
 
 
1.4.4 Regulation of Inflammasome Activation 
  The inflammasomes are tightly modulated by multiple mechanisms 
including transcriptional and post-transcriptional control, post-translational modifications 
and through other factors and pathways that regulate the expression of the inflammasome 
components like the receptors, the adapter ASC or the caspases as well as fine-tune the 
intensity and efficacy of inflammasome activation.  
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Regulation by Host Proteins Interactions 
Pyrin-containing regulators 
  A major class of inflammasome regulators includes proteins that contain 
only the pyrin domain. The PYD-only proteins (POPs) are found primarily in humans and 
higher primates but not in mouse. There are three POP proteins, POP1, POP2 and POP3 
that blocks the PYD-PYD interactions and subsequent inflammasome multimerization.  
  POP1 (also called PYDC1, ASC2) shares sequence similarity with the 
pyrin domain of ASC and its overexpression blocks IL-1β activation. It competitively 
binds to ASC, making the latter unavailable to bind NLRP3, thus dysregulating NLRP3-
mediated, canonical inflammasome activation. POP1 expression is induced by TLR-NF-
κB signaling, suggesting that it provides a regulatory feedback loop that may block 
further assembling of the inflammasome structure (85, 86). 
  Though POP2 is more similar to the pyrin domains of NLRP3, its mode of 
action is comparable to POP1. Recently Stehlik and group showed that POP2 inhibits 
inflammasome assembly by binding ASC and interfering with the recruitment of ASC to 
upstream sensors. Using transgenic mice expressing POP2, they showed that POP2 also 
reduces macrophage priming by inhibiting the activation of non-canonical kinase, IκBɛ, 
and IκBα and thus, protects the mice from excessive inflammation and acute septic shock 
(87). 
   The third pyrin-only protein gene, POP3 is present in the human PYHIN 
locus between PYHIN1 and IFI16, and is often considered as the fifth PYHIN protein in 
humans. Similar to the PYHINs, type-I IFN controls the expression of POP3 and shows 
sequence similarity with AIM2 and other PYHIN family members. POP3 interacts with 
	 52	
AIM2 and IFI16, and regulates DNA-induced cytokine responses. Knockdown of POP3 
expression in human macrophages resulted in increased AIM2 inflammasomes. Mouse 
macrophages expressing ectopic POP3 reduced AIM2-mediated inflammation during 
infections with the DNA virus, MCMV or modified vaccinia virus Ankara but did not 
alter NLRP1, NLRP3 or NLRC4 activation (88).  
  Interestingly, a murine IFN-inducible, PYHIN protein, p202 (also called 
ifi202) contains a single pyrin-domain and negatively regulates AIM2 activation. But 
instead of PYD-PYD interactions, it blocks AIM2 activation through DNA binding and 
interaction with AIM2 that prevents ASC clustering (89).   
 
CARD-containing regulators 
  Another class of proteins that modulate inflammasome signaling are the 
caspase recruitment domain or CARD-only proteins (COPs), whose modes of action are 
similar to that of the POPs. There are three COPs in humans, CARD16 (also called COP, 
PSEUDO-ICE), CARD17 (also called INCA) and CARD 18 (also called ICEBERG), all 
of which share high sequence homology with caspase 1. Evidence from biochemical 
interactions in overexpression systems suggests that they may negatively regulate caspase 
1 activity possibly by sequestration or blocking recruitment to ASC. Alternatively, a 
recent study showed that CARD16 could promote caspase 1 oligomerization to enhance 
activity. Other studies have shown that CARD16 and 18 can also interact with RIPK2 
indicating they may regulate other pathways as well. 
  A less-characterized caspase, caspase 12 has also been shown to regulate 
caspase 1 activity. Multiple polymorphisms are found in the CASP12 gene, which can 
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generate a full-length caspase (Caspase12L) or an inactive truncated form (Caspase12S). 
Caspase12L is found amongst populations of African descent that makes them 
hyporesponsive to LPS and protects from sepsis. Overexpression of caspase 12 in mouse 
negatively regulates caspase 1 activity. 
 
Post-translational modifications 
Phosphorylation  
  Modifications of the receptors and the adapter ASC by phosphorylation or 
ubiquitination regulate activity of the inflammasome. The phosphorylation of NLRC4 by 
protein kinase Cδ (PKCδ) was essential against Salmonella infections but not Shigella 
flexineri-induced responses in macrophages (90, 91). Dixit and group showed that a 
Serine residue (Ser533) in the helical domain 2 (HD2) of the NLRC4 NOD motif requires 
phosphorylation in unprimed macrophages to induce caspase 1 activation (90). 
Conversely, in primed cells, the need for phosphorylation is bypassed, with NLRP3 
expression that associates with NLRC4, independently of its Ser533 phosphorylation, to 
activate caspase 1 (91). Similarly, the dsRNA-dependent protein kinase (PKR or 
EIF1AK2) has been suggested to regulate the activities of NLRP3, NLRP1, NLRC4 and 
AIM2, though a role for PKR in the phosphorylation of these PRRs in inflammasome 
activation is yet to be elucidated (92, 93). Phosphorylation of the inflammasome adapter 
protein, ASC at multiple sites in its CARD domain by the kinases, Syk and JUN N-
terminal Kinase (JNK) are essential for caspase 1 activity.   
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Ubiquitination 
  Activation of NF-κB pathways that prime the immune cells is required for 
inflammasome activation. Priming has been known upregulate NLRP3 expression 
transcriptionally. In addition, it was demonstrated that it also enhanced NLRP3 
inflammasome signaling by eliciting the deubiquitination of NLRP3 by a Lys63-specific 
deubiquitinase, BRC33.  
  The multi-protein linear ubiquitin chain assembly complex (LUBAC) 
consists of three proteins, HOIL-1, HOIP and SHARPIN, of which HOIL-1 and 
SHARPIN are essential for TLR-dependent for NF-κB activation and inflammasome 
activation. LUBAC activates the inflammasome by directly interacting ASC, but not 
NLRP3 or AIM2, catalyzing its linear ubiquitination, through the E3 ligase activity of 
HOIL-1 and HOIP. However, SHARPIN inhibits inflammasome activation, likely 
through ubiquitination and degradation of the inflammasome. 
  K63-ubiquitination can provide either inhibitory or activating signal for 
the ASC-dependent inflammasomes. In macrophages, activation of autophagy results in 
decreased inflammasome activity with ASC displaying increased K63-linked 
ubiquitination and autophagosome recruitment in the NLRP3 or AIM2 inflammasome 
(described later in the section). In contrast, in response to viral RNAs or VSV infection, 
MAVS engages TRAF3, an E3 ligase and ASC. K63-linked ubiquitination of ASC, at 
Lys174, by TRAF3 was essential for inflammasome activation and IL-1β release, but also 
promoted autophagosome recruitment. Activation of the inflammasome and autophagy 
by the same signal provides a possible mechanism by which the host immune responses 
are self-limiting and controlled. 
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  Levels of IL-1β are also regulated by ubiquitination. TLR-induced pro-IL-
1β (Signal 1) that does not receive an inflammatory signal (Signal 2) is ubiquitinated and 
degraded at the proteasome. A high-risk strain of human papillomavirus (HPV16) uses an 
ubiquitin ligase E6-AP that promotes ubiquitination and proteasomal degradation of pro-
IL-1β and thereby evading host immune responses. 
 
Transcriptional and Post-transcriptional Regulation 
 Priming, through NF-κB activation, is the critical first step in the two-step 
activation process of inflammasomes. Priming (e.g. LPS-TLR4, Pam3-TLR2) constitutes 
the Signal 1 that induces a subset of proinflammatory genes including NLRP3, pro-IL-1β.  
Signal 2 (e.g. NLRP3 triggers such as K+ efflux, mitochondrial DNA or AIM2 triggers 
such as DNA viruses) are provided by the ligands that engage the receptors that activate 
the inflammasome formation, caspase 1 activity and IL-1β secretion.  
 Fungal PAMPs are recognized by several CLRs and TLRs that can prime 
cells (94). In addition to inducing caspase 1-independent, caspase 8-dependent IL-1β, 
dectin-1 signaling is also involved in fungus-induced priming for NLRP3 inflammasomes 
(95). As mentioned earlier, dectin-1 uses an immunoreceptor tyrosine-based activation 
motif (ITAM) to couple itself to Syk kinase for downstream signaling to NF-κB via the 
CBM scaffold resulting in cytokine production. Additionally, phagocytosis and reactive 
oxygen species (ROS) production result from dectin-1 engagement (96). Dectin-1-/- mice 
orally infected with C. albicans presented significantly reduced serum IL-1β levels (97). 
Similarly, mice lacking CARD9 as well as humans with mutations in dectin-1 and 
CARD9 show susceptibility to candidiasis and other fungal infections (97-101). The Syk 
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kinase-dependent NLRP3 priming also occurs in infections with Paracoccidioides 
brasiliensis (102), Cryptococcus neoformans (40) and Aspergillus fumigatus (41). 
Intriguingly, glucuronoxylomannan, the main capsule component of C. neoformans, 
inhibits Syk signaling and subsequently NLRP3 inflammasomes, which may assist in the 
infectivity of the fungus (40). Studies from our group showed that caspase-8, dectin-1 
and CR3 (another receptor capable of detecting β-glucan) are necessary for IL-1β 
processing by in dendritic cells infected with C. albicans (103). It also opened up new 
questions about C. albicans -induced, caspase 8 -dependent programmed cell death 
pathways (104). 
 Another pathway that has been implicated to enhance NLRP3 activation is 
the TAK1-JNK pathway, which is activated by lysosomal rupture (an NLRP3 trigger), 
and is essential for the priming of NLRP3-ASC pathway.  
 
Regulation by Autophagy 
  Autophagy is a cell-intrinsic, homeostatic process during which cellular 
components are recycled through the autophagosomes and lysosomes to benefit cell 
survival, and is triggered by starvation, damaged organelles and infection. Further, 
autophagy can regulate both cell death and inflammasome assembly, and depending on 
the conditions, can be either pro- or anti-apoptotic (105). Autophagy negatively regulates 
inflammasome activation and IL-1β release, such that mice that lack ATG16L1 
(autophagy-related protein 16-like 1), an essential component of the autophagy 
machinery, show increased caspase 1 activity and higher IL-1β, IL-18 levels in LPS-
treated macrophages (106). The mechanisms by which autophagy regulates the 
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inflammasome is not entirely elucidated. One theory suggests that autophagy removes 
ubiquitinated inflammasomes (107) or pro-IL-1β (108).  
  Induction of AIM2 or NLRP3 inflammasomes in macrophages triggers the 
activation of a Ras-like small G protein, RalB that promotes autophagosome formation, 
and was dependent on the presence of the inflammasome receptor, not ASC or caspase 1. 
In the assembled inflammasomes, ASC was Lys63 (K63)-linked polyubiquitinated that 
recruited the autophagic adaptor p62, which in turn delivered the inflammasome to the 
autophagosomes for degradation (107). Activation of autophagy with rapamycin, in 
macrophages, induces the degradation of TLR-induced pro-IL-1β in autophagosomes and 
blocked secretion of the mature IL-1β. Similarly, in vivo, treatment with rapamycin 
decreased levels of IL-1β in the serum upon LPS stimulation.  Inhibition of autophagy 
promoted the processing and secretion of IL-1β in an NLRP3- and TRIF-dependent 
manner and was dependent on ROS, but not NOX2 (108).  
  Another mechanism suggests that autophagy removes damaged 
mitochondria, which limits the availability of NLRP3 inflammasome triggers (109). 
ROS-generating mitochondria are constantly removed by mitophagy, a specialized 
process of autophagy. Treatment THP1 macrophages with a mitophagy inhibitor to, 
which, as expected, resulted in the accumulation of damaged mitochondria and increased 
concentrations of mitochondrial ROS that correlated with the dose-dependent secretion of 
IL-1β. Processing of proIL-1β caused by the blockade of mitophagy, that prevents the 
release of mitochondrial ROS and DNA into the cytoplasm, was NLRP3- and ASC-
dependent and not reliant on NLRC4. In contrast, caspase 1 activation in NLRP3 and 
AIM2 inflammasomes leads to blockade of mitophagy through multiple that allow 
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mitochondrial disassembly, ROS production, loss of membrane potential, to amplify 
mitochondrial damage, partly by the cleavage of a mitophagy regulator, Parkin. Hence, 
these studies show that inflammasomes and autophagy are tightly coordinated processes 
that control each other. The pathways are regulated at multiple steps to achieve an 
optimal level of inflammasome activation. 
 
Regulation through Crosstalk with Other Pathways  
Regulation by Interferons 
  Both type I (IFN-α/β) and type II (IFN-γ) are known to control 
inflammasome signaling. Type I IFN reduces the expression of pro-IL-1β and pro-IL-18 
as well as represses NLRP1b and NLRP3 inflammasomes in a STAT3- (through anti-
inflammatory cytokine, IL-10) and STAT1- dependent manners respectively. Similarly, 
type I IFN induction in vivo by poly (I:C) treatment reduces cell recruitment after 
injection with a NLRP3 activator, alum as well as increases susceptibility during C. 
albicans infection. In mycobacterium infection, T-cell derived IFN-γ was shown to 
inhibit NLRP3 inflammasome in vivo, through nitric oxide synthase that promotes 
nitrosylation and inactivation of NLRP3, and CD4+ T cell-derived IFN-γ suppresses IL-1 
in inflammatory monocytes. IL-1 production by macrophages and dendritic cells is also 
inhibited by type I IFN in infection with Mycobacterium tuberculosis. 
  Interferons can also activate inflammasome signaling. For example, AIM2 
activation during F. novicida needs STING-dependent production of type I IFN. As 
described before, the activation of caspase 11 in bacterial infections requires TLR4-
TRIF-IRF3 mediated IFN signaling. Both AIM2 and caspase 11 gene expressions are 
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stimulated by IFN signaling. Further, a family of IFN-iducible GTPases, GBPs 
upregulated by IFNAR-IRF1, control inflammasome activation. GBPs restrict the 
replication of intracellular pathogens and control antimicrobial processes such as 
oxidation, autophagy, to the destabilization of pathogen-containing vacuoles and direct 
killing of the pathogens. GBP2 and GBP5 were shown to be required for F. novicida-
dependent AIM2 activation and GBP2 is required for caspase 11 activation but not for 
inflammasome activation in response to poly (dA:dT) and LPS. In another study, GBPs 
were shown to enhance inflammasome signaling by promoting NLRP3–ASC 
oligomerization or by inducing pyroptosis.  
  Conversely, our group and others have observed that inflammasome 
activation can also dampen IFN responses. For example, AIM2 activation by DNA 
viruses or purified DNA ligands, such as poly (dA:dT) that activate the inflammasome 
represses the STING-dependent type-I IFN induction in response to DNA. Together, 
these observations begin to explain how different pathways, which are activated during 
infections or cellular stress, interact and how they may regulate each other, and the 
efficacy and intensity of immune responses. 
 
Regulation by Caspase 8, RIPK1/RIPK3 and Necroptosis 
 In addition to being able to form non-canonical inflammasomes dependent 
and independent of caspase 1, caspase 8 has multiple regulatory roles that can activate or 
inhibit the inflammasome as well as modulate signaling and priming of antigen-
presenting cells. Caspase 8 has been shown to be involved in modulating NF-κB 
signaling and production of pro-inflammatory cytokines in mouse macrophages and B 
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cells (78, 110-112). When mouse macrophages lacking both caspase 8 and the kinase, 
RIPK3 were infected with S. typhimurium, Citrobacter rodentium or E. coli or were 
stimulated with LPS (TLR agonist), Pam3CSK4 (a TLR2 agonist), muramyl dipepetide 
(MDP; a TLR2/4 agonist) or poly (I:C) (a TLR3 agonist), the macrophages failed to 
induce robust expression of pro-IL-1β, IL-6 and TNFα compared with wild-type 
macrophages or macrophages lacking RIPK3 alone. Further studies confirmed that the 
caspase 8 adapter, FADD (Fas-associated protein with death domain) is required for the 
NF-κB activation. It is known that the genomic deletions of Casp8 or Fadd confer 
embryonic lethality in mice, which is rescued by a parallel genomic deletion 
of Ripk3 (113-115). Hence, the macrophages deficient in caspase 8 or FADD also lack 
RIPK3. Conditional deletion of caspase 8 in B cells exhibit impaired phosphorylation and 
nuclear translocation of the NF-κB transcription factor, p65/RelA and concomitant 
decrease in expression of IL-6, TNFα, IFNβ and CXC-chemokine ligand 10 (CXCL10) in 
response to LPS stimulation. 
 The molecular mechanism by which caspase 8 mediates NF-κB signaling 
is unclear. One study found that full-length caspase 8 and its catalytic activity were 
crucial for driving NF-κB activities in humans (116), while another study in cancer 
patients showed that the DEDs of caspase 8 are sufficient (117). Additional studies have 
reported that the catalytic activity of caspase 8 is dispensable for NF-κB signaling (118). 
A two-pronged role for caspase 8 has also been proposed, where pro-caspase 8 
contributes to TNFR1-induced activation of NF-κB and the activated caspase 8 engages 
cleavage of NF-κB-inducing kinase (NIK; also called MAP3K14) to prevent the same 
(118)Caspase 8 also targets and cleaves the N-terminal fragment of c-FLIP (FLIP(L); 
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FLICE-like inhibitory protein), which generates a p43 fragment that forms a tripartite 
complex with TRAF2 and caspase 8 to activate the NF-κB signaling (119). Although the 
specific mechanism of caspase 8 involvement in NF-κB signalling is still unclear, it is 
evident that caspase 8 is critical for NF-κB-dependent priming and production of pro-
inflammatory cytokines. 
 In addition to its pro-inflammatory function, caspase 8 has anti-
inflammatory roles including inhibition of inflammasome activity. Caspase 8 deficient 
dendritic cells have increased inflammation that can be blocked by deletion of the TLR 
adaptor, MYD88, which suggests a role for caspase 8 in modulating TLR signaling (120). 
In skin, loss of caspase 8 expression promotes IL-1α secretion and the transcriptional 
activation of NF-κB-responsive genes during wound healing (121).	 Dendritic cells 
lacking caspase 8 can activate the NLRP3 inflammasome and release of IL-1β in 
response to LPS or Pam3CSK4 (a TLR2 agonist) alone, without the requirement of an 
inflammasome activator (122). This LPS-induced production of IL-1β in conditionally 
deleted DCs required RIPK1, RIPK3, the effector MLKL and the serine/threonine protein 
phosphatase, PGAM5 and hence could be blocked by genetic deletion of RIPK3 and 
necrostatin (an inhibitor of RIPK1). Further siRNA-mediated ablation of MLKL also 
rescued the Casp8-/- DCs. This suggests that LPS stimulation promotes an association of 
caspase 8 with FADD that inhibits RIPK1–RIPK3-MLKL complex and its downstream 
effector functions including the NLRP3 inflammasome activation (122). It has also been 
proposed that caspase 8 and FADD bind NLRP3 to directly inhibit the inflammasome 
(122).  
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Caspase 8 indirectly inhibits the inflammasomes is by its ability to prevent 
necroptosis. Necroptosis is an inflammatory and necrotic form of programmed cell death 
mediated by RIPK1 and RIPK3 independently of caspases (123, 124). Caspase 8 can bind 
and inhibit RIPK1-RIPK3-mediated inflammasome activation (122), as well as cleave 
RIPK1, RIPK3 and the deubiquitinating enzyme CYLD, which activates RIPK1 by 
removing its ubiquitin chains (125-127). Intestinal epithelial cells lacking caspase 8 
display spontaneous ileitis, loss of Paneth and goblet cells, elevated infiltration of 
granulocytes and CD4+ T cells into the lamina propria, and increased expression of 
inflammatory markers. Inhibition of RIPK1 and subsequently necroptosis, by necrostatin 
1 prevents spontaneous inflammation and TNF-induced lethality in mice epithelial cells 
lacking caspase 8 (128). Another study reported that caspase 8 prevents RIPK3-mediated 
necroptosis, death of enterocytes and immune cell infiltration of the colon (129). 
Similarly, mice intestinal epithelium lacking FADD are more susceptible to necrosis of 
epithelial cells, loss of Paneth cells and develop colitis, a phenotype that is rescued by 
deletion of RIPK3 (130). Further in-depth studies are required to discern the varied roles 
of caspase 8 as a regulator of inflammasomes. 
 
 
1.4.5 Effector functions of Inflammasomes  
  Beyond controlling infection in the host system, recent discoveries have 
revealed a range of effector functions of the inflammasome that include cell viability, 
induction of eicosanoids, phagosome maturation and roles in metabolism, aging and 
tumorigenesis. The inflammasomes have also been implicated in disorders such as 
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inflammatory bowel diseases, vitiligo, gouty arthritis, type 1 and type 2 diabetes (131-
137). 
  Eicosanoids are lipid molecules that include the prostaglandins, 
thromboxane and leukotrienes, and are derived from the membrane lipids. They are 
important for various homeostatic and pathological processes, such as leukocyte 
recruitment, increasing vascular permeability. The resultant active caspase 1 from 
inflammasome activation generates arachidonic acid that is converted to prostaglandins 
and thromboxane by the enzymes, cyclooxygenases. Macrophages also synthesize and 
secrete prostaglandins and leukotrienes upon inflammasome activation. This “eicosanoid 
storm” can also be activated by caspase 11. 
  As described earlier, autophagy is a mechanism of regulation for 
inflammasome activation but interestingly, the inflammasome itself has an inhibitory 
effect on autophagy. AIM2, NLRP3 and NLRC4 inflammasomes suppresses autophagy 
and autophagosome formation. Autophagy is pro-cell survival process versus 
inflammasome that is pro-cell death, the balance between the two processes decides the 
cell’s decision to survive or die. However, the NLRP6 inflammasome uses autophagy as 
a downstream effector mechanism to maintain intestinal homeostasis. Phagosome 
acidification and maturation are critical anti-microbial defenses that are dependent on the 
NLPR3 inflammasome. Acidification of phagosomes into lysosomes that carry Gram 
positive bacteria such as Staphylococcus aureus or Group B streptococcus require ROS 
production and accumulation of active caspase 1 on the phagosome double-membrane 
carrying the bacteria. Additionally, caspase 11 or caspases 4/5 promotes the fusion of 
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phagocytic vacuoles containing specific pathogenic bacteria such as Legionella 
pneumophila with lysosomes by manipulating the cytoskeletal assembly. 
  Exciting recent developments have linked inflammasomes to metabolism. 
While metabolism within the host system has been found to dictate the kind and intensity 
of inflammatory responses, many metabolic disorders (e.g. obesity, diabetes) are a result 
of deregulated, chronic inflammation. Recently, proteomic analyses revealed proteins in 
the glycolysis pathway (e.g. aldolase, triose-phosphate isomerase, glyceraldehyde-3-
phosphate hydrogenase, pyruvate kinase) as substrates of active caspase 1. Hence, the 
glycolytic rates are dampened in cells with active inflammasomes. Additionally, 
inflammasomes regulate lipid homeostasis as well. Caspase 1 activation by a pore-
forming, bacterial toxin called aerolysin activates the sterol regulatory element-binding 
proteins (SREBPs), that upregulate the expressions of cholesterol and fatty acid 
biosynthesis proteins. Caspase 1 is also involved in the metabolism of triglycerides, by 
enhancing its absorption in intestine, production in liver as well as clearance from blood 
during fasting conditions or uptake of excess lipid.  
   Inflammasome-independent functions of AIM2 include control of 
tumor progression in various tissues (described in detail in Section 1.6) while NLRP3 
regulates T-cell immunity. NLRP3 is expressed in differentiated T helper cells, but do not 
form inflammasomes and controls Th2 cell differentiation instead via IRF4-dependent 
Th2 cytokines induction. NLRP6 negatively regulates MAPK and NF-κB pathways in 
response to TLRs while NLRP12 blunts NF-κB and ERK activation, which is protective 
against colon inflammation and cancer. NLRP12 also functions as a negative regulator of 
cell migration in neutrophils, and blocks T cell-mediated IL-4 production. 
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  All these effector mechanisms possibly function together to mount a fast 
and effective innate immune response against an invading pathogen, and might 
manipulate the host immune system to function in a manner detrimental to the pathogen, 
and beneficial to the host while alerting the adaptive immune system to respond to the 
risks present.  
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1.5 Nucleic acids (NA) as triggers for immune responses 
Amongst the multiple PAMP or DAMP that the host immune system is 
equipped to identify, the appreciation for nucleic acids (NA) as a trigger for immune 
responses has escalated only in the last two decades. Foreign DNA or RNA as well as 
aberrantly expressed or differentially modified nucleic acids can elicit strong immune 
reactions within the host cells. Most receptors differentiate between the sugars, ribose and 
deoxyribose, that enable them to specifically recognize either RNA or DNA respectively. 
However, several sensors termed as Universal NA Sensors can recognize both RNA and 
DNA while there are other receptors that detect RNA:DNA hybrids which are often a by-
product of pathogen replication.  
 Introduction of nucleic acid into the host cytoplasm as well as in the nucleus via 
viral infection, viral and bacterial replication or transfection triggers multiple distinct, 
parallel and often redundant pathways that culminate in interferon production, 
inflammation, autophagy as well as cell death through pyroptosis, apoptosis or 
necroptosis. The currently known NA sensors include TLR3, TLR7/8, RIG-I/MDA5 (6, 
11, 138) and TLR9, cGAS, AIM2, IFI16 (8, 18-20) that can sense RNA and DNA 
respectively. Universal NA sensors include LRRFIP1, HMGBs, LSm14A and RNA:DNA 
hybrids trigger TLR9, NLRP3 and cGAS/STING pathways. 
 
1.5.1 RNA sensors 
The RNA immune receptors can recognize extracellular and intracellular, 
pathogen-derived single-stranded or double-stranded RNA. In order to avoid responding 
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to host cytosolic RNA, often these receptors distinguish foreign RNA by recognizing 
distinct modifications and specific lengths. 
 
RIG-I         
The RLR, RIG-I recognizes short blunt-ended, 5’-triphosphorylated (5’-ppp) dsRNA, or 
short hairpin, “panhandle” structured RNA found in negative-strand RNA viruses such as 
IAV, VSV, modifications that are absent in host mRNA (139, 140). Composition of the 
viral RNA ligand also play a role in RIG-I activation such as, poly (U/UC) motifs 
combined with a 5’-ppp, found in the genomic RNA of HCV. In addition to RNA viruses, 
RIG-I contribute to the detection of DNA viruses, such as Epstein-Barr virus (EBV), that 
detects 5’-ppp small RNA species generated through transcription of viral AT-rich DNA 
by RNA Polymerase III.  
 
MDA5        
MDA5 also identifies viral RNA, however, the distinct RNA ligands that activate MDA5 
signaling is largely unknown. It is widely considered that MDA5 detects long molecules 
of dsRNA, organized in web-like structures as found in the Picornaviridae and 
Caliciviridae virus families, other positive-sense RNA viruses as well as DNA viruses 
that transcribes long dsRNA. Further, MDA5 is activated by poly (I:C), a synthetic RNA 
that is equivalent to long dsRNA. Kato et al. recently showed that MDA5 can be 
activated by long dsRNA from reoviruses or by annealed sense and antisense strands of 
in vitro transcribed, synthetic RNA (141). Detection of RNA virus through its packaged, 
genomic RNA may occur upon its entry into the host cell. However, the receptors are 
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also activated by other RNA species, internalized with the virion as well as those 
produced during viral replication (e.g. SeV, IAV) during different times after infection.  
 
TLR3         
Endosomal TLR3 is a critical receptor that senses dsRNA, a common intermediate of 
viral replication but is also triggered by dsRNA of non-viral origin, especially 
endogenous mRNA and RNA released from necrotic cells. The TLR3 pathway can sense 
and potentially control infections by flaviviruses, hepatitis B and C viruses, herpesvirus, 
rotavirus, retroviruses, orthomyxoviruses and poxviruses as well as extracellular poly 
(I:C) that is internalized within endosomes (6).  
 
TLR7/8        
TLR7 and TLR8 also initiate immune responses to viral infection. Specifically, they 
recognize ssRNAs as their natural ligand as well as small synthetic molecules such as 
imidazoquinolines and nucleoside analogs. TLR7/8 senses GU-rich, ssRNA viral 
replication intermediates from SeV, IAV, Coxsackie B that are released the endosomes 
(142). 
 
1.5.2 DNA sensors 
Unlike RNA, changes in subcellular localization of DNA in cell, which is 
generally within organelles like nucleus, mitochondria or peroxisomes in a healthy cell, 
serves as an indicator of infection or cellular stress. DNA in the cytosol is associated with 
viral infection or tumorigenesis where the DNA acts either as PAMP or DAMP 
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respectively. Hence, when any DNA, pathogenic or host-derived, appears in the cytosol, 
it can trigger strong immune reactions in the form of type-I IFN production and/or 
inflammation. Any dsDNA longer than 25 bp with a phosphodiester backbone, present in 
the cytoplasm is capable of generating such immune responses. 
 
TLR9        
TLR9 was the first PRR discovered that initiates immune responses utilizes DNA as 
PAMP/DAMP. TLR9 senses single-stranded, unmethylated, CpG (deoxycytidylate-
phosphate-deoxyguanylate)-rich viral and bacterial DNA or oligodeoxynucleotides 
(ODN), containing the core sequence “GACGTT”. The CpG motifs are less frequent in 
the vertebrate genomes compared to bacterial or viral genomes. The CpG DNA with a 
sugar-phosphate backbone interacts with TLR9 in a sequence specific manner whereas, 
DNA with phosphorothioate backbone (where the sugars have a sulfur atom in the 
backbone instead of phosphorus) bind to TLR9 much less specifically, but show a CpG 
sequence-dependent activation. Thus, this difference between binding of two distinct 
ODN suggests that activation of TLR9 requires discrete conformational changes that are 
governed by the structure of the ODN (143). TLR9 is expressed in dendritic cells, 
macrophages, natural killer (NK) cells, and other antigen presenting cells. It is expressed 
within endosomes where it detects phagocytosed extracellular DNA as well as DNA 
released in the cytosol and taken up by the endosomes. Hence, it follows that TLR9-CpG-
DNA interaction occurs at the acidic pH (6.5–5.0) found in endosomes and lysosomes 
(143). TLR9 is critical for detection of multiple DNA viruses such as EBV, Human 
Papilloma Virus (HPV), Hepatitis B Virus (HBV), Herpes Simplex Virus (HSV) 1 and 2, 
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MCMV, Kaposi's sarcoma-associated herpesvirus (KSHV) and Murid herpesvirus 68 
(MHV-68). 
 
DAI/ZBP1        
After TLR9, DNA-dependent activator of IFN-regulatory factors (DAI; also known as 
ZBP1 or DLM-1) had been reported as an intracellular dsDNA sensor (144), but Zbp1-/- 
mice are capable of producing type I IFN after intracellular DNA stimulation (145), 
suggesting that the roles of DAI are either redundant or limited to specific cell types. 
Recently, DAI/ZBP1 was shown to respond to dsDNA virus by positively regulating 
programmed necrosis or necroptosis through its interaction with RIP3 during MCMV 
infection (146). 
 
cGAS and STING         
It had been known for a long time that pathogen-derived DNA could activate fibroblasts 
to produce type I IFNs (147). The existence of DNA sensors, other than TLR9, became 
apparent with the observations that transfection of pathogenic dsDNA could activate a 
thyroid cell line lacking TLR9 to induce multiple immune genes (148). Following the 
discovery of TLR9 as a sensor for CpG DNA, Akira and group showed that Tlr9-/- MEFs 
could still activate type-I IFN in response to synthetic B-form dsDNA or genomic DNA 
isolated from bacteria, viruses and mammalian cells. Further, Medzhitov and group 
showed that transfection of Immunostimulatory DNA (ISD), a 45bp dsDNA region from 
the Listeria monocytogenes genome to the cytosol induced type-I IFN in mice lacking 
both the TLR adapters, MyD88 and TRIF. The discovery of DNA-induced type-I IFN 
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pathway was propelled forward with the discovery of the adapter molecule STING 
(Stimulator of Interferon Genes). STING is the critical adapter required to induce type I 
IFN and NF-κB dependent inflammatory responses to cytosolic DNA. STING-/- mice 
have impaired cytokine responses and are susceptible to HSV-1 infection (149). 
Interestingly, STING deficient mice are also susceptible to VSV infection alluding to an 
involvement of STING in RNA virus pathogenesis, possibly through the sensing of host 
DNA released into damaged tissues (149). 
The C-terminal domain of STING directly recognizes bacterial cyclic-
dinucleotides (CDN) through its C-terminal domain resulting in its dimerization and 
activation of TBK1/IRF3 and NF-κB signaling. Bacteria often use CDNs as secondary 
messengers in intracellular signaling pathways. For example, cyclic-adenosine 
monophosphate (cAMP) and cyclic-guanine monophosphate (cGMP) from Vibrio 
cholerae stimulates type I IFN in a STING-dependent manner (150).  
Of all the cytosolic DNA receptors, so far, cGAS is the best-characterized DNA 
sensor with a clarified mechanism of STING activation and type-I IFN production. cGAS 
is an enzyme, identified in vertebrates, that catalyzes the production of endogenous 
cyclic-GMP-AMP (cGAMP) in a DNA-dependent manner. The secondary messenger 
cGAMP acts as a substrate for STING, which then activates the TBK1/IRF3-dependent 
IFNα/β pathway. cGAS belongs to the nucleotidyltransferase family of enzymes that 
catalyzes the conversion of mononucleotides into oligonucleotides and other higher order 
structures. cGAS directly binds to DNA using its N-terminal region, forms dimers that 
process 2’3’-cGAMP production from ATP and GTP, which is an intermediate capable 
of inducing STING-dependent IFN activation (151, 152). Structural studies have shown 
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direct binding of cGAMP to STING, stimulating its dimerization and activation (153, 
154). cGAMP also behaves as an intercellular signal that activates type-I IFN signaling in 
neighboring cells, by moving through cellular gap junctions (151). cGAS deficient 
macrophages, dendritic cells, and fibroblasts have completely abrogated type-I IFN 
responses to transfected DNA and DNA virus (155). Further, cGAS-/- mice were found to 
be susceptible to HSV-1 and VACV infections, and had higher viral loads during latent 
infection with MHV-68 (155, 156). 
 
DDX41        
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 (DDX41), a member of the DEAD/H 
helicases family identified from a siRNA screen, was characterized as a putative 
cytosolic DNA sensor (157). Knockdown of DDX41 in BMDC and THP-1 leads to an 
impaired IFN production in response to cytosolic DNA and HSV-1 infection (157). 
DDX41 also senses bacterial CDNs, cyclic di-AMP (cAMP) and cyclic di-GMP (cGMP) 
by directly binding through its DEAD catalytic domain, leading to STING-dependent 
activation of type I IFN (158). However, further elucidation of DDX41-dependent IFN 
signaling pathway in response to cytosolic DNA remains to be uncovered. 
 
DHX9/36        
DHX9 and DHX36 are DEAH RNA Helicase A helicases that bind CpG-B and CpG-A 
DNA respectively in plasmacytoid dendritic cells (pDC). DHX9 activates IRF-7 and 
IFNα production, while DHX36 activates IL-6 and TNFα through NF-κB pathway. RNAi 
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knockdown of DHX9 and DHX36 abrogated cytokine responses in HSV-1 infection, 
while responses to the IAV (an RNA virus) were unaltered (159). 
 
DNA-PK & Mre11       
Host DNA damage also induces type I interferon production. DNA-dependent protein 
kinase DNA-PK, a holoenzyme with three subunits: the catalytic subunit DNA-PKc and 
the DNA binding proteins Ku70 and Ku80, elicit IFN-β in response to DNA transfection, 
HSV-1 and co-localizes with sites of viral DNA replication in VACV infection in MEFs 
in an IRF3-dependent, NK-κB-independent manner. DNA-PK-deficient mice showed 
attenuated IFN response to VACV (160). Meiotic recombination 11 homolog A (Mre11), 
a double-strand break repair protein, along with its binding protein Rad50, is a cytosolic 
sensor for transfected dsDNA that induces IFN-β production in BMDCs. However, 
Mre11 was found to be dispensable for type-I IFN production in HSV-1 and Listeria 
monocytogenes infection in BMDC (161). The identification of DNA Damage Response 
(DDR) proteins as regulators of immune response to cytosolic DNA allude to 
interdependence of DNA damage and DDR with generation of DAMPs and DNA sensing 
pathways.  
  
RNA Polymerase III       
Cytosolic RNA Polymerase III (Pol III) uses transfected AT-rich DNA (poly dA:dT) in 
the cytoplasm as a template to generate short ssRNA transcripts, which are then 
recognized by RIG-I to activate type-I IFN (162). 
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AIM2 and IFI16     
The Aim2-like receptors or ALRs or the PYHIN proteins (e.g. AIM2, IFI16) have a 
conserved DNA sensing motif that make them good candidates for behaving as DNA 
receptors in immune sensing pathways. They are described in detail in the Section 1.6. 
 
1.5.3 Sensors for both RNA and DNA 
 Some less-studied pattern recognition receptors, also called universal NA sensors 
(e.g. LRRFIP1, HMGBs, LSm14A), have been implicated in triggering innate immune 
responses, which do not differentiate between the sugar backbones of nucleic acids and 
can identify both RNA and DNA with similar affinities. Hence, they often respond 
equally effectively to infections with bacteria, RNA or DNA viruses. 
 
LRRFIP1        
LRRFIP1 (Leucine-rich repeat flightless-interacting protein 1) has recently been 
implicated as a regulator of DNA-driven innate immune signaling. LRRFIP1 was found 
to bind to the Drosophila homolog flightless I and play a role in cytoskeletal 
development during Drosophila embrogenesis. An RNAi screen designed for discovering 
potential cytosolic DNA sensors showed that LRRFIP1 inhibited type-I IFN induction 
upon Listeria monocytogenes infection. LRRFIP1 knockdown also affected IFN 
production upon VSV infection as well as in response to poly (I:C), and the synthetic 
DNA species, poly (dG:dC) and poly (dA:dT), implicating LRRFIP1 as a sensor for 
dsRNA as well as both B and Z forms of dsDNA. Intriguingly, this function is 
independent of RNA Pol III. However, LRRFIP1 regulates type-I IFN activation through 
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a β-catenin-dependent co-activator pathway. Upon binding RNA or DNA, LRRFIP1 
mediates the phosphorylation of β-Catenin, which translocates to the nucleus and 
associates with the p300 acetyltransferase to induce increased IFNβ production (163). β-
catenin also activates IRF3 to do the same. Though, LRRFIP1 has been shown to act as a 
sensor in Listeria and VSV infections, further studies are required to delineate the role of 
LRRFIP1 as a nucleic acid immune receptor. 
 
HMGB1        
HMGB1 (High Mobility Group Box protein 1) is released from cells during necrosis and 
acts as a DAMP. It interacts with RAGE, TLR2 and TLR4 to induce inflammatory 
responses. HMGB1 binds both DNA and RNA to activate RIG-I and other NA sensors 
(164).  
 
LSm14A        
LSm14A is a component of RNA processing bodies (P-bodies). It has been shown to bind 
both DNA and RNA and induce type I interferon production through IRF3 and requires 
STING, MAVS, and RIG I respectively. This suggests that viral recognition may take 
place within P-bodies and LSm14A plays a role in antiviral activation through nucleic 
acid sensors (165). 
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1.5.4 Sensors for RNA:DNA hybrids 
Recent advances have classified RNA:DNA hybrids as a novel class of 
immunostimulatory molecules that behave as pathogen-associated or danger-associated 
ligands and can activate immune signaling pathways. Bacterial nucleic acids as well as 
retroviral replication intermediates form RNA:DNA hybrids in the infected host cell 
cytoplasm. In a healthy cell, the RNA:DNA hybrids are formed only within the nuclei 
and mitochondria as DNA replication intermediates (166) or transcription-induced R-
loops (166) or G-quadruplexes (167). Inhibitory studies showed that RNA Polymerase III 
generates cytosolic RNA:DNA hybrids within virus-free, human cancer cell lines, 
including transformed cell lines that may act as a danger signal for activating immune 
pathways (168). Endosomal TLR9 and cytosolic cGAS and NLRP3 have been implicated 
in detecting RNA:DNA hybrids in different contexts (45, 169, 170).  
 
TLR9         
Retroviral replication intermediates form RNA:DNA hybrids in both cytoplasm and 
endosomes of the infected host cells and can activate the endosomal receptor TLR9. 
TLR9 was shown to bind the hybrid molecules with high affinity and induced MyD88-
dependent pro-inflammatory cytokines and antiviral type I IFN in dendritic cells and 
human PBMCs (169). 
 
NLRP3        
Infection with an extracellular bacteria, enterohemorrhagic Escherichia coli (EHEC), 
generates bacterial RNA:DNA hybrids in the cytoplasm that was found to co-localize 
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with NLRP3 specks. Introduction of the hybrid molecules are sufficient to activate the 
NLRP3 inflammasome and this inflammatory response can be blocked by RNase H that 
degrades RNA:DNA hybrids (45).  
 
cGAS-STING        
cGAS knockout in THP-1 cells revealed that type-I IFN responses upon recognition of 
synthetic RNA:DNA hybrids of different lengths, produced enzymatically in vitro using 
transcribed RNA molecules (e.g. T7 RNA polymerase) as templates for reverse 
transcriptase, was found to be highly dependent on the cGAS–STING pathway. The in 
vitro studies showed that, similar to dsDNA recognition, a recombinant cGAS could 
produce cGAMP on detecting RNA:DNA hybrids (170).  
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1.6 Introduction to PYHIN proteins 
AIM2 and IFI16 belong to the same family of proteins called the PYHIN 
(Pyrin and HIN domain containing proteins) or IFI200 (Interferon-inducible with a 200 
amino acid repeat) proteins, classified by their defining structures, also known as ALR 
(Aim-2 like Receptors), following the discovery of AIM2 as an innate receptor that 
detects pathogen-derived DNA (171). 
The PYHIN genes are found in a cluster in many mammals within a syntenic 
region, situated between CADM3 (cell adhesion molecule 3) and a set of olfactory 
receptors and SPTA1 (spectrin alpha chain) genes. The human PYHIN genes, AIM2, 
IFI16, IFIX and MNDA are encoded on chromosome 1q23 (172, 173). There is a fifth 
gene, POP3 situated at the locus between IFIX and IFI16, which belongs to the Pyrin-
only Protein family (POP) (174). Comparatively, other mammals express variable 
number of PYHIN proteins. There are 13 PYHIN genes found on chromosome 1q band 
H3 in C57BL/6 mice within a locus flanked by the PYHIN genes, Aim2 and p205. 
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Figure 1.5: The PYHIN family of proteins in mice and humans. There 
are 13 PYHIN proteins in mice and 4 in humans. The pyrin (PYD) domains are 
indicated by pink boxes, and the HIN domain (in blue) subtypes (A, B or C) are 
denoted within boxes. 
MOUSE HUMAN
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The interferon-inducible PYHIN proteins are expressed in hematopoietic cells as 
well as in non-hematopoietic cells (e.g. skin epithelium). Spleen is a major site opf 
expression for most of the proteins. p204, p205 and p207 show the strongest expression 
in the skin, but are also expressed in heart and muscle (172). They are primarily nuclear 
proteins with defined nuclear localization signal (NLS) that may be monopartite, bipartite 
or both, although some PYHINs like Ifi204/p204 in mouse have a characterized nuclear 
export sequence as well that allows them to move in between the cytosol and nucleus. 
Some of the PYHIN proteins also undergo relocalization upon stimulation or 
overexpression with other proteins e.g. STING (173), upon heterodimerization with other 
PYHIN and/or by modification of their nuclear localization signals (e.g. acetylation of 
IFI16 causes relocalization to the cytoplasm). The exceptions are AIM2/Aim2 and 
Ifi202/p202 that lack an NLS and are almost exclusively localized in the cytoplasm, 
though Aim2 has recently been reported to sense DNA damage in the nucleus (175).  
The PYHIN proteins are characterized by the presence of a pyrin domain at the N-
terminal and one or two HIN200 domain at the C-terminal, flanking a variable 
intermediate spacer region. 
 
Pyrin/PAAD/DAPIN domain    
Pyrin domain (PYD), also known as the PAAD or DAPIN domain, is a 
member of the death domain (DD) family of proteins which is a 80 amino acids motif 
that consists of five α-helices, and can mediate homotypic interactions with other DD-
containing proteins.  It forms higher complexes that have been implicated in 
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inflammation, apoptosis and cell cycle. The only PYHIN proteins that do not contain a 
pyrin domain are the p202 variants, p202a and p202b. 
 
HIN200 domain     
The HIN (hematopoietic, interferon-inducible, nuclear) domain is a 
conserved 200 amino acid motif that consists of two-oligonucleotide/ oligosaccharide 
binding (OB) folds that form a β-barrel structure capable of binding NA, and are the 
characteristic DNA-binding domains found predominantly in the PYHIN proteins. The 
HIN200 (or HIN) domains are classified into three subtypes called HIN A, B or C 
depending on their consensus motifs. Structural analysis have shown that IFI16 HIN-A 
domain has a higher affinity to ssDNA that can wrap, stretch and form oligomers with 
ssDNA. In contrast, IFI16 HIN-B domain binds dsDNA with higher affinity but this 
binding was augmented by the presence of both HIN-A and HIN-B. Biochemical and 
structural studies using DNA-bound AIM2 revealed that in the absence of DNA, AIM2 is 
maintained in self-inhibited state, in a wrapped structure, where the region around the 
negatively charged α2- helix in the pyrin domain binds the DNA-binding interface of the 
HIN domain limiting the ability of the pyrin domain to initiate downstream signaling. 
Interestingly, work from Stetson’s lab using a transfected DNA-dependent cell death 
assay in AIM2 deficient THP-1 cells expressing individual chimeric PYHINs, showed 
that the proteins containing PYHIN1/IFIX HIN domain or MNDA HIN domain did not 
bind DNA to induce cell death. Additionally, both IFI16 HIN domains were required to 
bind dsDNA and induce cell death in this assay (176). 
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  The HIN domain has been implicated in protein-protein interactions and 
dimerization as well through a highly conserved motif MF/LHATVAT/S. The domain 
also contains a retinoblastoma (Rb)-binding site, LXCXE and putative Cyclin-dependent 
kinase (CDK)-2 phosphorylation sites (e.g. p204, p205, p203, p202, IFI16, MNDA) 
(177). 
 
Intermediate domain     
The intervening spacer regions, separating the two domains, that confer 
the maximum variability between proteins, are consistent in size and are rich in S/T/P 
residues. The NLS is located in this region, just after the pyrin domain and some PYHINs 
(e.g. p204, p205) have a common heptamer repeat sequence within the domain (177). 
 
Before the discovery of the role of PYHIN proteins in innate immunity, they were 
characterized as regulators of cell growth, differentiation and proliferation in apoptosis, 
tumor progression and DNA damage responses. Much of the functions of PYHIN 
proteins have been linked with cellular differentiation as many of the family members are 
upregulated to varying degrees at different stages of the process in multiple cell lineages. 
IFI16, PYHIN1/IFIX, p202, and p204 regulate cell cycle transcription factors such as 
p53, p21, pRb, and E2F resulting in cell cycle arrest (178). p202 acts as a transcriptional 
repressor targeting NF-κB (179), AP-1 (180, 181), MYOD1 (182), and myogenin (181, 
183). p204 also regulates gene expression during monocyte/macrophage differentiation 
and osteoblast differentiation. p205 acts as a putative tumor suppressor and controls 
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p21CIP/WAF gene expression via p53 in Saos2 cell lines as well as impacts gene expression 
in adipogenesis and osteogenesis via transcriptional mechanisms. 
  
1.6.1 PYHINs as Regulators of Immune Responses 
     
AIM2/Aim2     
AIM2 (also called PYHIN4) was identified during a functional screen for 
tumor suppressor genes in melanoma (100). Though not an NLR protein, AIM2 activates 
the inflammasome similar to the NLRs. The gene encodes an N-terminal pyrin domain 
and HIN200 domain, sub-type C. The pyrin domain of AIM2 interacts with the pyrin 
domain of ASC to recruit caspase 1 and form the inflammasome. 
  Activation of the AIM2 inflammasome is mediated by DNA binding to 
form the DNA:protein heteroduplex. Structural study shows that the positively charged 
HIN200 domain binds to the negatively charged sugar phosphate backbone of dsDNA, 
making contacts across the major and minor grooves, which makes AIM2 unable to form 
stable complexes with ssDNA (184). Like other DNA sensors, AIM2 does not 
discriminate between the origins of DNA, synthetic, mammalian, or microbial, but relies 
on the misexpression of DNA in the cytosol to initiate an immune response. AIM2 binds 
DNA independent of the sequence, but the dsDNA must be more than 80bp in length.  
  The DNA from invading intracellular bacteria which escape into the 
cytoplasm and the cytosolic DNA viruses activate the AIM2 inflammasome leading to 
the processing and secretion of IL-1β and IL-18. Francisella is a facultative intracellular 
pathogen that infects macrophages through phagosomes but escape into the cytosol to 
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replicate. Francisella novicida infection was known to induce IL-1β and IL-18 in an 
NLRP3- and NLRC4- indepedent ASC-dependent manner. Subcutaneous Francisella 
infection of Aim2-/- mice showed decreased IL-1β/IL-18 secretion and increased bacterial 
burden and mortality (185, 186). AIM2 is required for IL-1β production by macrophages 
and dendritic cells in response to infection with the intracellular bacterium Listeria 
monocytogenes, as well as the DNA viruses VACV and murine cytomegalovirus 
(MCMV) (171, 187). MCMV infection in Aim2-/- mice led to increased viral titers due to 
decreased NK cell activation, as a likely consequence of result of decreased IL-18R 
signaling (171). However, infection with attenuated MCMV severely dampens the AIM2 
inflammasome indicating that replication of the virus is required for AIM2 activation. In 
contrary to the hypothesis that AIM2 would respond to all DNA viruses, it was 
discovered that inflammasome activation during HSV-1 or MHV-68 infections is 
independent of AIM2, but require NLRP3, emphasizing the necessity of the cellular 
localization of the viral genomic DNA was critical in eliciting AIM2-dependent immune 
responses. In contrast, a recent study from Flavell and group observed that the Aim2-/- 
mice were protected against radiation-induced gastrointestinal as well as hematopoietic 
toxicity. They showed that AIM2 mediates the inflammasome-dependent death of 
intestinal epithelial cells and bone marrow cells in response to radiation-induced double-
strand DNA breaks caused by ionizing radiation and chemotherapeutic agents, and 
interestingly AIM2 detected the damaged DNA in the nucleus (175). 
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IFI16     
The human PYHIN family member, IFI16 contains one N-terminal Pyrin 
domain and two HIN200 domains (subtypes A and B) that can bind directly to dsDNA in 
a sequence-independent manner (183). IFI16 was first identified as a putative DNA 
sensor by its ability to pull down IFN-β-inducing VACV dsDNA motif in human 
monocytes cytosolic extracts (20). Knockdown of IFI16 in human THP-1 cells partly 
inhibited IRF3 activation and type-I IFN responses to transfected DNA and HSV-1 
infection (20). Similarly, another study observed that viral DNA intermediates from the 
RNA virus, HIV-1 as well as synthetic ssDNA corresponding to DNA formed during 
lentivirus replication cycle stimulates the IFI16-dependent STING-TBK-1-IRF3/7 
pathway, where IFI16 colocalizes with the lentivirus in the cytoplasm and is activated by 
stem regions in the single stranded DNA structure (188).  
  However, the role of IFI16 as a cytosolic DNA sensor has been 
controversial with debates about its necessity for type-I IFN production, which has been 
highly variable between studies. Recent studies from Stetson and group, using 
lentiCRISPR-mediated genetic disruption have demonstrated that cGAS-STING was the 
critical pathway for human cytomegalovirus (HCMV)-induced type-I IFN production in 
human primary and immortalized fibroblasts whereas IFI16 was dispensable for the same 
(176). However, work from other groups has established that IFI16 is a critical mediator 
that enhances the cGAS-cGAMP-STING axis of immune responses during infection 
(189-191). These studies used human fibroblasts, keratinocytes and macrophages to show 
that IFI16 is an essential component in type-I IFN induction, which co-operates with the 
cGAS-STING pathway during viral infections to enhance and control immune activation. 
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Orzalli et al., showed that nuclear cGAS interacted with and stabilized IFI16 in HSV-
infected human fibroblasts or human fibroblasts with transfected plasmid DNA, and 
IFI16 served as the primary sensor in the nucleus (189). Unterholzner and group used 
keratinocytes lacking IFI16 or cGAS to show that the sensors were not redundant in 
sensing exogenous DNA but that IFI16 interacted with cGAS in a DNA-dependent 
manner and was essential for the full activation of STING (190). Similarly, work from 
Jakobsen’s lab used CRISPR-Cas9 technology in human monocyte-derived macrophages, 
and phorbol myristate actetate (PMA) -treated THP1 cells, to show that IFI16 increased 
cGAMP production by enhancing cGAS activity, and is critical for downstream signaling 
by controlling the efficacy of STING dimerization, phosphorylation and recruitment of 
TBK1 to the STING complex (191). Additionally, our group also described IFI16 as a 
positive regulator involved in the transcription of critical ISGs in response to RNA virus 
infection (192).  
  Cell-specific, cellular distribution of IFI16 that varies between the nucleus 
and cytoplasm depending on cell types, determines the function of IFI16 as a pathogen 
sensor (193). IFI16 recognizes DNA from the nuclear-replicating herpesvirus, KSHV in 
infected endothelial cells, in the nucleus (21). It also sensed HSV-1 genomic DNA in 
infected human foreskin fibroblasts in the nucleus, and relocalized to the cytoplasm 
(194). These studies have also highlighted the role of IFI16 as an inflammasome 
activator. IFI16 co-localized with ASC and pro-caspase-1 in the KSHV-infected 
endothelial cells, first in the nucleus and then relocalized to the perinucleus. In the HSV-1 
infected human fibroblast, IFI16 recognized the virus in the nucleus, re-localized and co-
localized with ASC in the cytoplasm. Knockdown of IFI16 was found to block 
	 87	
processing of caspase-1 and IL-1β in response to KSHV and HSV-1, but not VACV 
infection (194). Additionally, cytosolic viral DNA derived from of incomplete HIV 
reverse transcripts, that lead to abortive HIV-infection of CD4+ T cells stimulates the 
IFI16 that triggers caspase-1-dependent pyroptosis (22). Conversely, other reports have 
shown IFI16 being unable to form inflammasome in other cell types indicating that 
further work is necessary to define the cellular contexts in which IFI16 activates the 
inflammasome (18). 
 
IFIX/PYHIN1      
The human PYHIN, IFIX (also called PYHIN1) was originally discovered 
as a tumor suppressor that promotes ubiquitination and subsequent degradation of pro-
survival proteins (195-197). IFIX contains the N-terminal pyrin domain and a C-terminal 
conserved HIN-A domain. Recently it was reported that IFIX detects herpesvirus DNA in 
both the nucleus and cytoplasm, binding foreign DNA via its HIN domain in a sequence-
independent manner, and leads to interferon responses (198). Further study from the 
group reported the IFIX had a dynamic localization during HSV-1 infection that changes 
from diffused nuclear and nucleoli distribution in uninfected cells to discrete nuclear 
puncta early in infected cells. Mass spectrometry showed that IFIX associated with 
multiple transcriptional regulatory proteins mediated by its HIN domain, to suppress viral 
transcription (199).  
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Ifi204/p204      
Though mice lack a clear homolog to IFI16, the mouse PYHIN p204 (also 
called Ifi204) is the closest in secondary structure to IFI16 and is considered its ortholog. 
Similar to IFI16, it contains a pyrin domain and two conserved HIN200 domains. 
Alongside IFI16, knockdown of p204 in mouse macrophages had partially inhibited 
IRF3, NF-κB and type-I IFN activation in response to DNA and HSV-1 infection (20). 
However, the p204 knockout mice showed no clear immune phenotype in response to 
DNA virus infection, possibly due to other IFN-activating pathways (e.g. cGAS) that 
protect the host in absence of p204.  
    
Ifi203/p203      
Using a murine leukemia virus (MLV) variant that induces a strong IFN-β 
response, and HIV, Ifi203 (along with DDX41 and cGAS) was identified as a sensor for 
the reverse transcribed DNA that required STING and TREX-1 to stimulate immune 
responses. In addition the group demostrated that the IFN-inducible cytidine deaminase, 
APOBEC3 (apolipoprotein B editing complex 3), which inhibits reverse transcription in 
the infectious retroviuses by introducing lethal mutations in the virus, restricting the viral 
load in vivo, serves as the primary defense. The cytosolic sensing is the secondary 
response and is critical for IFN-induction of anti-retroviral genes such as Apobec3 (200).  
   
Ifi205/p205      
The mouse PYHIN protein, p205 (also called Ifi205) is a nuclear protein 
with the characteristic pyrin domain and a conserved HIN domain subtype A. Aside from 
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the potential role of p205 as a tumor suppressor, it has been reported that Ifi205 also acts 
as a senor for cytosolic DNA. Ifi205 sensed cytosolic, self-DNA derived from 
endogenous retroelements in macrophages and activated cGAS and cGAMP-
independent, STING-dependent type-I IFN production. This pathway was blocked by 
AIM2 by sequestering cytosolic Ifi205 from STING (201). In this dissertation, I 
demonstrate that Ifi205/p205 acts as a nuclear co-transcriptional activator that controls 
the expression of immune genes such as ASC, and thereby regulates inflammasome 
activation in macrophages. 
 
    Several mechanisms have evolved within the host system 
that regulates the PYHIN proteins and the immune responses activated by them. As 
described previously in Section, POP3 and p202 limit the ability and activity of 
AIM2/Aim2 and/or IFI16 to form the inflammasomes through their Pyrin and HIN 
domains respectively. p202 has two HIN200 domains, the first of which sequesters 
cytosolic dsDNA available for initiating immune responses while the second HIN200 
domain is responsible for binding and inhibiting AIM2 resulting in the prevention of 
AIM2-ASC clustering. Another example of regulation within the PYHIN family is 
regulation of AIM2 by IFI16, where IFI16 can bind AIM2 and inhibit AIM2 mediated 
caspase-1 activation (202), by reducing the levels of AIM2 available for associating with 
ASC. Similar to NLRP3, AIM2, in a ligand-free environment, is found in an auto-
inhibited state, where the PYD is in association with the HIN domain. Only after binding 
of the HIN domain with dsDNA, the pyrin domain is freed and becomes available for 
binding with the ASC-pyrin domain (203). 
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1.6.2 PYHINs as Tumor Suppressors and in DNA Damage Response 
    The PYHIN proteins were initially characterized as a 
family of potential tumor suppressors. AIM2 or Absent in melanoma-2, as the name 
suggests was described as a protein that lost its expression in malignant, human 
melanoma cells (204). In addition to its function as a DNA sensor, AIM2 is also 
differentially expressed in multiple tumors, and is often down regulated in various 
cancers. AIM2 has been reported to inhibit fibroblast and breast cancer cell growth in 
vitro (205). AIM2 gene mutations have been found to correlate with gastric and 
endometrial cancers (206), and AIM2 gene expression can be silenced by DNA 
methylation in immortalized cells (207). Aim2 gene therapy in a mouse model of 
mammary tumor growth induced tumor cell death, and Aim2 expression greatly 
suppressed NF-κB transcriptional activity and was unresponsive to TNFα-mediated NF-
κB activation (205). 
  The AIM2 gene contains a site of microsatellite instability that results in 
gene inactivation in almost 50% of colorectal tumors (208). AIM2 deficiency has been 
correlated to poor prognosis in patients with colorectal cancer. One study showed that 
AIM2 is required to mediate protection against colorectal cancer, in an inflammasome-
independent mechanism. It suppressed tumor growth by blocking proliferation in 
enterocytes and expansion of the intestinal stem cell population. They also demonstrated 
that lack of Aim2 changed the composition of colon microbiota in mice, which favored 
tumor growth (209). Another study showed that in resting cells, AIM2 interacts with 
DNA-dependent protein kinase (DNA-PK), a phosphatidylinositol 3-kinase (PI3K)-
related family member that promotes protein kinase B (Akt) phosphorylation. AIM2 
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reduces Akt activation and controls tumor burden in colorectal cancer models, while 
Aim2-/- mice had increased tumor load, which was reduced by the use of an Akt inhibitor 
(210).	 A recent study rescued AIM2 expression in a colorectal cancer cell line and 
demonstrated that AIM2 inhibited increased apoptosis and blocked cell growth by 
inhibiting cell cycle transition from G1 to S phase of the cancer cells. Further analysis 
showed that AIM2 promoted apoptosis by suppressing the phosphatidylinositol 3-kinase 
(PI3K)/protein kinase B (Akt) pathway (211). Interestingly, all the studies agree that the 
mechanism, by which AIM2 suppresses tumor growth in colon cancer, is inflammasome-
independent.  
  DNA Damage Response (DDR)-induced signaling by DNA-damaging 
agents like ultraviolet light, ionizing radiations, or cancer chemotherapeutic agents, 
activates the ATM-p53 and ATM-IKKα/β-interferon (IFN)-β signaling pathways, leading 
to an induction of the p53 and IFN-inducible IFI16 gene. Further, upon DNA-damage, 
DNA accumulates in the cytoplasm, thereby inducing the IFI16 protein and STING-
dependent IFN-β production as well as activation of the inflammasome. Increased 
expression of IFI16 in cells also promotes p53-mediated transcriptional activation of 
genes, inhibition of cell cycle, cell growth and proliferation while fostering cellular 
senescence. IFI16 constitutively binds to BRCA1 breast cancer tumor suppressor and is 
involved in p53-mediated regulation of cell growth and apoptosis. Analyses of breast 
cancer cell lines and specimens revealed that decrease in the levels of IFI16 is closely 
associated with tumor progression. IFI16 deficiency induces levels of NBS1 (nijmegen 
breakage syndrome protein 1), which activates of DNA-PK (DNA-dependent kinase), 
phosphorylation of p53 and accumulation of p21WAF1. Hence, IFI16 negatively affects 
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p53-dependent transcription of p21 as well as p53 and p21 protein stability. Localization 
of IFI16 is determined by the status of BRCA1 protein under conditions of DNA damage, 
such as ionizing radiation. More recently, it has been shown that levels of IFI16 are 
increased by oxidative stress. Together, these results illustrate that IFI16 is involved in 
DNA damage signaling and responses in controlling tumor growth. 
  Initially, IFIX was discovered to function as a tumor suppressor. 
Expression of IFIX is diminished in breast tumor tissues and breast cancer cell lines like 
MCF-7 (195), and its overexpression suppressed the growth of breast cancer cell. IFIX 
negatively regulates HDM2 (a RING finger E3 ubiquitin ligase that degrades p53) by 
promoting its self-ubiquitination and degradation (196). IFIX exerts similar tumor 
suppressive activity by upregulating a metastasis suppressor called maspin (197). In both 
pathways involving HDM2 or maspin, IFIX is directly involved in ubiquitination 
reactions. 
  MNDA (myeloid nuclear differentiation antigen) is important for 
neutrophil apoptosis, where the nuclear MNDA is cleaved by caspases and relocated to 
the cytoplasm. A study reported that when healthy neutrophils are challenged with 
mediators of sepsis, apoptosis is induced, during which MNDA promotes proteasomal 
degradation of MCL-1 (myeloid cell leukemia-1), causing mitochondrial dysfunction that 
promotes the progression of apoptosis, and inflammation (212).  
  p205 localizes in the nucleus of hematopoietic and non-hematopoietic 
cells and acts as putative tumor suppressor by controlling p53-dependent expression of 
p21CIP/WAF in Saos2 cell line. p205 can block cell growth in a p53- and Rb- independent 
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manner, but it also induces the expression of Rb protein and can directly bind p53 and 
Rb.  
  These reports indicate that besides their roles in host defense and 
regulation of immune responses against invading pathogens, the PYHIN proteins play 
major role in tumor progression. The proteins may recognize the released or damaged 
self-DNA in the cytosol (due to damaged nuclear envelope) or nucleus, and co-ordinate 
multiple immune pathways to block tumor development and survival. 
 
1.6.3 Roles of PYHINs in health, infection and autoimmunity 
  Multiple pathogens have co-evolved with their host to combat the cytokine 
induction and early detection by the PYHIN proteins and have mechanisms for bypassing 
host immune signaling. HSV-1 presented the first example of a virus targeting a PYHIN 
protein. The HSV-1 immediate early protein ICP0 is known to be capable of inhibiting 
IFN-α/β signaling, however its mechanism of inhibition remained had been unclear. One 
of the mechanisms suggest that ICP0 target IFI16 for proteasomal degradation to evade 
immune responses (213). Further, Johnson et al., showed that ICP0 co-localized with 
IFI16 after infection with HSV-1, and likely targeted IFI16 for degradation by its 
phosphorylation. Additionally, HSV-1 infection induced the NLRP3 inflammasome 
along with IFI16, but it also blocked NLRP3 induced activation, at later time points, by 
immobilizing caspase-1 in actin clusters. Another study argued that though ICP0 impacts 
IFI16-related responses but that IFI16 may not necessarily be an ICP0 substrate (214). 
However, it agrees that HSV-1 infection leads to IFI16 degradation, which is a very 
effective in limiting prolonged viral detection. Recently, HSV-1 has also been shown to 
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target the PYHIN protein IFIX that co-localizes with nuclear proteasome post- infection 
and its pyrin domain is rapidly degraded in a proteasome-dependent manner. Unlike other 
host proteins targeted by HSV-1, degradation of IFIX is independent of ICP0, but 
requires immediate-early viral gene expression, suggesting a distinct viral host 
suppression mechanism (199). Human MNDA may also be targeted by viral proteins, 
such as Latency-associated nuclear antigen (LANA) from KSHV that co-localizes with 
MNDA, but the physiological relevance of the interaction are yet unknown (215). It is 
becoming more apparent that innate host sensors frequently utilize aggregation dependent 
amplification mechanisms for signal activation. Indeed, The HCMV protein, pUL83 also 
blocks IFI16 activation by interacting with its pyrin domain and blocking its 
oligomerization (216).  Li et al. demonstrated in a HCMV strain lacking pUL83, that 
IFI16 oligomerization is required for phosphorylation and nuclear translocation of IRF1 
and IRF3. But there was no change in caspase 1 activation. Surprisingly, the amino acids 
in the IFI16, which are required for oligomerization are not well-conserved in 
AIM2 (217), raising the possibility that during inflammasome activation AIM2 (and, may 
be IFI16 as well) oligomerizes differently or only through ASC recruitment, though 
overexpression of the pyrin domain of AIM2 results in filament formation (216). pUL83 
has also been reported to bind other nuclear PYHIN proteins, IFIX and MDNA, and can 
disrupt their ability to form nuclear oligomers (216).  
  The roles of PYHIN proteins in sensing DNA as well as regulating 
immune gene responses protect the host from from invading pathogens, but dysregulation 
of the PYHINs and their pathways can harm the host leading to diseases and autoimmune 
disorders. As describe before, differential expressions of the PYHIN proteins have been 
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reported in numerous diseases, from viral infections to cancer. However, it is not always 
clear whether the expression patterns are the cause or an effect of the disease in question, 
especially since the PYHINs inducible proteins. For example, PYHIN proteins have been 
reported to lie within a susceptibility locus for the autoimmune disease, systemic lupus 
erythematosus (SLE) (218) and the PYHIN1 locus has been identified as a novel 
susceptibility locus for asthma, especially for people of African descent (219).	Protective 
roles for AIM2 has been indicated in prostate diseases with increased levels of AIM2 
mRNA and protein in benign prostate hyperplasia and lower levels of AIM2 expression 
in prostate cancer epithelial cells. Genetic and epigenetic inactivation of AIM2 is 
prevalent in patients with mismatch repair-deficiency that is a major mechanism for 
colorectal tumorigenesis and sporadic colorectal cancers (220). Contrastingly, levels of 
AIM2 and inflammasome activity are enhanced in psoriatic lesions, a chronic 
autoimmune disease (221), possibly via sensing of self-DNA as well as in chronic 
vascular inflammation in abdominal aortic aneurysm (222). Increased levels of AIM2 and 
IFI16 have also been correlated to occurrence of oral squamous cell carcinoma, which 
inactivates the p53 system (223). Altered PYHIN1 and MNDA levels in a number of 
conditions have also been associated with diseases such as asthma, breast cancer, 
Lymphoma Myelodysplastic syndrome (MDS). Chronic autoimmune diseases such as 
SLE, systemic sclerosis, rheumatoid arthritis and Sjögren's syndrome have been reported 
to have anti-IFI16 autoantibodies (224-227). IFI16 re-localizes to the cytosol following 
UV treatment leading to DNA damage or upon viral DNA detection. It is hypothesized 
that IFI16 can also be released into the extracellular matrix that can bind to endothelial 
cells, propagating the stress signal and causing further damage. IFI16 acts as an immune 
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sensor for HIV and HIV patients often have elevated IFI16 mRNA levels, possibly due to 
chronic immune activation of IFI16. However, more insights into IFI16 activation, its 
subcellular localization in HIV patients will determine the detrimental or beneficiary role 
of elevated IFI16 levels in HIV patients.  
 Inflammasomes are critical immune regulators that help in maintaining a normal 
abundance of gut microbiota, an intact epithelial barrier and a continuous turnover of 
intestinal epithelial cells to prevent intestinal diseases such as inflammatory bowel 
diseases (IBD) and colorectal cancer. Increased expression of AIM2 in epithelial cells 
and IFI16 in both lymphocytes and epithelial cells was associated with increased 
inflammation in the mucosa of IBD patients, and anti-TNF treatments decreased 
expression of AIM2 and IFI16 in the patients (228). Further, another group reported 
intestinal epithelial cells are a primary source of IFI16 that is increased in the inflamed 
gut mucosa of IBD patients. IFI16 localized to both intestinal epithelial cells and lamina 
propria leukocytes, and was inducible by TNF, IL-1β and IL-33. However, as mentioned 
before, a controlled AIM2 expression is protective against colorectal cancer, and is 
critical for maintaining the proper gut microbiota that detects and clears harmful 
pathogens such as Listeria monocytogenes, Francisella tularensis and Aspergillus 
fumigatus and blocks the epithelial translocation of Salmonella typhimurium in the gut. 
 Further mechanistic studies with the PYHIN proteins are required in the 
pathogenesis of diseases, cancer and autoimmunity, to understand the contribution of 
these proteins in protection as well as in dysregulated host immune responses such that 
they may be considered as therapeutic targets or disease bio-markers. 
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Dissertation Objectives 
   
This dissertation has two major objectives:  
(1) To characterize the functions of the nuclear, murine PYHIN protein, p205/Ifi205 in 
innate immune responses, and its mechanism of action in regulating the pathways in 
macrophages, using a series of loss-of-function and gain-of-function approaches.  
(2) To determine the involvement of caspase 8-dependent inflammasome activation 
during Paracoccidiodes brasiliensis fungal infection ex vivo and in vivo using Caspase8-/- 
Rip3-/- mouse model. 
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Preface to Chapter II 
 
Most of the content of this chapter has been submitted for the following manuscripts/ 
publications: 
 
Sreya Ghosh, Christina Wallerath, Sergio Covarrubias, Veit Hornung, Susan Carpenter 
and Katherine A. Fitzgerald. The PYHIN protein p205 regulates the inflammasome by 
controlling Asc expression. Journal of Immunology, 2017 Sep 20; 199 (9): 3249–3260 
 
 
 
 
• The project was conceptualized by K.A.F., S.C. and S.G. 
• S.G. designed and performed the experiments. 
• C.W. and V.H. made the CRISPR/Cas9 knockout in B16 melanoma cell lines 
• S.G. and K.A.F. wrote the manuscript for publication.
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Chapter 2 
The PYHIN protein p205 controls innate immune responses by regulating the 
expression of the inflammasome adapter, Asc and other immune genes 
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Abstract 
 
Members of the interferon-inducible PYHIN protein family such as Absent in Melanoma-
2 and IFI16 bind double-stranded DNA (dsDNA) and form caspase-1 activating 
inflammasomes, important in immunity to cytosolic bacteria, DNA viruses or Human 
Immunodeficiency Virus. IFI16 has also been shown to regulate transcription of type I 
Interferons during Herpes Simplex Virus infection. The role of other members of the 
PYHIN protein family in the regulation of immune responses is much less clear. Here, we 
identified an immune regulatory function for a member of the murine PYHIN protein 
family, p205 (also called as Ifi205). Examination of immune gene expression in p205 
knockdown lines in bone marrow derived macrophages revealed that inflammasome 
responses to dsDNA as well as ligands that engage the NLRP3 inflammasome were 
severely compromised in these cells. Further analysis revealed that p205 knockdown cells 
showed reduced expression of Asc at the RNA and protein level. p205 knockdown 
resulted in reduced binding of actively transcribing RNA Polymerase II to the 
endogenous Asc gene resulting in decreased transcription and processing of Asc pre-
mRNA. Deletion of p205 in B16 melanoma cells using CRISPR/Cas9 showed similar 
loss of Asc expression. Ectopic expression of p205 induced expression of an Asc 
promoter-luciferase reporter gene and collaborated with other transcription factors such 
as c/EBPβ and p65/RelA to further enhance expression. Together these findings suggest 
that p205 controls expression of Asc mRNA to regulate inflammasome responses. These 
findings expand on our understanding of immune regulatory roles for the PYHIN protein 
family.
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Introduction 
 
 Foreign nucleic acids play a critical role in initiating innate and adaptive 
immune responses. Nucleic acid (NA) sensors expressed in distinct cellular 
compartments survey the extracellular and intracellular environment for signs of infection 
and initiate immune defenses against bacterial, viral and eukaryotic pathogens (229). NA 
sensors include RNA Sensors such as TLR3, 7/8 and RIG-I/MDA5 (6, 11, 138) as well as 
DNA sensors such as TLR9, AIM2, cGAS and IFI16 (8, 18-20). In addition, recognition 
of foreign nucleic acids especially dsDNA leads to assembly of an inflammasome, a large 
caspase-1 activating multiprotein complex that controls the proteolytic processing and 
release of IL-1β. Inflammasome activation also results in a proinflammatory form of cell 
death called pyroptosis. While most inflammasomes are composed of members of the 
NLR family, the dsDNA-activated inflammasome is formed following dsDNA binding to 
a PYHIN protein, Absent in Melanoma-2 (AIM2) (18). Work from several labs including 
our own has defined AIM2 as a cytosolic DNA binding innate immune receptor (18, 230-
232). AIM2 binds pathogen-derived dsDNA that accumulates in the cytosol during 
infection with DNA viruses or cytosolic bacterial pathogens (171, 185). In some 
instances, AIM2 can also recognize host dsDNA that gains access to the cytosol leading 
to autoinflammation (233). The related PYHIN protein IFI16 also forms an 
inflammasome during infection with Kaposi’s Sarcoma Herpes Virus (KSHV) and 
Human Immunodeficiency 1 (HIV1) (21, 22). 
 
 The PYHIN proteins were first characterized as a family of interferon 
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inducible proteins that are predominantly nuclear localized (183). PYHINs are 
constitutively expressed in different hematopoietic cell types, although most members of 
this family are also inducible by type I Interferon in non-hematopoietic cells (183). 
Phylogenetic analysis of the mammalian PYHIN proteins also called the AIM2-like 
receptors or ALRs show strong evolutionary and functional diversity (172). The murine 
PYHIN locus has undergone extensive gene duplication with more than 13 members 
encoded in the murine genome in contrast to the human gene family with 4 genes (172, 
173). PYHIN proteins have been implicated in a wide-range of cellular processes 
including transcription, tumor suppression, cell cycle, cell growth, differentiation and cell 
death(183).  The majority of the PYHIN proteins share the same structural domains. They 
contain an N-terminal α-helical domain known as the Pyrin domain capable of homotypic 
protein-protein interactions and one or more HIN200 domains. Most PYHIN proteins 
contain a nuclear localization signal in their N-terminus that can be either monopartite, 
bipartite or both. Some family members also contain a nuclear export sequence that 
enables them to shuttle between the nucleus and the cytosol. Aim2 is the most conserved 
family member. Unlike the other PYHINs, AIM2 is localized in the cytosol. Phylogenetic 
analysis indicates that, with the exception of AIM2, there is a complete lack of orthology 
among mammalian ALRs.  
 
 While the role of AIM2 and IFI16 in dsDNA recognition and immune activation 
has been well established, the role of other members of the PYHIN protein family, 
especially those in the mouse remains unclear. Recently, genetic studies in mice lacking 
the entire PYHIN locus and analysis of type I IFN induction following dsDNA treatment 
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in cells from these animals demonstrated no clear link to dsDNA recognition and 
induction of type I IFN in murine myeloid cells (176). It remains to be defined therefore 
whether the PYHINs have other immune regulatory functions. In this study we examined 
the contribution of the murine PYHIN protein p205 (also called p205) in innate 
immunity.  p205 is primarily expressed in macrophages and granulocytes (234). p205 
shares the highest homology with p204 and the human PYHIN protein, MNDA (235). 
p205 has been implicated in cell growth, and differentiation playing roles in 
hematopoiesis, adipogenesis and osteogenesis (236-238). To evaluate a possible immune 
function for p205, we investigated the ability of p205 to control immune gene expression. 
Using a series of loss of function and gain of function approaches combined with 
functional studies we demonstrate that p205 regulates transcription of important immune 
genes. In particular, we found a critical role for p205 in controlling expression of the 
inflammasome adapter molecule Asc. This effect of p205 was not related to the prior 
work linking AIM2 and IFI16 to sensing of foreign DNA. Rather we find that p205 
works in the nucleus to control Asc gene expression. These findings add to our 
understanding of PYHIN proteins in innate immunity, expanding their functions beyond 
dsDNA sensing to regulating innate immune responses through gene regulation.  
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Material and Methods  
 
Reagents and Plasmids:  
Lipopolysaccharide (LPS) and poly-dAdT (pdAdT) were obtained from Sigma-Aldrich 
and Immunostimulatory DNA oligonucleotides were synthesized as described (20). 
Nigericin and ATP were from Invivogen and Sigma respectively. Polyinosinic-
polycytidylic acid (poly I:C) was obtained from Invivogen. Sendai virus (Cantrell strain) 
was purchased from Charles River Laboratories (Wilmington, MA). Lipofectamine 
2000® Transfection Reagent was from Invitrogen. GeneJuice was from Novagen 
(Madison, WI). Universal type I IFN and IFN-γ were from PBL Interferon Source 
(Piscataway, NJ) and PeproTech (315-05), respectively. S. typhimurium (SL1344 lab 
strain) was from M. O'Riordan. The plasmids used were p65-pCMV4, c/EBPβ-pcDNA 
(Addgene), pGL3-enhancer luciferase reporter (Promega). Other plasmids such as Asc in 
pMSCVneo (Clontech), p205-HA in pRZ-retro, Aim2-FLAG, p204-HA, p205-HA in 
pEF-BOS or HA-tagged ΔHIN-p205, ΔPYD-p205 and ΔH/ΔP-p205 in pMSCV-PIG 
(Addgene) were made in the lab. 
 
Cell culture, Stimulations, ELISA and Cell death assays:  
Primary bone-marrow derived macrophages (BMDM) from C57BL/6J mice, cultured 
with L929 supernatant as a source for Macrophage Colony Stimulating Factor (MCSF), 
were transformed using CreJ2 virus to make immortalized BMDM (iBMDM). The cells 
were cultured in DMEM with 10% FCS and PenStrep. Antibiotics for selection were used 
as required. Cells were primed with repurified LPS at 100 ng/ml for 2-3h and stimulated 
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with Salmonella sp., Nigericin or ATP for 1h, pdAdT and Interferon Stimulatory DNA 
(ISD) for 6h, poly I:C and Sendai virus for overnight. Cells infected with Salmonella 
typhimurium and media containing gentamicin (100 µg/ml) was added to kill the 
extracellular bacteria. Supernatants from the stimulated cells were analyzed for the 
cytokines, IL-1β (eBiosciences) and IFN-β by ELISA. Cell death was measured by 
quantitating the amount of LDH, which is released into the supernatant upon cell lysis, 
using CytoTox96 Non Radio Cytotoxicity Assay (Promega) kit. 10% Triton-X was added 
to the cells as a representation of 100% cell death. 
 
shRNA mediated silencing:  
The shRNA sequences targeting p205 were cloned into a lentiviral pLKO.1 TRC cloning 
vector. Two separate shRNA sequences for p205 used either targeted the coding region 
(KD CDS) (Dharmacon TRCN0000095887 or TRCN0000095885) or the 3’ untranslated 
region (KD 3’UTR) (Dharmacon TRCN0000095884). HEK 293T cells were transfected 
with 4 µg shRNA along with 3 µg pSPAX (gag/pol) and 1 µg pMD2 (VSV-G) plasmids 
for production of lentiviral particles. Viral particles were collected at 48 h, filtered and 
added to immortalized BMDM. As controls, BMDM were transduced with either an 
empty pLKO.1 vector (EV) or pLKO.1 containing an shRNA sequence targeting GFP 
(GFP shRNA). The cells were selected for effective transduction by selection with 
puromycin (5 µg/ml). 
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qRT-PCR and Nanostring:  
RNA was extracted using Qiagen RNeasy Kit. cDNA was synthesized from 1 µg total 
RNA using either iScript cDNA synthesis kit  (Bio-Rad) or QuantiTect Reverse 
Transcription Kit (Qiagen). Quantitative RT-PCR was performed using iQ SYBR Green 
supermix (Bio-Rad) or QuantiNova SYBR Green PCR Kit (Qiagen). Primers were 
constructed to respective genes (Table 1). Target genes expressions are relative to 
housekeeping genes expression and were normalized to respective controls. The 
expression of a subset of genes including p205, p204, Mnda, Mndal and Aim2 were 
measured using nCounter (Nanostring). Briefly, endogenous RNA transcript counting 
was performed on total RNA hybridized to a custom gene expression CodeSet and 
analyzed on an nCounter Digital Analyzer (29). The counts were normalized to internal 
spike-in and endogenous controls per Nanostring Technologies’ specifications. The 
heatmaps were generated using the Morpheus software. 
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Table 1: qRT- PCR Primers for mRNA 
Gene Forward (5' à  3') Reverse (5' à  3') 
p205 GTATGAGTGAAGAAAAGACTGAC GGATATTGGTGACTGGCATG 
p205 AAGATCAAGGCATCTGGGAAAG CCTCTGGGAATGTTCTGGTTC 
p204 GACAACCAAGAGCAATACACCA ATCAGTTTGCCCAATCAGAAT 
Mnda TGTGAAGAACCCACAGCCAT TGATTTTTGGTTCTTAGCCGAAA 
Gapdh ATTGTCAGCAATGCATCCTG   ATGGACTGTGGTCATGAGCC 
Hprt TGAAGAGCTACTGTAATGATCAGTCAA AGCAAGCTTGCAACCTTAACCA 
Asc (3'UTR) CCAAACATGCACAAATCAGTC AAATGGGGAGCCAGGAATCA 
Asc int2-ex3 CACCCTTGCACAGCCTATCT CTCCGTCCACTTCTGTGACC 
Asc ex2/3-ex3 CAGCCAGAACAGGACACTTT CTCCGTCCACTTCTGTGACC 
Asc ex1-ex1/2 CTGCGAGAAGGCTATGGG CTCCAGACTCTTCTTTAGT 
Asc ex1-in1 CTGCGAGAAGGCTATGGG GAACAAGGGGACACACT 
IL-1α mature TCTCAGATTCACAACTGTTCGTG AGAAAATGAGGTCGGTCTCACTA 
IL1α int5-ex6  CACACACACACACACATCTGC GGGCTGGTCTTCTCCTTGAG 
IL1α int1 CGCTCTTCCCGTTTTGTAAG GTGGCCATGTGTGTGTCACT 
IL1α int2 TCCTCCTCCTCCTCCTTCTC GAACCTGATGGCCTCTCTCA 
IL-6 ex3-ex5 AACGATGATGCACTTGCAGA GAGCATTGGAAATTGGGGTA 
IL-6 ex2-ex2/3 GACTGATGCTGGTGACAACC TTGCACAACTCTTTTCTCAT 
IL-6 ex2-int2 AACGATGATGCACTTGCAGA TTGAAAGTAAACGTGACAAG 
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Western Blot and Co-immunoprecipitation:  
For detecting caspase-1 and IL-1β in the supernatants and lysates, 20% vol RIPA buffer 
and 30% vol SDS-loading dye were added directly to the wells containing cells and 
media. The samples were boiled at 100°C for 15’-30’ and were run on 13% 
polyacrylamide gels. Cytosolic and nuclear fractions for protein detection were prepared 
by using Active Motif Nuclear Extract Kit. Co-immunoprecipitation assays were carried 
out with 5x106 cells (treated or untreated) in ice-cold RIPA buffer (without SDS and 
DOC) using Protein A Dynabeads (Novex/Life Technologies, Cat#10001D) conjugated 
with specific antibodies, and immunoblotted for proteins of interest. Antibodies used 
were against Asc (Santa Cruz, Cat# sc-22514-R or Cell Signaling, Cat# 67824), IL-1β 
(R&D Systems, Cat# AF-401-NA), caspase-1 (Adipogen, Cat# AG-20B-0042), Aim2 
(eBioscience, 14-6008), Nlrp3 (Enzo Life Sciences), Histone 3 (Abcam, Cat# ab1791), 
c/EBPβ (Santa Cruz, Cat# sc-150), Usf2 (Santa Cruz, Cat# sc-862), Gapdh (Sigma, Cat# 
G9295), β-actin (Sigma, Cat# A3854) HA-tag (Anti-HA-Peroxidase; Roche, Cat# 12 013 
819 001), and FLAG-tag (Sigma, Cat# A8592).  An affinity purified polyclonal antibody 
against p205 was generated using the following peptide: AGLDRLINFCERVPTL-amide) 
was generated (21st Century Biochemicals). 
 
Confocal Microscopy:  
HEK 293T cells were transfected with p205 tagged with CFP and 24h post-transfection, 
the cells were washed with PBS and stained with Acridine Orange and/or Cholera toxin-
B (CtxB) (Thermofisher) and were visualized by confocal microscopy (Leica 8000) for 
localization. 
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Luciferase assays:  
The Asc gene promoter from -2000 +10 bp was cloned into pGL3-Enhancer reporter 
vector upstream of the firefly luciferase gene. The promoter-reporter construct was either 
transfected alone or co-transfected with plasmids expressing p205, p204, Aim2, p205 
deletion mutants, p65/RelA or c/EBPβ or a combination thereof in HEK 293T cells. A 
plasmid expressing Renilla luciferase gene under thymidine kinase (pGL4-TK Renilla) 
promoter was included as transfection efficiency control. Data is represented as fold 
change over Asc reporter construct alone, and relative to transfection efficiency. 
 
Chromatin Immunoprecipitation:  
Cells were crosslinked with 1% formaldehyde for 10 min with gentle shaking. The 
crosslinking reaction was stopped by 125mM Glycine solution for 10 min on shaker. The 
crosslinked cells were lysed in cell lysis buffer containing 1% SDS and sonicated for 10 
cycles (30s on, 30s off) using Bioruptor®300. The DNA was quantified, and 5 µg of total 
chromatin was immunoprecipitated with specific antibodies and Dynabeads Protein G 
(Novex/Life Technologies, Cat#10009D) overnight. The beads were washed with high 
and low salt buffers, and the crosslinked protein-DNA was eluted. The DNA was then 
reverse crosslinked, purified and quantitated by qPCR amplification with primers at Asc, 
Gapdh genes (Table 2). Antibodies used were against total RNA Polymerase II (RNAPII; 
Active Motif Cat# 39097), phospho Serine-2 RNA Polymerase II (Ser2 RNAPII; Abcam 
Cat# ab5095), phospho Serine-5 RNA Polymerase II (Ser5 RNAPII; Abcam Cat# 
ab5131) or IgG isotype (Abcam, Cat# AB37415 and Cell Signaling, 5415). 
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Table 2: Primers for Chromatin Immunoprecipitation 
Gene Forward (5' à  3') Reverse (5' à  3') 
Asc upstream TCAGCCTAGCCAAAAAGCCA GACTCCCCCACCCTCTTTTC 
Asc TSS 1 CACGAGATGCCATCCTGGAC CCCATAGCCTTCTCGCAGTT 
Asc TSS 2 CTGCAGATGGACGCCATAGA TGTGAGCTCCAAGCCATACG 
Asc downstream CACTCATTGCCAGGGTCACAG CCTGGAGGAGGGAGTCCTTG 
Gapdh TSS TGAAGGTCGGTGTGAACGG CAATCTCCACTTTGCCACTGC 
 
CRISPR/Cas9-mediated gene knockout:  
B16 mouse melanoma cells were cultured in DMEM containing 10% FBS, 0.5% 
Ciprofloxacin and 0.0075 % β-mercaptoethanol and transfected with 200 ng of plasmid 
containing mCherry-Cas9 and a U6 promoter-driven gRNA against p205 (Target 
Sequence: ATGAAGCCGAAGATGAGACCTGG) using Lipofectamine 2000® 
according to manufacturer’s protocol (239). Two days after transfection cells were sorted 
for mCherry expression. Positive cells were plated at limiting dilution to obtain single 
cell clones. Genotyping of the B16 clones was conducted by deep sequencing (Illumina, 
MiSeq) as previously described (240) using the following primer sequences: 5’-
ACACTCTTTCCCTACACGACGctcttccgatctCGTGAAGAAGATCAAGGCATCTG-
3’ and 5’-  
TGACTGGAGTTCAGACGTGTGctcttccgatctAAATCTCAGGGAGAAGTGGGGGA
-3’ (uppercase letters: 1st PCR adapter sequences, lowercase letters: linker sequences, 
uppercase letters: target site specific primer sequences). Cell clones harboring all-allelic 
frame shift mutations were then selected as p205 KO cell clones. 
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Statistics: 
ELISA and luciferase assays are presented as mean ± SD from three independent 
biological replicates and are representative of at least three separate experiments. Data 
was analyzed using two-way ANOVA by Prism 6 Software (GraphPad, San Diego, CA). 
The p values < 0.05 were considered significant (*p < 0.05, **p < 0.001, ***p < 0.005, 
****p < 0.0001) and n.s. = non-significant, unless otherwise indicated.
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Results 
 
p205 is highly inducible by LPS, type I and type II Interferons  
  The p205 gene is encoded on chromosome 1q, the last of the 13 
consecutive genes of the mouse PYHIN locus. p205 is encoded on the reverse strand and 
flanked by p202b at the 5’-end and several olfactory receptor genes as well as the Spta1 
gene at its 3’-end (Figure 2.1.A). p205 is expressed in murine primary bone marrow 
derived macrophages and treatment of these cells with type-I IFN, IFN-γ and LPS 
treatments further upregulated its expression, similar to other PYHIN genes such as 
Mnda and p204 (Figure 2.1B, C and D). The inducible expression of p205 was as robust 
as the well-characterized immune genes such as Il6 or Cxcl10 that are used as positive 
controls. 
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BA
Figure 2.1: p205 is highly induced by Type I and Type II Interferons, and LPS. 
(A) Schematic of the p205 mouse gene. Primary BMDMs stimulated with (B) Type-I IFN 
(100 U/ml), (C) IFN-γ (20 ng/ml) or (D) LPS (200 ng/ml), at different time points 
(0, 2, 4, 8, 16, 24 h) were tested for p205 mRNA expression as well as other PYHIN 
genes, Mnda, p204 and Aim2. Levels of IL-6 or Cxcl10 mRNA were included as positive 
controls. Gene expression is reported relative to a combination of three housekeeping 
genes- Gapdh, Hprt, β-actin.  
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Inducible and overexpressed p205 localizes primarily to the nucleus  
  The NLS Mapper prediction software projected p205 to have a 
monopartite signal, ‘PTLKKRAEIL’ (score >5) and two bipartite signals, 
‘TAQKRKGMSEEKTDVKKIKAS’, ‘FHLKRERGQPKLVCGDHSFVKVTKAGKKK’ 
(score >6) that predict the protein is preferentially nuclear. However, as Brunette et al 
showed previously, overexpressed p205 may change localization as with change in 
stimuli, such as STING overexpression (173). Hence, we tested p205 localization when 
overexpressed as well as upon induction. We looked at the levels of induced p205 protein 
in macrophages and tested for its subcellular localization. Treatment of primary BMDM 
with LPS, type-I IFN and IFN-γ increased p205 protein expression and it was mainly 
expressed in the nucleus (Figure 2.2A). Further, we stimulated primary BMDM with 
type-I IFN at different time points and separated the cell lysates into nuclear and 
cytosolic fractions, which were immunoblotted for endogenous p205. Upon IFN-
treatment, p205 expression was robustly increased over time in the nucleus (Figure 
2.2B). 
 Furthermore, immortalized macrophages transduced with the hemagglutinin (HA) 
tagged p205 were fractionated into nuclear and cytosolic extracts. Analysis of these 
fractions by Western blot showed that overexpressed p205 localized to the nucleus in the 
immortalized macrophages as well (Figure 2.2C). Similarly, we observed the 
localization of ectopically expressed p205 in HEK 293T cells by imaging a CFP-tagged 
p205 construct using confocal microscopy and p205 appeared to be predominantly in the 
nucleus (Figure 2.2D).  
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Figure 2.2: Inducible and overexpressed p205 primarily localizes to the nucleus.
(A) Primary BMDM untreated (Ctl) or treated with LPS for 6h, with type-I IFN for 16h 
or with IFN-γ for 16h were separated into nuclear and cytosolic fractions and 
immunoblotted for endogenous p205 (n.s.- non-specific band). (B) Western blot 
analysis of endogenous p205 expression in the nuclear and cytosolic extracts of 
primary macrophages treated with type-I IFN as indicated. Usf2 and Gapdh were 
used as controls for nuclear and cytosolic fractions respectively (n.s.- non-specific 
band). (C) Immunoblot analysis of the nuclear and cytoplasmic fractions of wild-type 
BMDM transduced with empty vector (EV) and wild-type BMDM overexpressing 
HA-tagged p205 using anti-HA antibody. Histone 3 and Aim2 were used as controls 
for nuclear and cytosolic extracts respectively. (E) Confocal microscopy of CFP-tagged 
p205 (green) in HEK 293T cells stained for nucleus using Acridine orange in first panel 
and Cholera Toxin B (CtxB) staining plasma membrane in second panel. Data is 
representative of two independent experiments. 
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Generating shRNA-mediated p205 knockdown in immortalized bone marrow 
derived mouse macrophages 
 Bone marrow derived macrophages or BMDM from C57BL/6 wild-type 
mice were transformed and immortalized by CreJ2 virus. Resting macrophages express 
modest levels of p205 that can be robustly induced upon stimulation with Interferon or 
LPS. The immortalized macrophages were stably transduced with pLKO.1 lentiviral 
particles either containing short-hairpin RNA (shRNA) targeting p205 (p205 KD) or GFP 
(GFP shRNA) or, with no shRNA sequence (EV Ctl). The shRNA to p205 either targeted 
the 3’ untranslated region (KD 3’UTR) (Figure 2.3A) and the coding region (KD CDS) 
(Figure 2.3B). After positive selection with puromycin for transduced cells, the levels of 
p205 were assessed by quantitative PCR (qPCR). The shRNAs targeting the coding 
region showed efficient knockdown of p205, with no effects on other closely related 
family members, p204 and Mnda. This effect was also evaluated using Nanostring where 
p205 mRNA was reduced with little impact on 4 other related PYHIN genes (p204, 
Mnda, Mndal and Aim2) (Figure 2.3C).  
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Figure 2.3: shRNA-mediated p205 knockdown in immortalized BMDM.
Immortalized BMDM transduced with shRNA targeting either (A) 3’UTR or (B) CDS 
of p205 gene were inspected for expression of p205, Mnda and p204 mRNA relative
to β-actin mRNA and normalized to expression in GFP shRNA BMDM. (C) Heatmap 
of PYHIN gene expression in p205 KD 3’UTR and KD CDS BMDM compared to 
control (Ctl) BMDM.  
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Knockdown of p205 in macrophages results in compromised inflammasome 
activation 
 In order to ascertain the potential immune functions of p205, the 
macrophages with reduced p205 expression were tested for their abilities to respond to 
various stimuli and launch effective cytokine expression. Following the involvement of 
other PYHIN proteins in the IFN-pathway, we first evaluated the induction of type-I IFN 
in these macrophages. The p205 knockdown and control BMDM were treated with LPS, 
poly dAdT (pdAdT), Interferon Stimulatory DNA (ISD), Sendai virus (SV) or poly I:C, 
all of which induces type I IFN, the levels of which were measured by ELISA. For most 
of these ligands the inducible expression of IFNβ was largely unaffected by the absence 
of p205 (Figure 2.4A). However, transfection with pdAdT, a dsDNA mimetic, showed a 
heightened IFNβ response in the macrophages lacking p205. Besides the IFN-pathway, 
PYHIN proteins such as AIM2 and IFI16 have also been implicated in the inflammasome 
pathway that produces IL-1β. Hence, the macrophages were treated with LPS (200 ng/ml) 
for two hours and stimulated with transfected pdAdT or ISD, or Nigericin that activate 
the Aim2 and Nlrp3 inflammasomes respectively. LPS behaves as Signal 1 that primes 
the cells via TLR signaling allowing transcriptional induction of several pro-
inflammatory genes such as pro-IL1β, while stimulation with DNA or Nigericin (a 
bacterial toxin from Streptomyces hygroscopius that forms pores in membranes) activates 
the inflammasome, which processes pro-IL1β into active IL-1β. Macrophages lacking 
p205 showed a much-diminished response to pdAdT stimulation indicative of an 
impaired Aim2 inflammasome but surprisingly, the cells were also unresponsive to 
Nigericin stimulation that induces the Nlrp3 inflammasome (Figure 2.4B). 
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Pro-forms of caspase 1 and IL-1β are unaffected in macrophages lacking p205 
  To discern whether p205 knockdown was affecting the priming (Signal 1) 
or the processing of pro-IL1β (Signal 2), the lysates and the supernatants from the 
stimulated macrophages were tested for both the inactive and proteolytically processed 
forms of both caspase-1 and IL-1β by Western blot (Figure 2.4C). Cells with reduced 
p205 lacked the active IL-1β, as expected; however, there was no difference in the 
transcription of pro-IL-1β upon LPS signaling ruling out an effect of p205 on TLR 
signaling. Moreover, even though no change was observed in the levels of quiescent 
caspase 1 in the p205 knockdown macrophages with the control cells, no cleaved, active 
form of the caspase 1 was being made. Taken together these observations implied that 
reduction in p205 affected inflammasome dependent activation of caspase-1 leading to 
reduced processing of pro-IL1β. 
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Figure 2.4: p205 knockdown in macrophages results in impaired inflammasome 
activation. The p205 knockdown BMDMs were primed with LPS (200ng/ml) for 3h 
and then stimulated with transfected pdAdT (1μg/ml for 6h), transfected ISD (3μM for 
6h), Nigericin (10μM for 1h), ATP (5μM) or, stimulated alone with Sendai virus (SV; 
overnight) or poly I:C (overnight). Secreted (A) IFNβ and (B) IL-1β levels were 
assessed by ELISA. (C) GFP shRNA CTL, p205 KD 3’UTR and KD CDS were primed
with LPS (200ng/ml) for 3h and then stimulated with pdAdT (1 μg/ml for 6h) or 
Nigericin (10 μM for 1h) and the supernatants and the lysates from the macrophages
were immunoblotted for pro-IL1β (35 kD), cleaved form of IL-1β (p17), pro-caspase 1 
(45kD) and the active subunit of caspase 1(p20).
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Reduced expression of p205 impacts Asc expression 
   For further mechanistic analysis of the lack of inflammasome activation in 
absence of p205, we inspected the levels of the receptors Nlrp3 and Aim2 as well as the 
inflammasome adapter Asc in LPS-stimulated macrophages. There was no difference in 
the levels of Nlrp3 or Aim2, however Asc protein expression was completely abrogated 
in the macrophages with reduced p205 expression (Figure 2.5A). We established the loss 
of p205 in the LPS-stimulated macrophages using a newly generated antibody against 
p205, and the macrophages with reduced p205 showed diminished Asc expression 
(Figure 2.5B). Further analysis showed that the Asc mRNA levels were also impacted in 
the macrophages lacking p205 (Figure 2.5C). We inspected the shRNA sequences and 
they showed no sequence similarity with the Asc mRNA, indicating that the decrease in 
Asc transcript levels was not due to an off-target effect of the shRNA. Collectively, these 
results show that p205 affects Asc mRNA expression. 
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Figure 2.5: Loss of p205 leads to a defect in Asc expression.
(A) Levels of Nlrp3, Aim2, Asc and β-actin proteins were elucidated by Western blot 
in LPS stimulated (200 ng/ml) GFP shRNA CTL, p205 KD 3’UTR and KD CDS 
macrophages. (B) Immunoblot of p205, Asc and β-actin proteins in LPS-stimulated 
(200 ng/ml for 6h) p205 knockdown macrophages. (C) Levels of p205 and Asc mRNA 
(relative to β-actin and normalized to GFP shRNA BMDM) were detected by qPCR 
in the same cell lines. 
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p205 controls inflammasome activation via its adapter molecule, Asc 
 The Asc cDNA was cloned into a retroviral vector, pMSCV, and viral 
particles were generated to transduce macrophages lacking p205 to rescue Asc 
expression. The transduced macrophages were selected with neomycin, and the levels of 
restored Asc were inspected by Western blot. Asc proteins levels in the p205 knockdown 
macrophages were stably restored comparable to the control cell lines (Figure 2.6A). 
Inflammasome activation and IL-1β production with were fully restored in these 
macrophages with renewed Asc expression, following LPS priming and pdAdT 
transfection or Nigercin treatment (Figure 2.6B).  
 Salmonella typhimurium also activates the inflammasome. When 
Salmonella is in its log phase of growth i.e. the bacteria are actively dividing they are 
recognized by Nlrc4, while when in their non-dividing or stationary growth phase, 
Salmonella is primarily recognized by Nlrp3. Unlike Nlrp3 or Aim2, Nlrc4 itself contains 
a CARD domain, and can directly recruit and activate pro-caspase 1 as well as engage 
Asc to do so. Hence, Nlrc4 activates the inflammasome in a manner that is only partially 
dependent on Asc. The p205 knockdown cells were challenged with Salmonella sp. either 
in their stationary phase or in log phase after LPS stimulation for one hour. In the 
stationary phase (overnight culture), Salmonella sp., which primarily activates Nlrp3 to 
trigger inflammasomes showed minimal IL-1β production by ELISA. But when the same 
cells were infected with the actively dividing Salmonella (4-6hr fresh culture), the 
macrophages retained part of their inflammasome activating capability that was again 
rescued to its full potential upon reconstitution with Asc (Figure 2.6C). The IFN-β 
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responses were largely unaffected by Asc reconstitution except upon pdAdT transfection 
where p205 knockdown enhanced IFN-β production (Figure 2.6D). 
 Furthermore, stimulation with LPS and subsequent pdAdT transfection in 
the p205 knockdown macrophages reconstituted with Asc showed renewed processing of 
caspase 1 and IL-1β into their active, cleaved forms signifying a functional 
inflammasome (Figure 2.6E and F). Taken together, these findings attribute the loss of 
inflammasome responses in p205-knockdown cells directly to p205-dependent effects on 
Asc expression. 
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Figure 2.6: p205 controls inflammasome activation through its adapter
molecule, Asc. (A) Western blot analysis of Asc overexpression in the p205 
knockdown BMDM either left untreated or treated with LPS treated (200 ng/ml for 3h). 
Asc reconstituted cell lines tested for IL-1β production (B) on stimulation with LPS 
(200 ng/ml for 3h) and pdAdT (1 μg/ml for 6h) or ATP (5 μM for 1h) and (C) with 
overnight culture (stationary phase) or log phase culture of Salmonella typhimurium 
by ELISA (D) IFN-β levels were tested by ELISA in the Asc-reconstituted macrophages 
stimulated with LPS (200ng/ml for 3h), transfected pdAdT (1 μg/ml for 6h) or ISD 
(3μM for 6h), or Sendai virus (overnight) (E) Levels of caspase 1 and IL-1β processing 
in the Asc reconstituted cells were detected by Western Blot and (F) cell death was 
measured by amounts of LDH released with LPS (200 ng/ml for 3h) and pdAdT 
(1 μg, 2 μg, or 3 μg per ml for 6h) and/or ATP (5 μM for 1h) stimulation.
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Restoring p205 expression rescues Asc expression and inflammasome activation 
 We next strived to restore the expression of p205 in the knockdown cells. 
p205 cDNA with a hemagglutinin (HA) tag at the C-terminal was cloned into pRZ 
retroviral vector. Viral particles were generated and stably transduced into p205 
knockdown macrophages containing shRNA targeting the 3’UTR of p205 transcripts.  
The transduced cells were selected with zeocin (200 ng/ml). The p205 gene expression 
was first measured by qPCR (Figure 2.7A). Reconstitution of p205 restored Asc mRNA 
expression in these knockdown cell lines (Figure 2.7B). p205 protein expression was 
detected using an anti-HA antibody. Cell lysates from GFP shRNA, p205 KD 3’UTR cell 
lines along with the p205 KD 3’UTR cell line reconstituted with p205-HA were 
separated into nuclear and cytoplasmic fractions. The reconstituted HA-tagged p205 was 
found to be primarily nuclear. Level of Asc protein in both nucleus and cytoplasm was 
increased in cells expressing p205-HA (Figure 2.7C). Analysis of IL-1β release by 
ELISA in these macrophages expressing p205-HA further demonstrated that 
reconstitution of p205 restored inflammasome dependent responses (Figure 2.7E and F). 
Collectively these findings provide further evidence that p205 behaves as a regulator 
controlling Asc expression and inflammasome responses.  
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p205 overexpression enhances Asc expression in macrophages but the reverse is not 
true 
 The HA-tagged p205 was ectopically expressed in the wild type 
immortalized BMDM (Figure 2.8A) resulted in the increase of Asc mRNA levels 
compared to that found in the control cell lines (Figure 2.8B). However, the ectopic 
overexpression of Asc in the p205 knockdown macrophages had no obvious effect on the 
reduced p205 transcript levels. Furthermore, stable overexpression of p205-HA in wild 
type macrophages showed a concomitant increase of Asc mRNA (Figure 2.8C). 
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Knockdown of p205 protects the macrophages from pyroptotic cell death 
 Activation of inflammasome also leads to an inflammatory cell death 
called pyroptosis that can be monitored by measuring the amount of lactate 
dehydrogenase enzyme (LDH) released. Transfection of pdAdT and stimulation with 
ATP in macrophages leads to Aim2 and Nlrp3 inflammasome dependent release of LDH 
respectively. Consistent with the other effects on inflammasome function, the release of 
LDH, hence, cell death was also significantly affected in macrophages lacking p205. 
Restoration of Asc in the p205 knockdown cell lines rendered these cells susceptible to 
more cell death compared to the levels seen in the control cell line (Figure 2.6F).  
Similarly, more cell death was observed upon reconstitution with p205 in the knockdown 
cells stimulated with LPS and transfected pdAdT or ATP (Figure 2.7F). Hence, loss of 
p205 diminishes the inflammatory responses and protects from inflammasome-dependent 
pyroptotic cell death.  
 
Loss of p205 in macrophages results in reduced recruitment of actively transcribing 
RNA Polymerase II to the endogenous Asc gene 
 The reduced mRNA levels of Asc in cells lacking p205 could be due to 
either effects on Asc gene transcription or Asc mRNA stability. To further explore how 
p205 affected Asc mRNA levels we performed chromatin immunoprecipitation assays to 
explore the binding of RNA Polymerase II (RNA Pol II) to the endogenous Asc promoter, 
as a marker for active transcription, in both the GFP shRNA and p205 KD BMDM. 
Figure 2.9A shows a schematic of the Asc gene locus and the location of the primers 
used to evaluate RNA Pol II binding. Using antibodies to RNA Pol II and an isotype 
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control, IgG we evaluated binding of RNA Pol II to the endogenous Asc gene. RNA Pol 
II binding was considerably lower in the p205 KD cell lines using a series of primers as 
indicated (Figure 2.9B).  
 We further analyzed the functional status of RNA Pol II using antibodies 
to RNA Pol II phosphorylated either at position Serine 5 (Serine-5P RNA Pol II) or at 
Serine 2 (Serine-2P RNA Pol II) in its C-terminal domain.  The RNA Pol II carboxy-
terminal domain (called CTD or CT7n) is responsible for controlling the transcriptional 
activity of the polymerase. The CTD contains multiple repeats of a heptapeptide 
sequence, YSPTSPS (e.g. 26 in yeast, 44 in Drosophila melanogaster and 52 in 
mammals) rich in hydroxyl groups that are differentially phosphorylated and essential for 
its function. When preferentially phosphorylated at Serine 5 alone, there is only abortive 
transcription where the RNA Pol II can initiate, but not elongate further or process 
functional mRNA. The change from an initiating to an actively elongating or transcribing 
RNA Pol II occurs with the increased phosphorylation of the Serine 2 residue on the CTD 
repeats. Consistent with the findings with antibodies to total RNA Pol II, both Serine-5P 
RNA Pol II (Figure 2.9C) and Serine-2P RNA Pol II (Figure 2.9D) distributions on the 
Asc gene were considerably lower in the p205-shRNA cells compared to the GFP shRNA 
BMDM.  
 As controls, the recruitment of total RNA Pol II, Serine-5P RNA Pol II 
and Serine-2P RNA Pol II to the housekeeping gene, Gapdh, was measured and the 
occupancy levels were unchanged between the GFP shRNA and p205 KD macrophages 
(Figure 2.9E).  
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p205 knockdown impacts transcription as well as the mRNA processing of Asc 
mRNA 
 However, the decreased occupancy of RNA Pol II at the endogenous Asc 
locus in the p205 KD macrophages was less severely affected than what the Asc mRNA 
levels suggested. Compared to the near ablation of Asc mRNA expression observed in 
the absence of p205, there was still some RNA Pol II being recruited to the Asc gene. 
Recent studies have shown that RNA Pol II is also a major player in successful mRNA 
processing and splicing. Serine-2 phosphorylated RNA Pol II is responsible for mRNA 
elongation, recruitment of spliceosome and mRNA processing. Transcription and splicing 
are dependent on each other- a phenomenon termed co-transcriptional splicing. Hence, to 
understand if p205 was regulating transcription as well as mRNA processing of the Asc 
transcript, we measured the levels of Asc pre-mRNA as well as that of the processed and 
mature mRNA in macrophages with or without p205 (Figure 2.10). By designing primers 
that specifically measure either pre-mRNA or mature mRNA (Table), we observed that 
though there was some leaky transcription going on in the BMDM lacking p205, there 
was minimal processing of the Asc pre-mRNA into its mature form. We also tested for 
the GAPDH pre-mRNA and mature mRNA status and observed no difference between 
the knockdown and control macrophages. Thus, we inferred that p205 controls Asc 
expression both at the level of gene transcription as well as processing of mRNA. 
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Figure 2.10: Knockdown of p205 affects transcription and processing of Asc 
mRNA. qRT-PCR analysis of p205, nascent or mature Asc mRNA expression (relative
to the housekeeping genes, Hprt and Gapdh, and normalized to EV CTL BMDM) in 
p205 knockdown macrophages.
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CRISPR/Cas9-mediated knockout of p205 affects Asc expression 
  In addition to shRNA–based loss-of-function approach, we strived to 
define the influence of p205 on Asc gene expression using an independent strategy and in 
a different cell-type that expresses p205. We carried out CRISPR/Cas9 mediated 
knockout of p205 in B16 melanoma cell line derived from C57BL/6 mice. Plasmids 
expressing Cas9 and the sgRNA targeting specific regions of p205 were transfected into 
B16 melanoma cells to generate p205 knockout (p205 KO) cells. A clone of these cells 
was produced and evaluated for p205 deficiency using sequencing, qPCR and Western 
blot, and similar clone without p205 knockout was used as a control (p205 WT). No 
induction of p205 mRNA was observed in p205 KO after overnight stimulation with 
IFN-γ compared to the WT (Figure 2.11A). Additionally, unlike the WT cells, there was 
no detectable p205 protein expression in the KO cells when stimulated with Sendai virus 
(Figure 2.11B).  
 We tested these p205 KO cell lines for Asc expression and found that the 
B16 melanoma lines lacking p205 had a similar loss of mature Asc mRNA (Figure 
2.11C) and protein (Figure 2.11D). These observations further support our shRNA-based 
studies and emphasize upon the importance of p205 as a regulator of Asc gene 
expression. 
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A
Figure 2.11: CRIPSR/Cas9-mediated knockout of p205 affects Asc expression.
(A) Expression of p205 mRNA in IFNγ-stimulated wild type (WT) and p205 knockout (KO) 
B16 melanoma cell lines relative to Hprt and normalized to non-treated (NT). (B) p205 and 
β-actin protein expression in WT and p205 KO cell lines stimulated with Sendai virus (n.s.- 
non-specific band) (C) Mature mRNA and pre-mRNA profile of Asc expression (relative to 
Hprt and normalized to WT) and (D) Western blot analysis of Asc and β-actin in WT and 
p205 KO B16 melanoma cell lines.
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p205 drives expression from an Asc gene-luciferase reporter in a dose-dependent 
manner 
  To understand the mechanisms involved in the transcription of Asc, we 
cloned the Asc promoter region (-2000 to +10 Asc gene) as a reporter gene upstream of a 
firefly luciferase gene. This Asc gene-reporter construct was transfected into HEK 293T 
cells together with increasing concentrations of p205. Ectopic expression of p205 led to a 
dose dependent increase in the Asc-luciferase reporter gene activity. This effect was 
specific to p205, as transfection of two related DNA-binding PYHIN proteins p204 and 
Aim2 had no effect on reporter expression (Figure 2.12A). Further to determine the roles 
of the specific domains of p205 on reporter gene expression, we generated deletion 
mutants of p205 that either lacked the pyrin domain (ΔPYD), the HIN domain (ΔHIN) or 
both (intermediate region only; ΔH/ΔP). We tested the deletion mutants for their ability 
to drive the Asc gene reporter but the mutants lacking either the HIN or pyrin domain 
failed to induce any significant expression from the reporter (Figure 2.12B) suggesting 
the importance of both the DNA-binding HIN domain and protein-binding pyrin domain 
of p205 in controlling transcription. 
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Figure 2.12: Full-length p205 protein drives expression from Asc gene-luciferase 
reporter. HEK 293T cells were transfected with a mixture containing 10 ng of TK-Renilla 
luciferase with 1 ng of Asc promoter firefly luciferase reporter and increasing amounts of 
(A) p205-HA, p204-HA or Aim2-FLAG, or (B) with full length p205 or p205 deletion 
mutants as indicated. Corresponding immunoblots show the expression of the respective
constructs in the HEK 293T cells. All luciferase values were measured and normalized to 
Renilla values. Values are displayed as fold change over the Asc reporter construct alone. 
Data is representative of three independent experiments.
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p205 synergizes with other transcription factors to enhance expression from the Asc 
gene reporter 
 Bioinformatics analysis of the Asc promoter region for response elements 
of known transcription factors revealed binding sites for c/EBPβ and NF-κB amongst 
others. Previously, Parsons et al has shown that TNFα treatment could enhance Asc 
expression through p65/RelA in MCF7 cell lines, though the luciferase reporter assay 
results in the study were not conclusive. Furthermore, p205 has been shown to co-
localize and bind directly with the CCAAT/enhancer binding protein-β (c/EBPβ) in 
mouse adipose-derived stem cells. Also, c/EBPβ has also been implicated in the 
induction of several proinflammatory genes in macrophages. Therefore we tested the 
effect of ectopic expression of c/EBPβ or p65/RelA on Asc reporter gene expression. In 
both cases these inducible transcription factors showed modest increase in Asc luciferase 
reporter activity in a dose dependent manner (Figure 2.13 left panel). In addition, co-
expressing p205 together with either c/EBPβ or p65/RelA further enhanced Asc reporter 
gene expression (Figure 2.13 middle panel). However, when minimal concentrations of 
c/EBPβ and p65/RelA were transfected together with increasing concentrations of p205, 
we observed a strong, synergistic increase of activity from the Asc gene-luciferase 
reporter (Figure 2.13 right panel).  
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Figure 2.13: p205 synergizes with c/EBPβ and p65/RelA to drive Asc gene luciferase
reporter activity. Transfection of increasing concentrations of c/EBPβ, p65/RelA and 
p205 alone or, co-transfection of increasing concentrations of p205-HA with either c/EBPβ 
or p65/RelA with Asc promoter-reporter or, transfection of the Asc promoter-reporter with 
increasing concentrations of p205 with both c/EBPβ and p65/RelA, as indicated. 
All luciferase values were measured and normalized to Renilla values. Values are displayed 
as fold change over the Asc reporter construct alone. Data is representative of three 
independent experiments.
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p205 interacts with c/EBPβ in HEK 293T and macrophages 
In addition to c/EBPβ, p65/RelA and p205 synergistically activating 
expression from the Asc gene reporter in HEK 293T, we wanted to test whether proteins 
interact in a complex. We transiently transfected HA-tagged p205 and c/EBPβ in HEK 
293T and observed that p205 specifically interacted with overexpressed c/EBPβ (Figure 
2.14A). To test whether p205 and c/EBPβ interacted endogenously as well, we co-
immunoprecipitated the proteins in resting and LPS-stimulated (200ng/ml for 3h or 6h) 
wild-type macrophages. p205 could successfully pull down c/EBPβ, and vice versa, in 
both unstimulated and LPS-induced macrophages, as was observed by co-
immunoprecipitation assays (Figure 2.14B). Together these observations imply that p205 
can increase Asc gene expression, and can collaborate with c/EBPβ or p65/RelA as well 
to do so. 
 142	
A
Input -HA c/EBP
I.P.
I.B.:
p205HA
B
I.B.:
p205
I.P.
p205 c/EBP
   I.B.:
c/EBP
LPS (h):
BMDMHEK 293T
n.s.
p205
   I.B.:
c/EBP
0        3        6 0        3        6
p205
n.s.
short exposure
long exposure
Figure 2.14: p205 interacts with c/EBPβ in HEK 293T and BMDM.
(A) Co-immunoprecipitation and immunoblot of overexpressed HA-tagged p205 
and c/EBPβ in HEK 293T cells using anti-HA and anti-c/EBPβ antibodies. 
(B) Co-immunoprecipitation and Western blot of endogenous p205 and c/EBPβ 
in LPS-stimulated BMDM using antibodies against p205 and c/EBPβ. Data is 
representative of two independent experiments (n.s.- non-specific band).
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p205 and other transcription factors co-operate to drive Asc gene reporter activity  
  Bioinformatic analysis also displayed sites for transcription factors, c-Rel 
and p53 in the Asc gene promoter. Transfection of c-Rel and p53 alone showed modest 
increase from the Asc gene reporter (Figure 2.15A). Co-transfection of c-Rel and p53 
with increasing concentrations of p205 with the reporter, compared to transfected p205 
alone showed an additive effect (Figure 2.15B). Further, co-transfection of p205 with 
c/EBPβ and c-Rel did not show a synergy in the activation of the Asc gene reporter 
suggesting that c-Rel dependent activation occurs non-competitively and independently 
of p205 and c/EBPβ-mediated transcription of Asc (Figure 2.15C). 
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Figure 2.15: p205 co-operates with cRel and p53 to drive Asc gene reporter activity. 
(A) Transfection of increasing concentrations of cRel and p53 alone with Asc gene reporter
(B) Transfection of p205 alone or co-transfection of increasing concentrations of p205
with either cRel and p53 with Asc gene-reporter, as indicated. (C) Transfection of increasing 
concentrations of p205 alone with fixed amount of c/EBPβ and c-Rel with Asc gene reporter.
All luciferase values were measured and normalized to Renilla values. Values are displayed 
as fold change over the Asc reporter construct alone. Data is representative of two 
independent experiments.
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Shorter mutants of Asc gene-luciferase reporter are not inducible by p205 
  We cloned shorter promoter-reporter constructs containing only 500 bp, 
800 bp, 1000 bp or 1500 bp upstream of the transcription start site of the Asc gene and 
found that the p205-dependent increase in reporter gene expression was maximal in Asc 
gene construct that contained promoter sequence 2000 bp upstream, and reporter activity 
lost in constructs that were less than 1500 bp upstream of the transcription start site (TSS) 
(Figure 2.16A). We cloned the sequence between -2000 to -1500 Asc gene in the 
luciferase reporter to test whether that region was necessary and sufficient to drive Asc 
gene reporter activity, but p205 was unable to drive reporter activity from the construct 
(Figure 2.16B) indicating that the cis and distal regions of the Asc promoter region that is 
necessary for driving expression. 
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Figure 2.16: Shorter Asc gene-luciferase reporters are not inducible by p205.
(A) HEK 293T cells were transfected with a mixture containing 10 ng of TK-Renilla 
luciferase with 1 ng of Asc promoter firefly luciferase reporter constructs (2000 bp, 
1500 bp, 1000 bp, 800 bp and 500 bp upstream of the transcription start site) alone 
or with 25 ng of p205. (B) An Asc gene reporter construct with sequence -2000 to 
-1500 bp upstream was transfected similarly in HEK 293T cells with TK-Renilla and 
25 ng p205. The immunoblot show p205 expression in the HEK 293T cells. All 
luciferase values were measured and normalized to Renilla values. Values are shown 
as fold change over the Asc reporter constructs alone. Data is representative of three 
independent experiments.
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p205 drives expression from a NF-κB luciferase reporter as well 
 The effect of p205 was also studied on p125 IFNβ-luciferase reporter as 
well as a NF-κB luciferase reporter. p205 had no effect on IFN promoter construct but it 
showed substantial increased activity from the NF-κB reporter that consists of 5 tandem 
NF-κB sites as well as from an IL-8 reporter indicating that p205 could drive expression 
of other NF-κB genes in HEK 293T cells (Figure 2.17A).	Induction	of	the	NF- κB, IL-8, 
PRDIII and IFNβ-luciferase reporters were tested with transfected p65/RelA or mSTING 
as positive controls (Figure 2.17B). Following the specific effect of p205 on the NF-κB 
reporter, the loss of induction by p205 on shorter Asc reporter constructs and previous 
studies showing that 1200+ bp of Asc promoter was insufficient for induction, and that 
p65/RelA can interact with p205 and other pyrin-containing proteins, we concluded that 
p205 might be interacting with other factors on the NF-κB sites on the Asc promoter to 
affect gene expression. 
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Figure 2.17: p205 drives expression from NF-κB luciferase reporter.
(A) HEK 293T cells were transfected with a mixture containing 10 ng of TK-Renilla 
luciferase and 25 ng of p205 with 1 ng of Asc gene reporter, 5 ng of NF-κB reporter, 
IL-8 reporter, PRDIII reporter and IFN-β reporter (B) The Asc gene reporter, 
NF-κB reporter, IL-8 reporter, PRDIII reporter and IFN-β reporter were transfected 
similarly in HEK 293T cells with TK-Renilla and 25 ng p62/RelA or STING. cells. All 
luciferase values were measured and normalized to Renilla values. Values are shown 
as fold change over the Asc reporter constructs alone. Data is representative of two 
independent experiments.
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p205 regulates expression of other immune genes in LPS-stimulated macrophages 
  We wanted to determine the impact of p205 on the global expression of 
immune genes in resting and LPS-stimulated bone marrow derived macrophages. We 
collected RNA from either untreated or LPS-treated control and p205 knockdown 
BMDM for multiplex gene expression analysis (nCounter, NanoString) that included a 
selected panel of immune genes. Each immune gene in the NanoString panel is 
represented by fluorescently labeled probes that hybridize directly to the target mRNA, 
and gives a highly sensitive count of mRNA. We observed changes in multiples genes, 
especially in the LPS stimulated macrophages. Genes such as MyD88, Aim2, Il18, Irf3, 
Irf5, Stat1, Stat3 showed no change between the control and the p205 knockdown lines. 
We selected a subset of genes that exhibited a considerable decrease in both the 
knockdown cell lines. As expected, we observed a decrease in the Asc gene expression in 
both the resting and LPS-stimulated macrophages. Other immune genes that showed a 
strong decrease in expression in the LPS-stimulated p205 knockdown macrophages were 
Ccl4, Ccl5, Cd86, Cox2, Cxcl2, Il10, Il1α, Il12α, Il6 and Ifnα as represented by the 
heatmap (Figure 2.18).  
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Figure 2.18: p205 affects expressions of other immune genes in LPS-stimulated
macrophages. Heatmap of Nanostring analysis of immune genes expression in p205 
knockdown macrophages stimulated with LPS (200 ng/ml for 3h).
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We further inspected the levels of IL-1α and IL-6 mRNA in p205 knockdown 
macrophages. Since IL-1α, IL-6 are not expressed in resting state, we stimulated the 
macrophages with LPS for different times (0, 3, 6, 12 h) to observe if loss of p205 
changed its expression over time. We observed that the induction of IL-1α and IL-6 
mRNA was much lower in the knockdown cells with LPS stimulation, corresponding to 
the low p205 expression (Figure 2.19A). As expected, there was no Asc expression in 
LPS-stimulated p205 knockdown macrophages. Parallel to Asc mRNA expression in 
p205-deficient cells, we designed primers to distinguish between the levels of IL-1α and 
IL-6 pre-mRNA and mature mRNA in these cells (see Table 1). Both IL-6 and IL-1α pre-
mRNA and mature mRNA levels were affected in p205 knockdown macrophages treated 
with LPS for 6 hours. Interestingly, the mRNA profile of IL-1α in LPS-stimulated 
macrophages mirrored that of Asc. The mature form of IL-1α mRNA was negligible 
whereas a low amount of its pre-mRNA was present in the macrophages lacking p205 
(Figure 2.19B). Hence, p205 regulates immune responses by controlling transcriptional 
activation of other immune genes such as Il1α, Il6. 
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Figure 2.19: Knockdown of p205 affects expression of other inflamamtory genes. 
(A) qRT-PCR analysis of p205, Asc, IL-1α and IL-6 mRNA in p205 knockdown macrophages
with LPS stimulation (200ng/ml) for 0, 3, 6, 12 hours. (B) Expression of p205 and nascent or 
mature L-1α and IL-6 mRNA in p205 knockdown macrophages (relative to the housekeeping 
genes, Hprt or Gapdh, and normalized to EV CTL BMDM)
LPS treatment (h) LPS treatment (h)
LPS treatment (h)
** * * *** ** ***
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NLRP3 and NLRC4 inflammasomes are partially compromised in ALR-/- mice 
  Stetson and lab generated an ALR-/- mouse that lacks the PYHIN/ALR 
locus on chromosome 1 containing the 13 PYHIN genes. Deletion of all the ALR/PYHIN 
genes indicates that it also lacks Aim2, and thus ALR-/- cells are unresponsive to triggers 
for the Aim2 inflammasomes. Since ALR-/- cells would also be lacking p205 among other 
PYHIN genes, we wanted to test for activation of other inflammasomes such as NLRP3 
and NLRC4 (Figure 2.20A and B). As expected, IL-1β production upon pdAdT 
transfection in both primary BMDM and BMDC was absent. Interestingly, NLRP3-
dependent IL-1β secretion was partially impaired in ALR-/- BMDM and dendritic cells 
upon stimulation with Nigericin or ATP. Infection with Salmonella typhimurium in 
stationary phase (overnight culture) as well as log phase (4-6 h culture) also showed 
impaired IL-1β secretion. Hence, in these cells, there’s a partial phenotype of p205 
deficiency on IL-1β activation, but there’s the possibility than the PYHIN proteins may 
cross regulate each other’s functions and often, the PYHIN proteins have been observed 
to differentially regulate similar pathways.  
Further, upon observation of the defect in IL-1β secretion in the ALR-/- primary 
BMDM and BMDC, we tested the expression of Asc in the cells. We generated ALR-/- 
immortalized macrophages that showed no p205 protein expression (Figure 2.20C left 
panel). Consistently, compared to wild-type immortalized macrophages, there was a 
marked reduction of Asc protein expression in these macrophages at basal level as well as 
after LPS stimulation (Figure 2.20C right panel). Hence, p205 is important for 
maintaining Asc expression in the cells, though some cross-regulation by the other 
PYHIN proteins (lacking as well in ALR-/- cells) may also be involved.  
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Figure 2.20: NLRP3 and NLRC4 inflammasomes are partially compromised in 
ALR-/- mice. IL-1β production in LPS-induced (200 ng/ml) ALR knockout (A) primary BMDM 
and (B) BMDC in response to pdAdT transfection (1 µg for 6h), stimulation with Nigercin 
(10 or 20 µM for 1h), ATP (5 or 10 µM for 1h) or infection with E.coli or Salmonella
typhimurium (in stationary phase or log phase) by ELISA (C) p205, Asc and β-actin protein 
expression in immortalized wild-type (WT) and ALR knockout (ALR-/-) macrophages with
or without LPS stimulation (200 ng/ml for 6h).
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Discussion 
 Studies over the last decade have defined the importance of AIM2, a 
cytosolic DNA binding protein as a regulator of caspase-1 activity and proteolytic 
processing of IL-1β and IL18 (29). The role of the PYHINs in sensing dsDNA was 
further highlighted by the identification of IFI16 as a regulator of type I IFN gene 
transcription following HSV-1 infection (20). 
 Early studies had also linked members of the murine PYHIN family to 
type I IFN gene regulation. Knockdown of mouse Ifi203 and mouse p204 have been 
shown to dampen the IFN response to infection with multiple pathogens, including HSV-
1, human immunodeficiency virus (HIV), murine leukemia virus (MLV), Francisella 
tularensis, and Mycobacterium tuberculosis (20, 241, 242). Despite these studies, a recent 
genetic study from Gray et al using mice lacking the entire PYHIN locus, lacking all 13 
PYHIN genes, found that there was no change in the IFN signature when challenged with 
various immunostimulatory DNA ligands, DNA virus infection and lentivirus infection 
(176). This body of work indicates that the murine PYHIN proteins play limited roles in 
DNA ligand recognition at least in the myeloid cells and fibroblasts tested in these 
studies, raising the possibility that the PYHINs have alternative functions in these cells.  
 Prior to the discovery of AIM2 and IFI16 as sensors of microbial DNA, 
PYHIN proteins were shown to regulate cell growth, differentiation, tumor suppression 
and DNA damage responses (235). IFI16, IFIX, p202, and p204 regulate cell cycle 
transcription factors such as p53, p21, pRb, and E2F resulting in cell cycle arrest (178). 
p202 acts as a transcriptional repressor targeting NF-κB (179), AP-1 (180, 181), MYOD1 
(182), and myogenin (181, 183). p204 also regulates gene expression during 
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monocyte/macrophage differentiation and osteoblast differentiation (243-245).  
 Here we expand upon these studies and define p205, a murine PYHIN 
protein as an additional regulator of gene expression in innate immunity. Using a series 
of loss of function approaches (both shRNA and CRISPR/Cas9 mediated gene editing), 
we report that p205 regulates expression of the inflammasome adapter protein Asc and in 
so doing controls inflammasome activation pathways broadly. Cells lacking p205 failed 
to activate caspase-1 and control inflammasome dependent processing of IL-1β in 
response to multiple ligands that engage the AIM2 inflammasome as well as the NLRP3 
inflammasome. The abrogated inflammasome activation in the p205 KD macrophages 
upon pdAdT stimulation also likely explained the enhanced IFNβ levels detected in these 
cells, since prior work from our lab and others have shown that activation of the AIM2 
inflammasome by intracellular DNA antagonizes the type I IFN pathway (171, 246). In 
cells with defects in inflammasome responses, there is a more robust dsDNA driven 
induction of type I IFNs.  
 By carefully measuring expression levels of key components of the Aim2 
and Nlrp3 pathways, we found that cells lacking p205 had reduced expression of Asc. 
This effect was observed at both the protein and mRNA levels. The compromised 
inflammasome dependent responses observed in these cells could be fully rescued by 
ectopically expressing either p205 or Asc itself. Cells lacking p205 had reduced RNA 
Polymerase II binding to the Asc gene indicating that p205 functioned in part to control 
Asc gene transcription. In addition, by comparing the levels of the Asc pre-mRNA to 
those of the mature transcript, we could also observe additional effects on Asc mRNA 
processing. It is broadly accepted that the CTD of RNA Pol II is involved in efficient 
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transcription as well as mRNA processing (247, 248), and the Serine-2 phosphorylated 
polymerase determines the rate of mRNA elongation, spliceosome assembly and splicing 
efficiency (249). Thus we deduced from our ChIP experiments and qPCR analysis of Asc 
pre-mRNA and mature transcripts, that the absence of p205 not only affects Asc gene 
transcription but also affected the processing of the immature Asc mRNA.  
 Further, we show that in regulating gene expression, p205 cooperates with 
both c/EBPβ and p65/RelA to drive Asc expression. The transcription factor c/EBPβ is 
important in controlling macrophage differentiation. c/EBPβ remains fully active in 
resting macrophages and stays positioned on target genes, ready to stimulate transcription 
with other inducible transcription factors (250). p205 has previously been shown to 
interact with c/EBPβ in adipocytes. p205 interacts with c/EBPβ in unstimulated 
macrophages as well, and maintains basal expression of Asc, while under stimulated 
conditions, LPS-inducible p205 may interact with both c/EBPβ and activated NF-κB 
transcription factors to further enhance expression. 
Previous studies have shown that Asc, originally identified as TMS1 
(Target of methylation induced silencing-1) is influenced by DNA methylation. The Asc 
gene contains a 600-bp long CpG island located near the transcription start site and the 
methylation status of this CpG island correlates with the expression level of Asc/TMS1. 
The methylation status of the CpG island, as well as promoter proximal pausing of RNA 
Polymerase II in multiple cancer cell lines and tissues result in reduced expression of Asc 
(251-259). Our studies indicate that Asc levels are influenced by p205 in murine 
macrophages adding additional understanding to the regulation of this important immune 
gene. Our findings expand on our understanding of transcriptional regulatory roles for the 
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PYHIN proteins. p205 has previously been shown to control p21CIP/WAF gene expression 
via p53 in Saos2 cell lines and to impact gene expression in adipogenesis and 
osteogenesis via transcriptional mechanisms. p205 acts as a transactivator synergizing 
with p53 to induce expression of the cell cycle inhibitor p21 to inhibit cell growth. In 
adipocytes, p205 interacts with c/EBPβ and c/EBPα to further activate the transcriptional 
activity of c/EBPα and PPARγ. All of these studies help establish evidence for PYHIN 
proteins as regulators of gene expression. The discovery of p205 as a regulator of 
inflammasomes via transcriptional regulation of Asc further supports a role for the 
PYHIN proteins as regulators of gene expression and in addition emphasizes the 
importance of PYHIN family members in innate immunity. 
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Chapter 3 
Dectin-1/Syk signaling through caspase-8 promotes caspase-1/11-independent 
inflammasome activation upon Paracoccidioides brasiliensis infection
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Abstract 
 
Paracoccidioides brasiliensis is equipped with an arsenal of virulence factors that are 
crucial for causing infection. NLRP3 inflammasome has been defined as a mediator of P. 
brasiliensis-induced cell damage, and also in promoting an effective Th1 immune 
response. However, the loss of caspase-1 only partially reduced IL-1β levels. Here we 
identify an additional pathway for IL-1β production in response to P. brasiliensis 
infection. By engaging dectin-1 and Syk signaling, P. brasiliensis initiated caspase-8-
mediated IL-1β production, an event that was necessary and sufficient for transcriptional 
priming and posttranslational cleavage of pro-IL-1β. Caspase-8 subsequently synergizes 
with the canonical inflammasome pathway to control caspase-1 processing and caspase-
1/11-independent IL-1β maturation, providing a regulatory role in host resistance to in 
vivo P. brasiliensis infection. Together these findings revealed a novel function for 
dectin-1 in innate immune response of host cells to P. brasiliensis infection, 
demonstrating a connected network between non-canonical caspase-8 and canonical 
caspase-1 inflammasomes to coordinate IL-1β production upon P. brasiliensis challenge. 	 	
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Introduction 
  
The systemic granulomatous disease, paracoccidioidomycosis (PCM), is initiated 
when airborne particles produced by the mycelial stage of Paracoccidioides brasiliensis 
are inhaled and converted into pathogenic yeast in the lungs due to an increase in 
temperature (260, 261). This morphological transition, crucial for the establishment of the 
infection, is accompanied by extensive structural changes in cell wall architecture and 
composition. Both forms have comparable contents of glucans (36–47%), but differ in the 
type of glucan predominantly expressed (262). The polysaccharides shift (263, 264) has 
been proposed as a virulence factor during P. brasiliensis infection (265), as it 
presumably enhances the fungal survival in the mammalian host by modulating the β-
glucan-triggered inflammatory response (266, 267). 
 β-1,3-glucans are recognized by dectin-1 (Clec7A), a C-type lectin receptor 
(CLR) that drives CARD9/Bcl-10/MALT1 scaffold assembly via Src/Syk- dependent 
signaling to activate the transcription factor NF-κB (268, 269). It was suggested that P. 
brasiliensis-dependent Syk kinase phosphorylation (270) culminates in pro-IL-1β 
production (102), and relies on the dectin-1 pathway (271). The expression, maturation 
and secretion of IL-1β are tightly controlled processes that require at least two signals: 
synthesis of the precursor pro-IL-1β through pattern-recognition receptor- mediated NF-
κB activation (signal 1) and processing of the immature pro-IL-1β by caspase-1 or 11-
dependent inflammasome complexes to generate mature, bioactive IL-1β (signal 2) (71, 
272). However, besides dectin-1-induced IL-1β transcription, this CLR also functions as 
an extracellular sensor that directly activates caspase-8, which then cleaves pro-IL-1β 
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during Candida albicans infection (80, 273), emphasizing that diverse and complex 
molecular platforms can form inflammasomes. Caspase-8 cleaves the inactive form of IL-
1β at the same site as recombinant caspase-1 producing similar mature IL-1β fragments 
(79) and similar to caspase-1, forms Asc (apoptosis-associated speck-like protein) puncta 
after Salmonella typhimurium and Aspergillus fumigatus infections (111, 274). Since 
there exists a caspase-1 and 11-independent inflammasome pathway regulating IL-1β 
maturation after fungal invasion, we were interested in understanding the mechanisms 
underlying the non-canonical inflammasome activation. Particularly, we focused on 
defining the contribution of caspase-8 in the modulation of inflammasome-mediated 
immune response during P. brasiliensis infection, as the absence of caspase-1 did not 
completely abrogate IL-1β levels in the infected macrophages (39). In this study, we 
show that caspase-8 activated by P. brasiliensis interacting with the adapter molecule 
Asc after engagement of dectin-1/Syk signaling orchestrates the caspase-1/11-
independent IL-1β release and impairs fungal growth. The appearance of the non-
canonical caspase-8 inflammasome as a partner for IL-1β secretion during P. brasiliensis 
infection demonstrates the versatility of this platform to recruit distinct effector proteins 
to tailor the immune response and sheds new light on the complexity of this host-
pathogen interaction. 
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Material and Methods 
 
Mice:  
Mouse strains were maintained in specific pathogen-free conditions and bred at the 
University of Massachusetts Medical School. C57BL/6 mice were bred in-house or 
obtained from Jackson Labs (Bar Harbor, ME). Casp1/11-/- mice were provided by Dr. V. 
Dixit (Genentech, South San Francisco, CA) , and Clec7a-/- mice were from Dr. G. D. 
Brown (University of Aberdeen, King's College, Aberdeen, U.K.). Asc-/- were from 
Millennium Pharmaceuticals. Rip3-/-Casp8-/- were obtained from Dr. W.J. Kaiser and Dr. 
E.S. Mocarski (Emory University School of Medicine, Atlanta, GA). Rip3-/- mice were 
provided by Dr. D. Green (St. Jude Children’s Research Hospital, Memphis, TN) and in 
some cases by Dr. F. K.-A. Chan (University of Massachusetts Medical School, 
Worcester, MA). All mice were on a C57BL/6 background. 
 
Fungal infection:  
The yeast cells of P. brasiliensis (Pb) 60855 strain (ATCC 60855), obtained from Dr. B. 
S. Klein (University of Wisconsin, Madison, WI), were cultured for 7 days at 37°C in 
brain heart infusion agar medium (Sigma Aldrich) supplemented with 5% FBS (Life 
Technologies). To prepare the inocula, the yeast cells were harvested and maintained 
overnight under agitation in F12 Coon's Modification medium (Sigma Aldrich) at 37ºC. 
The yeast phase suspension was transferred to sterile tubes and centrifuged (400 x g) for 
10 min at 4°C. The pellets were resuspended in PBS (pH 7.2–7.4), diluted and counted 
using a hemocytometer and a light microscope. The viability was determined by the 
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fluorescein diacetate (5mg/mL)-ethidium bromide (1mg/mL) method. Only fungal 
suspensions containing more than 90% of viable yeast cells were used. The cells were 
infected with viable fungi at a multiplicity of infection (MOI) of 1 or 5 whereas each 
animal was inoculated intravenously with 1x106 yeast cells. 
 
Recovery of CFUs (colony-forming units) and Cytokine Analysis:  
The numbers of viable yeast cells in the organs (lungs, liver, and spleen) of the Pb60855-
infected mice were determined at 30 days post-infection (dpi) by counting the CFUs. 
Fragments of the lung, liver, and spleen were aseptically collected, weighed, and 
homogenized using a sterile tissue grinder. The resulting macerate was diluted 10-fold in 
sterile PBS and plated onto Petri dishes containing brain heart infusion agar enriched 
with 5% FBS. The plates were incubated at 37°C for 7 days, and the number of CFUs per 
gram of tissue was calculated. For cytokine analysis of the lungs samples of the animals, 
the tissue in lysis buffer was tested at 10-fold dilution, and amount of cytokine released 
was calculated as per gram of tissue. 
 
Histopathological analysis: 
Animals selected at random from each group were sacrificed at 30 dpi. The lungs were 
excised, fixed with 10% formalin for 48 h, and embedded in paraffin. Tissue sections (5 
mm) were stained with H&E for analysis of the lesions in the lung tissue using standard 
protocols. 
 
Bone marrow-derived dendritic cell (BMDC) differentiation and stimulation:  
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Bone marrow progenitor cells were obtained from femurs and grown in RPMI 1640 
medium with 10% heat-inactivated serum, 1% penicillin-streptomycin, 1% sodium 
pyruvate, 1% NEAA, 20 ng/mL of recombinant GM-CSF, 50 mM 2-ME for 7–10 days to 
differentiate into dendritic cells. On day 7, BMDCs were seeded in cell culture plates and 
the next day were primed or not with Pam3CSK4 (200ng/mL) for 3 hours and then were 
infected with P. brasiliensis at an MOI of 1 or 5 for 24 hours. Where indicated, 
Pam3CSK4-primed BMDCs were treated either with caspase-1 (z-YVAD-fmk), caspase-
8 inhibitors (z-IETD-fmk) (both Santa Cruz; 50uM) for 2 hours or with 40uM of Syk 
inhibitor (piceatannol; InvivoGen) for 1 hour before adding the fungus. As a control, cells 
were incubated overnight with a canonical inflammasome activator such as pdAdT 
(poly(deoxyadenylic-deoxythymidylic) acid). For pdAdT transfection, each reaction 
consisted of 1ug of poly(dA:dT) per one million cells (Sigma-Aldrich) mixed with 
(1:2)(v/v) of Lipofectamine® 2000 Transfection Reagent (Invitrogen). After 15 min, 
DNA complexes were added to BMDCs in Opti-MEM (Gibco) and incubated for 16 
hours. 
Cytokine analysis:  
Cytokines in culture supernatants were measured by ELISA (eBioscience or R&D 
Systems), according to the manufacturers’ instructions. 
Western blot: 
Cell lysates and culture supernatants either combined or separated were denatured in 
loading buffer containing SDS and DTT, boiled and subjected to 13% SDS-PAGE gel. 
SDS-PAGE–separated proteins were transferred to nitrocellulose membranes, blocked 
with 1% nonfat dry milk and immunoblotted with primary antibodies against caspase-1 
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(Adipogen; clone casper-1), pro–caspase-8 (Enzo Life Sciences; clone 1G12 or Cell 
Signaling Technology; #4927), cleaved caspase-8 (Cell Signaling Technology; clone 
D5B2), IL-1β (R&D Systems), Asc (Millipore; clone 2EI-7 or Santa Cruz Biotechnology; 
sc-22514-R) and β-actin (Sigma Aldrich; clone AC15), followed by secondary anti-
rabbit, anti-rat, anti-mouse or anti-goat HRP antibodies (BioRad Laboratories). In some 
cases, proteins from the cell culture supernatants were precipitated by the methanol-
chloroform extraction method. The bands were quantified densitometrically using the 
ImageTool 2.0 software (University of Texas), and the results were expressed as arbitrary 
units. 
 
Caspase-8 activity and cell death assay:  
Caspase-8 activity in cell lysates was assayed using Caspase-Glo 8 Assay kit (Promega). 
Cell death was assessed detecting the release of lactate dehydrogenase (LDH) by 
CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega), according to the 
manufacturer’s instructions. The percentage of cytotoxicity was calculated as (LDH 
infected - LDH uninfected)/(LDH total lysis - LDH uninfected) x 100. LDH total lysis 
was determined by lysing the cultures with Triton X-100. 
 
Asc oligomerization assay: 
Asc oligomerization assay was performed as described (275) with minor modifications 
(276). In brief, BMDCs were primed either with LPS or Pam3CSK4 (50ng/mL) overnight 
and incubated with pan-caspase inhibitor z-VAD (25uM) 30min before the 24-hour 
stimulation with P. brasiliensis or pdAdT. Cytosolic lysates from the cells were enriched 
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for inflammasome fractions by low-speed centrifugation and subjected to cross-linking 
with disuccinimidyl suberate (DSS) (2 mM). The crosslinked samples were analyzed for 
Asc oligomerization by immunoblotting. 
 
Confocal immunofluorescence:  
Following infection, BMDCs were washed twice with PBS and fixed in 4% 
paraformaldehyde for 30 min, followed by blocking with 5% normal goat serum (Dako) 
in Perm/Wash buffer (BD Biosciences) for 1 hr. Cells were incubated with a mouse anti-
Asc antibody (1:500 dilution, clone 2EI-7; Millipore) overnight followed by incubation 
with a rabbit anti-caspase-8 (1:500 dilution, 8592; CST) for an additional 1 hr. The 
secondary antibodies used were Alexa Fluor 488 anti-rabbit IgG and Alexa Fluor 633 
anti-mouse IgG. Cells were counterstained in DAPI mounting medium (1:1000 dilution; 
Vector Laboratories). Cells and inflammasomes were visualized and imaged using a 
Leica TCS SP8 confocal microscope at the Research Core Facility at University of 
Massachusetts Medical School.  
 
Statistical analysis:  
GraphPad Prism 5.0 software was used for statistical analysis. The data were represented 
as mean ± standard errors of the means (SEM) and the differences observed among the 
experimental groups after infection were examined by applying one-way ANOVA 
followed by the parametric Tukey’s test for comparing multiple groups. p < 0.05 was 
considered statistically significant.
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Results 
 
P. brasiliensis-induced IL-1β secretion is dependent on both caspase-1 and caspase-8 
  Regulation of IL-1β production in macrophages and dendritic cells has 
focused on caspase-1, the predominant interleukin-1-converting enzyme (ICE) 
downstream of the NLRP3 (nucleotide-binding oligomerization domain–like receptor 
family pyrin domain–containing 3) inflammasome signaling complex, which is the best 
characterized enzyme for the proteolytic maturation of IL-1β (29). However, some 
studies have also implicated caspase-8 either as a direct executioner caspase for 
generating the mature 17-kDa IL-1β or as an initiator caspase for the activation of 
caspase-1 in response to infection by diverse microbial pathogens (76, 79). However, the 
‘if and how’ of caspase-8 activation during P. brasiliensis infection is still unknown. 
Caspase-8 is synthesized as a single chain zymogen, procaspase-8 (p55), which consists 
of two death effector domains and two active domains (p18 and p10) (277). To monitor 
the activation status of caspase-8 after P. brasiliensis infection, we infected BMDCs, and 
24 hours p.i., immunoblotted for the presence of the caspase-8 p18 subunit, which is 
yielded upon procaspase-8 proteolysis (278). The procaspase-8 processing into the small 
catalytic (p18) subunit as well as the intermediate 43kD form, that avoids apoptosis 
(279), was markedly augmented in Pam3CSK4-primed dendritic cells infected with P. 
brasiliensis, which explains the reduced procaspase-8 level in WT cells after incubation 
with the yeast form (Figure 3.1A). Additionally, the infection of BMDCs with P. 
brasiliensis induced caspase-8 activity in the two fungal concentrations tested (Figure 
3.1B), denoting that P. brasiliensis recognition positively regulates caspase-8 activation. 
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Figure 3.1: Caspase 8 is activated during P. brasiliensis infection.
(A) WT BMDCs were primed with 200 ng/mL of Pam3CSK4 for 3 hours and infected
with P. brasiliensis (MOI 5) for 24 hours before lysates and supernatants were collected and 
immunoblotted for caspase-8 and caspase-1, respectively. Supernatant proteins were 
precipitated with methanol and chloroform. Control cells were stimulated with canonical 
inflammasome activator pdAdT after LPS priming. (B) Caspase-8 activity induced by 
P. brasiliensis in Pam3CSK4-primed WT BMDCs after 24 hours of stimulation with indicated 
MOI of fungus. The results are presented as relative light units. 
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  As caspase-8 has been linked to pro-IL1β maturation in response to 
stimulation via TLR4 (79) as well as after fungal recognition by dectin-1 (80, 273), next 
we investigated whether caspase-8 was involved in P. brasiliensis-induced IL-1β 
production. Blocking caspase-8 activity with a chemical inhibitor (z-IETD-fmk) that 
binds irreversibly to active caspase-8 significantly attenuated the release of active IL-1β 
(Figure 3.2A), but did not affect TNF-α production after stimulation with P. brasiliensis 
(Figure 3.2B). Consistent with that, we also found suppressed cleavage of pro-IL-1β in 
z-IETD-treated cells compared to the untreated cells (Figure 3.2C), demonstrating the 
importance of caspase-8 for pro-IL-1β processing. Accordingly we noted that caspase-8 
inhibition prevented cell cytotoxicity, resulting in lower LDH release, indicating 
decreased cell death (Figure 3.2D). Altogether these data suggest that infection with P. 
brasiliensis leads to processing of pro-IL-1β after fungal recognition not only through the 
activation of caspase-1-dependent inflammasome responses but also through caspase-8. 
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Figure 3.2: Caspase-8 activates P. brasiliensis dependent IL-1β processing and release. 
(C) Culture supernatants harvested from WT BMDCs activated for 3 hours with Pam3CSK4, treated the 
last 2 hours with caspase-1 (z-YVAD-fmk) or caspase-8 (z-IETD-fmk) inhibitors and subsequently 
challenged for 24 hours with P. brasiliensis were analyzed by ELISA to measure the levels of secreted 
IL-1β and (D) TNFα. (E) z-YVAD-fmk or z-IETD-fmk were added to Pam3CSK4 or LPS-primed BMDCs 
2 hours before either infection with 5 yeast of P. brasiliensis per cell or incubation with pdAdT. After 24 
and 16 hours, respectively, the samples prepared by combining cell lysates with culture supernatants 
were immunoblotted for IL-1β. (F) Pam3CSK4-primed BMDCs untreated or treated with z-YVAD-fmk 
or z-IETD-fmk were cultured with P. brasiliensis prior to the assessment of extracellular LDH. 
Values correspond to the percentage of LDH release compared with cells lysed with Triton X-100. 
Data show the averages ± SD from triplicate wells of at least three independent experiments.
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Caspase-1/11 deficiency exacerbates P. brasiliensis-induced caspase-8 maturation  
  Though mouse BMDM lacking caspase-1 failed to produce appreciable 
levels of IL-1β (39, 280), the deficiency of caspase-1 only partially reduced IL-1β 
production. Therefore, it is possible that caspase-8 may also be playing a role in this 
process. To explore the relative contribution of caspase-8 for the caspase-1/11-
independent IL-1β secretion, we analyzed caspase-8 activation and its enzymatic activity 
in the absence of caspase-1 and 11. Surprisingly, P. brasiliensis-induced caspase-8 
processing and activity were greatly enhanced (41.5%) in caspase-1/11–deficient BMDCs 
(Figure 3.3A and B), These data correlated with the key role of caspase-8 in mediating 
IL-1β secretion in Casp1/11-/- cells, since the administration of caspase-8 inhibitor 
completely abolished the residual IL-1β production from the untreated dendritic cells that 
have no caspase-1 or 11 (Figure 3.4A). On the other hand, under the same conditions, the 
z-IETD treatment of P. brasiliensis-stimulated Casp1/11-/- BMDCs did not interfere with 
TNF-α production (Figure 3.4B). In agreement with the hypothesis that caspase-8 is 
essential for IL-1β release when caspase-1 and 11 are not present, the expression of the 
processed mature form of IL-1β, p17 was severely impaired in BMDCs from Casp1/11-/- 
mice, and it completely disappeared under caspase-8 blockade (Figure 3.4C). We 
conclude that P. brasiliensis activates the non-canonical caspase-8 inflammasome 
pathway, which is required for IL-1β release in the absence of caspase-1 and 11. 
Establishing that dendritic cells require caspase-8 activation when caspase-1 is absent and 
that this non-canonical caspase-8 inflammasome is suppressed by caspase-1 in WT cells, 
we set out to address whether Asc, a key component for caspase-1 activation after P. 
brasiliensis infection (39), was also involved in this process. Even though Asc-/- cells are 
 174	
hampered in IL-1β secretion (Figure 3.5A and B), Asc deletion boosted P. brasiliensis-
induced caspase-8 proteolysis (Figure 3.5C) and activity (Figure 3.5D). Therefore, 
canonical caspase-1 inflammasome pathway inhibits the potent non-canonical caspase-8 
inflammasome activation, but in the context of caspase-1/11 deficiency, IL-1β secretion 
is mechanistically dependent on the robust contribution of caspase-8 activity.   
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Figure 3.3: P. brasiliensis triggers caspase 1-independent caspase 8 activation.
(A) BMDCs from indicated mice were primed with Pam3CSK4, infected with P. brasiliensis at 
(5:1) for 24 hours. The cell lysates were subjected to caspase-8 staining by Western blotting. 
(B) Caspase-8 activity in Pam3CSK4-primed WT or Casp1/11-/- BMDCs 24 hours after 
stimulation with Pb60855 was determined by the generation of luminescent signal as result of 
caspase-8 substrate cleavage (Caspase-Glo 8 Assay kit). The results are presented as 
relative light units (RLU)
 176	
Figure 3.4: Caspase-8 is responsible for the caspase-1-independent IL-1β 
secretion triggered by P. brasiliensis. (A) BMDCs obtained from WT or Casp1/11-/- mice 
were primed with Pam3CSK4 and under caspase-8 activity blockade were incubated for 24 hours 
with P. brasiliensis at a MOI of 5:1. The amounts of IL-1β and (B) TNFα were quantified by an 
ELISA assay. (C) IL-1β processing on whole cell extracts was detected after incubation of 
Pam3CSK4-primed WT and Casp1/11-/- BMDCs with DMSO or z-IETD-fmk and infection with 
MOI-5 for 24 hours. Data are mean ± SD from one of three independent experiments. 
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Figure 3.5: ASC deficiency activates caspase 8 after P. brasiliensis infection.
(A) IL-1β secretion by WT and Asc-/- BMDCs stimulated with Pam3CSK4 and P. brasiliensis for 
3 and 24 hours, respectively, was defined by ELISA. (B) Pam3CSK4-primed WT and Asc-/- 
dendritic cells were incubated with P. brasiliensis. 24 hours later, pro-IL-1β conversion into 
biologically active IL-1β was analyzed by western blotting of total cell lysates. In parallel, 
WT cells were treated with LPS and pdAdT as control. (C) Caspase-8 activation and (D) activity 
were examined in BMDCs from WT and Asc-/- mice that were stimulated for 3 hours with 
Pam3CSK4 and for an additional 24 hours with P. brasiliensis.
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Caspase-8 recruits to Asc speck assembly upon P. brasiliensis infection promoting 
IL-1β release through caspase-1 activation  
  Since caspase-8 plays a role in the regulation of inflammasome-generated 
IL-1β, we sought genetic evidence of the potential role of caspase-8 in the canonical 
inflammasome activation response. The genetic deletion of caspase-8 in mice results in 
embryonic lethality (281), which can be rescued by a simultaneous ablation of receptor 
interacting protein kinase-3 (RIP3) (113, 114). We differentiated BMDCs from caspase-
8–deficient mice in a RIP3-deficient background and examined IL-1β release and 
caspase-1 activation following P. brasiliensis infection. Interestingly, P. brasiliensis-
induced IL-1β production was diminished in Rip3-/- and Rip3-/-Casp8-/- BMDCs (Figure 
3.6A), but the amount of TNF-α produced by those cells was comparable to WT (Figure 
3.6B). Similarly, the amount of mature IL-1β in the supernatants of stimulated BMDCs 
was also decreased in Rip3-/-Casp8-/- compared to WT and Rip3-/- cells (Figure 3.6C). 
Nevertheless, considering the known function of caspase-8 as a positive modulator of 
NF-κB transcriptional signaling (77, 78, 116, 118), the reduction in the quantity of 
mature IL-1β from the P. brasiliensis-stimulated Rip3-/-Casp8-/- cells could reflect both 
attenuation of inflammasome assembly as well as less pro-IL-1β substrate available for 
activation. As shown in Figure 3.6C, the levels of pro-IL-1β after Pam3CSK4 priming 
were intact in WT, whereas dendritic cells lacking either RIP3 alone or caspase-8 and 
RIP3 both had less of the 35kD precursor form. However, this decrease did not happen 
when the cells were stimulated with P. brasiliensis, which confirms the effect of caspase-
8 on signal 2 (inflammasome mediated pro–IL-1β processing) instead of signal 1 (NF-
κB–mediated pro–IL-1β induction). Consistently, Rip3-/-Casp8-/- BMDCs infected with P. 
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brasiliensis expressed normal levels of pro-caspase-1, but presented a significant defect 
in inducing caspase-1 activation compared to WT and Rip3-/- cells (Fig 3.7A), which 
correlated with the lower caspase-1 maturation observed on TLR2 agonist-primed WT 
cells treated with z-IETD-fmk, prior to P. brasiliensis stimulation (Figure 3.7B). To 
extend our findings, we evaluated whether even with the faint caspase-1 activation in 
Rip3-/-Casp8-/- BMDCs, caspase-1 still contributes to IL-1β maturation. Caspase-1 
inhibition clearly limited the ability of Pam3CSK4-primed Rip3-/-Casp8-/- BMDCs to 
produce mature IL-1β in response to P. brasiliensis (Figure 3.8A and B). Thus, these 
data indicate that caspase-8 licenses caspase-1 activation in the P. brasiliensis-triggered 
inflammasome, mediating efficient canonical inflammasome activation.  
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Figure 3.6: Caspase 8 is required for casapse 1 dependent IL-β production. 
(A) Quantification of IL-1β and (B) TNF-α in the culture supernatant of Pam3CSK4-primed WT, 
Rip3-/- and Rip3-/-Casp8-/- dendritic cells 24 h postinfection with P. brasiliensis. (C) Unprimed 
or Pam3CSK4-primed BMDCs were left uninfected or stimulated with P. brasiliensis for 24 hours. 
The supernatant together with the cell lysate were harvested and immunoblotted to detect 
IL-1β cleavage. 
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Figure 3.7: Caspase 8 is required for casapse 1 activation. 
(A) p20 and p45 caspase-1 subunits were determined in supernatants and lysate, respectively, 
collected from P. brasiliensis-infected WT, Rip3-/- and Rip3-/-Casp8-/- BMDCs, previously primed 
with PamCSK4. (B) WT BMDCs were stimulated with 200 ng/mL of Pam3CSK4 for 3 hours, with 
the last 2 hours preceding the addition of P. brasiliensis in the presence of 50uM z-IETD. 
Precipitated supernatants and lysates were immunoblotted for the indicated proteins. 
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Figure 3.8: Caspase-1 controls IL-1β release in the absence of RIP3 and caspase-8. 
BMDCs from wild-type, Rip3-/- and Rip3-/-Casp8-/- mice were stimulated with Pam3CSK4. After 
1 hour we added DMSO or z-YVAD-fmk (50uM) in the cell cultures and kept it for 2 hours until 
proceed to the 24-hour P. brasiliensis infection. The culture supernatants or the whole cell extract 
from the infected BMDCs were collected (A) to measure the concentrations of secreted IL-1β by 
ELISA and (B) to analyze the processed form of  IL-1β by western blotting, respectively. 
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A key question that arises from these results is how does caspase-8 impact 
caspase-1 inflammasome activation. Inflammasome activation results in Asc 
redistribution in the host cytosol to arrange a single cytoplasmic focus, called an Asc 
speck, which can be visualized using microscopy techniques (282). Hypothesizing that 
caspase-8 may be recruited to the P. brasiliensis-induced Asc inflammasome platform, 
we stained for caspase-8 and Asc to determine whether caspase-8 forms a distinct speck-
like protein and/or co-localizes to the same Asc puncta. Comparing the distribution of the 
fluorescently labeled proteins, our immunofluorescence analysis showed a significant co-
localization of caspase-8 and Asc in dendritic cells stimulated with Pam3CSK4 and P. 
brasiliensis (Figure 3.9A). Hence, our observation places caspase-8 as a component of 
the Asc inflammasome complex during P. brasiliensis infection. 
  Currently it is known that Asc forms a single supramolecular platform 
composed of oligomerized Asc dimers that allows the recruitment and subsequent auto-
activation of caspase-1 (275). In that case, one possibility is that caspase-8 facilitates Asc 
oligomerization. In order to find out the oligomeric state of Asc in P. brasiliensis-
stimulated WT, Rip3-/- and Rip3-/-Casp8-/- cells, we pelleted Asc aggregates with 
relatively low speed centrifugation and subjected it to chemical crosslinking. Asc was 
predominantly found as monomers and dimers in the pellets from WT, Rip3-/- and Rip3-/-
Casp8-/- BMDCs, and isolated in equal amounts between WT and Rip3-/- cells. In 
contrast, the oligomerizarion of Asc in Rip3-/-Casp8-/-- infected dendritic cells was 
strikingly weaker (Figure 3.9B). Thus, these results show that caspase-8 is an upstream 
mediator of the canonical caspase-1-dependent inflammasome, demonstrating a 
connection between these two signaling pathways during P. brasiliensis infection. 
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Figure 3.9: Caspase 8 promotes ASC oligomerization and speck formation. 
(A) ASC oligomerization in inflammasome-enriched and cross-linked lysates of Pam3CSK4-primed 
WT, Rip3-/- and Rip3-/-Casp8-/- BMDCs that were put in contact with P. brasiliensis for 24 hours. 
All cultures contained the pan-caspase inhibitor z-VAD-fmk (25uM). Monomers, dimers, and 
oligomers of ASC are indicated accordingly. Where indicated wild-type BMDCs stimulated for 
3 hours with LPS (200 ng/ml) and treated with pdAdT overnight were used as the positive control. 
(B) Caspase-8 (blue) and ASC (green) confocal micrographs taken from Pam3CSK4-primed 
BMDCs seeded on coverslips and stimulated with P. brasiliensis during 24 hours. DAPI was 
used for nuclear staining. Scale bars, 7,5µm. 
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P. brasiliensis recognition by dectin-1 engages IL-1β processing through a 
noncanonical caspase-8 inflammasome pathway 
  IL-1β cleavage downstream of the C-type lectin receptor, dectin-1 in 
dendritic cells can proceed through a noncanonical pathway involving the activation of 
caspase-8 (80). Hence, we sought to understand how P. brasiliensis activates the non-
canonical caspase-8 inflammasome, by checking whether dectin-1 was involved in 
caspase-8-induced pro-IL-1β processing. To ensure that the IL-1β cleavage elicited by P. 
brasiliensis occurs through β-glucan receptor we verified the processing of IL-1β in WT 
and Clec7a-/- cells after fungal challenge. To exclude the effects of dectin-1 on pro-IL-1β 
accumulation, we primed Clec7a-/- cells with Pam3CSK4 to guarantee dectin-1 
independent pro-IL-1β production. Even though dectin-1 could play a role in priming, 
acting upstream of inflammasome signaling, this C-type lectin receptor was also 
important for pro-IL-1β / IL-1β conversion after P. brasiliensis infection, as the reduction 
in IL-1β released was prominent (Figure 3.10A and B). As we hypothesized, this defect 
was not caused by less pro-IL-1β production, but because Pam3CSK4-primed Clec7a-/- 
dendritic cells infected with P. brasiliensis did not provoke caspase-8 activation (Figure 
3.10C and D).  
  Upon ligand binding to the extracellular carbohydrate-recognition domain 
of dectin-1, the immunoreceptor tyrosine-based activation motif (ITAM)-coupled 
cytoplasmic tail is phosphorylated by Src tyrosine kinases causing the subsequent 
recruitment and activation of Syk (268, 283, 284). To ascertain the participation of Syk 
kinase as a potential transducer for dectin-1-mediated IL-1β secretion, we treated 
Pam3CSK4-primed WT BMDCs with piceatannol, a Syk kinase inhibitor, prior to P. 
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brasiliensis infection. Unlike DMSO-treated control cultures, TLR2 agonist-primed WT 
cells that received piceatannol before P. brasiliensis infection had compromised release 
of IL-1β (Figure 3.11A and B), supporting the idea that P. brasiliensis recognition 
incites IL-1β production via Syk kinase. The next question we asked was, how is Syk 
kinase mediating IL-1β cleavage. The treatment of BMDCs with piceatannol 
accompanied by P. brasiliensis stimulation not only dampened caspase-8 activity (Figure 
3.11C) and activation (Figure 3.11D), but also interfered with caspase-1 processing 
(Figure 3.11E), which may be a consequence of activation of multiple receptors that 
converge on Syk. Collectively, Syk kinase signaling is fundamental for IL-1β production 
upon P. brasiliensis recognition as it is necessary for both non-canonical and canonical 
inflammasome activation. 
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Figure 3.10: P. brasiliensis sensing by dectin-1 induces caspase-8 inflammasome
-mediated IL-1β maturation. (A) IL-1β concentration in BMDCs from WT or Clec7a-/- mice 
stimulated with Pam3CSK4 plus P. brasiliensis at an MOI of 5 for 24 hours. (B) Western blotting 
of the processed IL-1β p17 subunit in whole cell extracts from Pam3CSK4-primed WT and 
Clec7a-/- dendritic cells infected with P. brasiliensis. LPS-primed WT BMDCs cultured with 
pdAdT overnight were used as the control for IL-1β production. (C) The lysates from Pam3CSK4-
treated WT and Clec7a-/- BMDCs, which were infected or not with P. brasiliensis for 24 hours, 
were fractionated by SDS-PAGE and incubated with caspase-8 antibody. (D) Caspase-8 activity 
measured after 24 hours of incubation with P. brasiliensis in Pam3CSK4-treated wild-type BMDCs 
or in BMDCs lacking dectin-1. 
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Figure 3.11: Syk kinase signaling activates both caspase 8 and caspase 1 
inflammasome-dependent processing of pro-IL-1β. (A) Pam3CSK4-stimulated BMDCs 
from WT mice with or without Syk kinase inhibitor (piceatannol 40uM) treatment were infected 
with P. brasiliensis for 24 hours and then the supernatants were assayed for IL-1β. (B) BMDCs
from WT mice were infected with P. brasiliensis (MOI 5) for 24 h in the absence or presence of
40µM Syk inhibitor. The combination of supernatant and cell lysate was analyzed by 
immunoblotting to determine the levels of IL-1β released. (C) Assay of caspase-8 activity in 
wild-type BMDCs stimulated with P. brasiliensis and treated or not with Syk inhibitor. 
(D) Pam3CSK4-primed WT BMDCs were pretreated with Syk inhibitor for 1 hour followed by 
24-hour P. brasiliensis infection. Cell lysate samples were used to probe caspase-8 and 
(E) pro-caspase-1, while the supernatant was precipitated by methanol and chloroform before 
carrying out the caspase-1 western blotting. On the panel D, the intensities of immunoreactive 
caspase-8 p 18 bands in the western blotting were quantified through densitometric analysis.
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Caspase-8 augments host resistance to P. brasiliensis infection 
  Subsequently, our effort was to look for in vivo evidence that would 
connect the non-canonical caspase-8 inflammasome to the immune responses against P. 
brasiliensis. To ascertain whether non-canonical caspase-8 inflammasome response 
protects against challenge with P. brasiliensis, we infected WT, Rip3-/- and Rip3-/-Casp8-/- 
mice with 1x106 viable yeasts of P. brasiliensis to analyze the fungal colonization in 
tissues. Rip3-/-Casp8-/- mice had large numbers of fungi in their lungs compared to Rip3-/- 
mice, which behaved similarly as wild-type control mice, while no significant changes 
were observed in the liver and spleen (Figure 3.12A). The reduced ability in attenuating 
fungal growth in P-brasiliensis-infected Rip3-/-Casp8-/- mice was also confirmed in 
histological sections by the presence of extensive lesions containing fungi colonies 
(Figure 3.12B). When the H&E staining was used to visualize the pulmonary fungal 
distribution, we found that P. brasiliensis was localized within granulomatous foci in WT 
and Rip3-/- mice, but was more widespread in the Rip3-/-Casp8-/- mice, which failed to 
confine the pathogen inside granulomas (Figure 3.12B upper panel). Additionally, at 30 
days post-infection, while the immune cells surrounded the granulomatous areas in the 
lung tissues from WT and Rip3-/- mice, the intense inflammatory reaction of Rip3-/-Casp8-
/- mice was diffuse and infiltrated the alveolar spaces (Figure 3.12B lower panel). 
Together these findings show that caspase-8 plays a critical role in mediating protective 
immune defense in vivo and that a deficiency in non-canonical caspase-8 inflammasome, 
leads to a dysregulated inflammatory response, which is unable to control P. brasiliensis 
replication.  
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Figure 3.12: Caspase-8, but not RIP3, deficiency confers susceptibility to P. brasiliensis 
infection in vivo. (A) The fungal burden in the lungs, livers, and spleens from wild-type, Rip3-/- 
and Rip3-/-Casp8-/- mice after 30 days post infection with 1x106 yeast cells of P. brasiliensis 
60855 strain. (B) Photomicrographs (original magnification, upper panel: 40x and lower panel: 4x) 
of granuloma lesions from the WT, Rip3-/-, and Rip3-/-Casp8-/- mice at 30 dpi. The lung sections 
were fixed in formalin, paraffin embedded, stained with H&E, and analyzed by light microscopy. 
The asterisks indicate the fungi in the tissue. Each dot represents a male mouse.
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Discussion 
  A major signaling pathway involved in the release of IL-1β is the 
activation of the classical or canonical inflammasome pathway, a multi-protein platform 
that activates caspase-1 (285). Beside caspase-1, additional caspases such as caspase-8 
and caspase-11 have also been implicated in the inflammasome-dependent control of IL-
1β processing and maturation (286). As the inflammasome is a dynamic complex that 
recruits different components to a single molecular platform depending on the contextual 
cue, the emergence of non-canonical inflammasomes for pro-IL-1β processing 
emphasizes the diversity of the innate immune system to combat pathogens, indicating 
that several effectors can form inflammasomes during infection in vivo.  
  Caspase-8, first described in 1996, is classically known for its function as 
a mediator of the death receptor–induced extrinsic pathway of apoptosis, that is triggered 
by several death receptors such as TNF-receptor type 1 (TNFRI) and CD95, both 
requiring the FAS-associated death domain (FADD) protein (287, 288). However, 
unexpectedly, caspase-8 is not always involved in apoptotic signaling (289). Substantial 
evidence has built up regarding its non-apoptotic functions, including activation of the 
transcription factor NF-κB (116, 118, 290) and production of mature IL-1β (79). 
Although IL-1β secretion coordinated by caspase-8 activation is not restricted to fungal 
pathogens (76, 78, 111, 291), a body of literature reinforces the influence of this caspase 
in IL-1β production during C. albicans, A. fumigatus and, Cryptococcus neoformans 
infections (80, 273, 274, 292). Previosuly, we demonstrated that the production of IL-1β 
during P. brasiliensis infection is not exclusively due to caspase-1 signaling (39). In 
order to reveal an alternative route for IL-1β secretion, we expanded our views to clarify 
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the interplay between the non-canonical caspase-8 and the canonical caspase-1 
inflammasome pathways after P. brasiliensis infection.  
  Here, we showed that the moderate level of caspase-8 activation observed 
in Pam3CSK4-primed WT dendritic cells incubated with P. brasiliensis was controlled 
by caspase-1/11, because in caspase-1 and -11-sufficient cells the expression and activity 
of these two proteases bypasses vigorous caspase-8 proteolysis and activity. However, 
caspase-8 served as an accessory to induce IL-1β production in P. brasiliensis-infected 
BMDCs under conditions in which canonical caspase-1 inflammasome activation is 
prevented. Consistent with these results, C. neoformans-infected dendritic cells also turn 
to caspase-8 activation when caspase-1 is absent, since caspase-1 suppresses the non-
canonical caspase-8 inflammasome activation (292). Beyond that, the delayed export of 
mature IL-1β in conjunction with increased level of the 18-kDa caspase-8 subunit after 
sustained nigericin treatment also proceeds in a caspase-1 and -11-independent way 
(293).	An explanation for the improved caspase-8 activation in Casp1/11-/- cells is that 
caspase-8 and caspase-1/11 compete with each other. Consequently, caspase-1 and -11 
ablation assures that more Asc would available to bind to 55-kDa procaspase-8. 
 Like other caspases, caspase-8 is translated as a monomeric zymogen 
comprised of a pro domain followed by a large and small catalytic subunit. The pro 
domain of caspase-8 monomers, consists of two death effector domains (DEDs) that 
interact with the N-terminal PYRIN domain of Asc (275, 294) and mediate colocalization 
with the AIM2 inflammasome in Francisella tularensis-infected cells (295). Through 
confocal experiments, we found that caspase-8 interacts and colocalizes together with the 
adapter protein Asc in a single cytoplasmic speck during P. brasiliensis infection, similar 
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to earlier published observations (111, 274, 292, 294, 295). It will be interesting to 
investigate the spatial orientation of caspase-1 and Nod-like receptor proteins in the Asc-
caspase-8 inflammasome in future studies to understand whether the components of the 
canonical inflammasome pathway also reside in the same Asc complex.  
  Even when caspase-1 and 11 are present, we demonstrate that caspase-8 
mediates IL-1β maturation upon P. brasiliensis infection. The reduced IL-1β processing 
assigned to the pharmacological inhibition of caspase-8 was corroborated using the Rip3-
/-Casp8-/- double knockout mice. Caspase-8 deficiency, more than RIP3 deficiency, 
disturbs P. brasiliensis-induced IL-1β secretion in Pam3CSK4-primed BMDCs, 
disrupting caspase-1 activation and Asc oligomerization. The requirement of caspase-8 
for caspase-1 activation suggests that caspase-8 might be upstream of caspase-1, but 
future studies will dissect the mode of action of caspase-8 to elucidate whether the 
protease acts directly or is a parallel pathway that converges with the canonical 
inflammasome to facilitate IL-1β production. Caspase-8 could regulate caspase-1 
activating cellular inhibitors of apoptosis proteins (cIAPs), which have been shown to 
interact with caspase-1, through their respective N-termini, in a complex containing 
TRAF2 (TNF receptor-associated factor 2) to direct the non-degrading K63-linked 
polyubiquitination of caspase-1 that could favor either the assembly of inflammasome or 
coordinate its activity (81). Several groups have demonstrated the involvement of 
caspase-8 in the cleavage of the caspase-1 pro form over the last few years (78, 274, 
291). The exception is the Salmonella typhimurium-sensing pathway, in which caspase-1 
processing in Rip3-/-Casp8-/- macrophages is preserved (111). Nevertheless, how caspase-
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1 and caspase-8 operate, whether synergistically or independently, as well as the nature 
of the activators that determine this relationship remain to be fully elucidated. 
 Mechanistic studies also described that apart from IL-1β cleavage, 
caspase-8 regulates the synthesis of pro-IL-1β mRNA (111). At the transcriptional level, 
caspase-8 is involved in NF-κB-dependent upregulation of pro-IL-1β in LPS-primed 
BMDCs (77). However, another observation revealed that the transcriptional role of 
caspase-8 is not confined to TLR4-induced signaling alone, but extends to NF-κB and 
MAPK activation by the TLR2 ligand Pam3CSK4 (78), which is in agreement with our 
data that showed a weaker protein band for the p35kDa precursor form of IL-1β in Rip3-/-
Casp8-/- dendritic cells compared to Rip3-/- and WT cells. It has been established that the 
catalytic functions of caspase-8 as well as caspase-8-mediated IL-1β production in 
response to heat killed C. albicans are regulated by cFLIP (cellular FLICE-inhibitory 
protein) (296). Furthermore, caspase-8 forms a heterodimer with cFLIP (297) and the 
cFLIP cleavage fragments generated by association with caspase-8 are involved in 
NF-κB activation (298). Combined with our results, it raises the possibility that cFLIP 
proteolysis, a prerequisite for induction of NF-κB activation, does not occur in dendritic 
cells deficient for both caspase-8 and RIPK3, which could explain why the levels of pro-
IL-1β are low after TLR2 engagement. Although the Il1b gene upregulation induced by 
caspase-8 is not applicable to the experimental model of P. brasiliensis infection, 
additional inquiries are needed to better comprehend the precise mechanism by which 
caspase-8 contributes to efficient NF-κB-mediated gene transcription.  
  In addition, we demonstrate that dectin-1-mediated IL-1β production after 
P. brasiliensis challenge requires the non-canonical caspase-8 inflammasome, permitting 
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us to uncover a previously unknown pathway for dectin-1 in P. brasiliensis-infected 
dendritic cells. In fact, in our fungal model, dectin-1 is connected to the posttranslational 
cleavage of pro-IL-1β, but alternatively could regulate IL-1β transcription on priming. 
Similarly, dectin-1-ligand β-glucan participates in both NLRP3 inflammasome activation 
and NF-κB-mediated priming (95, 299). Moreover, it has been shown that dectin-1 
signals alone can activate NF-κB in BMDCs (268, 300), but not in BMDM due to the 
differential use of CARD9 (300). For IL-1β secretion, we saw that inflammasome 
activation was amplified in dendritic cells rather than macrophages (data not shown). 
Regardless of the undesirable IL-1β secretion in certain myeloid cells populations, 
quiescent dendritic cells have increased amounts of NLRP3 transcripts (301, 302), higher 
NLRP3 promoter activity (303) compared to macrophages, and GM-CSF treatment 
maximizes the pro-IL-1β production by NF-κB activating agonists (304), prompting them 
to achieve a satisfactory activation threshold for the NLRP3 inflammasome.  
  Several studies firmly underline the effectors and regulatory mechanisms 
of pattern recognition receptors (PRRs) in innate and adaptive immunity against this 
fungal pathogen (305, 306). However, they did not study their relevance for IL-1β 
induction and secretion, probably because the compensatory pathways seem to mask the 
immunological differences caused by PRR deficiencies. Based on our results, at least one 
additional pathway is responsible for pro-IL-1β induction in dendritic cells since a 
remnant IL-1β production was consistently observed in Clec7a-/- BMDCs. As dectin-1 
manipulates the expression of Toll-like receptors (TLRs) during PCM (271), and P. 
brasiliensis is simultaneously sensed by TLR2 and TLR4 (307, 308) further 
investigations are necessary to unveil the roles of these TLRs for IL-1β production.  
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  Interestingly, Pam3CSK4 priming greatly boosted this response compared 
to LPS (data not shown), suggesting a more prominent expression of the pro-IL-1β 
precursor form after engagement of TLR2 signaling in P- brasiliensis-infected BMDCs. 
In accordance, Netea et al., 2002 (309) verified that TLR2 neutralization in mononuclear 
cells, using a specific anti-TLR2 antibody, leads to a significant reduction of C. albicans-
induced TNF-α and IL-1β production, whereas anti-TLR4 treatment did not influence the 
secretion of these proinflammatory cytokines. In contrast, the IL-1β production triggered 
by Aspergillus fumigatus hyphae on telomerase-immortalized human corneal epithelial 
cells is mediated through both signaling pathways, TLR2 and TLR4 (310). However, the 
sensing pathway engaged by P. brasiliensis to trigger pro-IL-1β synthesis varies with cell 
type. As the transcript levels of genes that encode TLRs and MyD88 are not elevated in 
P. brasiliensis-infected BMDCs (311), the induction of pro-IL-1β in BMDCs is only 
dependent on Syk kinase (102).  
  Even though Syk kinase operates on pro-IL-1β expression during P. 
brasiliensis infection, in our present work we also identified that it plays a pivotal 
function in controlling both non-canonical caspase-8 and canonical caspase-1 
inflammasome activation. In contrast, Gringhuis et al. (80) demonstrated Syk signaling 
induced by non-phagocytosed C. albicans was restricted to caspase-8 activity in human 
dendritic cells. Considering that the requirement of Syk for dectin-1 function is confined 
to cell type (96, 269), this discrepancy may result from variations in the experimental 
approaches or reflect species-based differences that come from the use of either human or 
murine-derived dendritic cells.  
 197	
  Other studies also have linked the NLRP3 inflammasome to Syk-induced 
IL-1β processing in mouse dendritic cells and macrophages infected with fungi (42, 95, 
299). The proposed mechanism is that Syk augments canonical inflammasome activation 
upon dectin-1 signaling by generating reactive oxygen species (ROS) (42, 95, 96, 299), 
chemical compounds that are relevant to NLRP3/caspase-1 inflammasome activation in 
P. brasiliensis-stimulated murine dendritic cells (102). Another important aspect is that 
Syk represents a common point in the signaling pathways of CLEC6A (also known as 
dectin-2) and CLEC4E (also known as Mincle). Unlike dectin-1, dectin-2 and Mincle 
have no known intracellular signaling motifs (312, 313). Instead, they associate with 
ITAM-containing adaptor protein Fc receptor γ chain (FcRγ) to propagate the signal 
(312, 314, 315). Future investigations are likely to dissect the necessity of these receptors 
during PCM.  
  Finally, we demonstrated a greater fungal load in P. brasiliensis-infected 
Rip3-/-Casp8-/- mice denoting a critical role for caspase-8 in host protection. Likewise, the 
same phenotype was described in response to Citrobacter rodentium (78), A. fumigatus 
(274) and Yersinia pestis (291, 316). As mice lacking caspase-8 on a Rip3-deficient 
background (Rip3-/-Casp8-/-) or dendritic cells with deleted caspase-8 (Casp8fl/flItgaxcre) 
have defects in cell death that cause lymphocytes accumulation (113, 122), and the 
capsular polysaccharide component galactoxylomannan from C. neoformans induces 
apoptosis of human T-cells, through caspase-8 activation (317), we believe that caspase-8 
mediated cell death might prevent unwanted or excessive innate immune responses. 
Nonetheless, whether cell death is directly responsible for the inability of caspase-8-
deficient animals to clear P. brasiliensis or for the mobilization of bystander cells that 
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rapidly produce cytokines and phagocytose pathogen-associated cell debris remain to be 
studied. The new insights gained from deciphering how pathogen recognition shapes the 
development of appropriate innate immune responses during P. brasiliensis infection 
allow a better understanding of the underlying cause of inflammation after host-pathogen 
interactions.
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Chapter 4: Discussion, perspectives and implications 
 
  Innate immunity navigates a very fine line between launching an effective 
onslaught against an invading pathogen or self-derived dangers, and controlling these 
responses in such a way so that harm to the host is minimal. Hence, innate immune 
responses are regulated by multiple factors upon which the balance between pathogenesis 
and autoimmunity is hinged. Too less a response, the infection wins or damage persists, 
whereas prolonged or too intense a response, and the healthy host cells and tissues are 
damaged. Multiple layers of regulation have evolved that control immune responses, 
some of which have been described earlier in this dissertation. For example, stimulation 
of inflammatory pathways upon the detection of microbial agents or nucleic acids leads 
to the production of pro-inflammatory as well as anti-inflammatory cytokines and 
chemokines, that counteract each other. Temporal regulation, feedback inhibition of gene 
expression and degradation of effector components are a few critical factors that fine-tune 
a necessary and sufficient immune response to pathogens or danger molecules, and are 
involved in switching off the responses over time. 
 
p205 as a Regulator of Immune Genes and Inflammation 
   
In this dissertation, I outline a novel function of a PYHIN protein in 
regulating inflammation. Previous studies indicate that Asc is upregulated in response to 
cytokines such as IL-1β, IFN- γ, TNF- α and LPS in immune cells (318-320), but the 
mechanism of this regulation has not been clearly elucidated. p205 is a nuclear protein 
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that is highly inducible upon stimulation with the microbial PAMP, LPS as well as by the 
cytokines IFN-α/β and IFN-γ. Deficiency of p205 impaired the Aim2 and Nlrp3 
inflammasomes and had a partial effect on Nlrc4 inflammasomes. In resting 
macrophages, loss of p205 abrogated the expression of the inflammasome adapter 
protein, Asc. Here, I show that p205 is required in maintaining Asc expression in resting 
macrophages as well as B16 melanoma cells, and induction of p205 (e.g. TLR4-
dependent signaling through LPS or the interferons) during infection or cellular stress 
stimulates Asc expression further, in a feed-forward mechanism, which is recruited to 
form a caspase-1 dependent inflammasome required for maturation and activation of the 
inflammatory cytokine, IL-1β. This study illustrates that besides acting as receptors for 
DNA damage and invading pathogens, the DNA-binding PYHIN proteins also control the 
immune pathways by regulating immune gene expressions (Figure 4.1).    
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Figure 4.1: p205 and Inflammasome Activation. p205 expressed in the cell 
nucleus controls Asc gene expression in resting cells. Upon priming of macrophages 
by TLR agonists such as LPS (Signal 1) that induces pro-IL1β expression, p205 
expression is also enhanced. In these primed cells, induction of the receptors like 
NLRP3 or AIM2 (Signal 2) by their respective ligands leads to the recruitment of the 
adapter Asc, and subsequently pro-caspase 1 that forms the inflammasome. The 
activated caspase 1 then cleaves the pro-IL1β into its active, secreted form that 
stimulates a downstream inflammatory response. 
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p205 deficiency diminished inflammasome activation due to decreased 
Asc protein and mRNA expression. Loss of p205 affected the RNA Polymerase II 
transcription machinery at the endogenous Asc gene. It reduced the recruitment of total 
RNA Pol II as well as the differentially phosphorylated RNA Pol II that are responsible 
for transcriptional initiation and elongation as well as mRNA processing and maturation. 
p205 also interacted with other known transcription factors such as c/EBPβ and p65/RelA 
to synergistically enhance Asc gene expression. ASC/TMS1 gene activity has been 
known to be regulated by DNA methylation, which blocks RNA Pol II recruitment, and 
by promoter proximal pausing, which recruits an RNA Pol II that can initiate 
transcription but does not allow transcriptional elongation. In the context of p205, I 
suggest that p205 is an integral part of the larger transcriptional complex containing RNA 
Pol II with or without other transcription factors that is required for effective Asc gene 
expression. Loss of p205 from this transcriptional complex allows for some leaky 
transcription at the endogenous Asc gene but blocks efficient transcription and mRNA 
maturation. Further, the reduced levels of the initiating as well as elongating RNA Pol II 
in the absence of p205 alludes to the inability of RNA Pol II to successfully initiate 
and/or elongate gene transcription even though it is recruited to the gene promoter. 
Hence, other immune genes that are regulated by p205 may not exhibit a similar 
phenotype of leaky pre-mRNA production, but may simply be inhibited by p205 at the 
transcription level - as RNA Pol II pausing and aborted initiation is characteristic of the 
gene promoter, and not the transcription factor. 
   
 203	
The interaction of p205 with c/EBPβ opens up possibilities about the 
genes that may be regulated by p205, as well as how p205 is doing so. The transcription 
factor, c/EBPβ remains poised on multiple gene promoters in resting macrophages while 
upon induction by LPS, it initiates gene expression (250). c/EBPβ acts by binding to 
DNA, and recruiting other factors or co-activators to open up the chromatin structure to 
facilitate transcription. c/EBPβ can interact with NF-κB and other proteins for trans-
activating gene expression. Interestingly, in our study we observed that p205 interacted 
with c/EBPβ in LPS-stimulated macrophages as well as in the resting cells. Hence, 
c/EBPβ and p205 cooperate in resting cells to sustain Asc gene expression that is 
expressed constitutively, whereas in context of inducible genes such as IL-1α or IL-6, 
c/EBPβ might collaborate with p205 to effectually initiate gene expression during 
stimulation, as indicated by the decreased mRNA levels of these genes in LPS-induced 
macrophages lacking p205. Similarly, NF-κB signaling via TLR4-LPS can induce 
p65/RelA collaboration with p205 that would enhance a LPS-mediated induction of Asc 
expression and other immune genes. p65/RelA induces gene expression by altering the 
chromatin signature towards successful transcription. It facilitates the recruitment of co-
activator complexes (e.g. p300/CBP histone acetyltransferase complex), removal of 
inhibitory modifications, and recruits general transcriptional machinery to the gene. 
Hence, upon stimulation, p205, along with c/EBPβ, can recruit p65/RelA to generate a 
more accessible chromatin conformation that further augments inducible gene 
transcription (Figure 4.2). 
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Figure 4.2: Schematic model describing the mechanism of action by which p205 
regulates Asc gene expression by modulating transcription as well as mRNA 
processing. 
p205
p205
Figure 4.1: Schematic model describing the mechanism of action by which p205 
regulates Asc gene expression by modulating transcription as well as mRNA processing 
 205	
In our study, we were unsuccessful in generating p205-/- knockout mice 
with ES-cell microinjection due to very low chimera percentage in the pups. Instead we 
used an ALR-/- mouse model that has the complete PYHIN/ALR locus deleted and hence, 
lacks the 13 PYHIN genes including p205 (176). On testing primary bone marrow-
derived macrophages and dendritic cells from these animals we observed a partial defect 
in the Nlrp3 and Nlrc4 inflammasomes as well. However, at first, we did not observe a 
strong effect on Asc protein expression in the primary macrophages and dendritic cells. 
Primary macrophages and dendritic cells are cultured in conditional media that contain 
Macrophage Colony Stimulating Factor (MCSF) and Granulocyte Macrophage Colony-
Stimulating Factor (GM-CSF) that are responsible for differentiating hematopoietic stem 
cells, and thus stimulate multiple signaling pathways. Any such pathway, or a component 
of it (e.g. c/EBPβ), upon differentiation, can regulate signaling cascades that are 
otherwise controlled by p205 in the resting or LPS- and IFN-induced differentiated cells. 
However, in immortalized ALR -/- macrophages, Asc protein expression was markedly 
reduced, confirming our previous observations that p205 indeed regulates Asc 
expression. This can be due to multiple reasons including that immortalization of the cells 
augments the effect of p205 on Asc expression, which is not unlikely as both the proteins 
have been previously associated with tumor progression. Additionally, PYHIN proteins 
can interact with each other, and quite possibly be regulating themselves as well as 
similar pathways. Deletion of all 13 PYHIN genes could be overshadowing the singular 
effect attributable to p205. A point to be noted here, several PYHIN proteins, including 
p204, p205 have been reported to be induced and necessary during myeloid cell 
differentiation; hence, deletion of the complete PYHIN locus can change the make-up of 
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the primary macrophages and dendritic cells. However, the decrease in IL-1β production 
in the differentiating primary macrophages and dendritic cells was consistent across 
separate ALR -/- mice, which is in agreement with our observations that there is defect in 
the machinery responsible for IL-1β maturation upon Nlrp3 and Nlrc4 activation. 
 
A previous study on ASC/TMS1 induction in breast cancer epithelial cells 
predicted the involvement of p65/RelA upon TNF-α stimulation but lacked experimental 
evidence. Using an ASC promoter reporter construct, 1254 bp upstream of the translation 
start site, they did not observe sufficient induction with TNF-α stimulation or p65/RelA 
transfection (321). They predicted that promoter regions distal to the translation start site 
would be involved. These observations agree with our study, where p205 could drive 
expression only from the Asc promoter construct containing up to 2000 bp upstream of 
the translation start site. Bioinformatics of the Asc promoter predicted transcription sites 
for c/EBPβ and NF-κB factors scattered within the gene sequence. Hence, it is likely that 
more than one DNA response element and a specific, folded secondary structure is 
essential to initiate effective Asc gene transcription. 
 
  So, which motifs of p205 are involved in mediating gene transcription? As 
mentioned earlier, the PYHIN proteins consist of at least one conserved 200 amino acid 
domain that is capable of binding DNA. Interestingly, HIN-A domain, as found in p205, 
is considered to bind single stranded DNA with higher affinity, compared to HIN-C 
domain of AIM2 and the combination of HIN-A and HIN-B domains of IFI16 that 
preferentially bind double stranded DNA (183). Thus, it is quite likely that the HIN 
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domain of p205 is responsible for binding to the transcriptional elements on the gene 
promoters. However, so far reports indicate that the binding of DNA by the HIN domains 
is sequence-independent, which is contradictory to how transcription factors act. 
Additionally, from our reporter studies we observed, that both pyrin and HIN domains of 
p205 were required to drive expression from the Asc gene luciferase reporter. This 
suggests that while p205 may bind the gene promoter DNA mediated by its HIN domain, 
the specificity of binding may be promoted by protein-protein interactions between the 
p205-pyrin domain with other factors. Hence, p205 binds to another transactivator or 
transcription factor and recruited to the gene promoter where it clamps on to the exposed 
single-stranded DNA in a sequence- independent manner. 
 
For example, Pyrin protein, encoded by the gene MEFV, that forms 
inflammasomes and is the genetic basis for familial Mediterranean fever (FMF), is 
cleaved by caspase 1 and interacts with p65/RelA and other NF-κB factors to enhance 
NF-κB-mediated signaling (322). Intriguingly, a protease cleavage site prediction tool 
(ExPASy) predicts that p205 also has a single caspase 1 cleavage site within its pyrin 
domain, at Asp59 that would generate a N-terminal fragment, and it might interact with 
p65/RelA under stimulated conditions to induce gene transcription.  
 
Future directions 
   
  Outstanding questions about the functions of p205 include determining the 
DNA sequence that is bound by p205 (by ChIP sequencing), the array of genes that are 
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regulated by p205, and whether it cell-type specific (using DNA microarray) and 
deciphering all the interacting partners of p205 (by Mass spectrometry) that form the 
transcriptional complex involved in gene regulation. Another model that can prove useful 
in studying the functions of p205 (independent of other PYHIN proteins) is the ALR-/- 
mouse; however, it has to be kept in mind, that PYHIN proteins may regulate each other 
and often, have been reported to be working in tandem to regulate different pathways 
(e.g. cell growth and proliferation, cell differentiation). Further, defining the functional 
homolog of p205 in humans that regulates Asc and other inflammatory genes would 
make the candidate an exciting therapeutic target in autoimmune and inflammatory 
disorders. 
 
  The innate immune system has evolved to detect microbial threats as well 
as self-derived danger molecules in the cells. In context of immune responses, Asc is 
expressed in resting cells and had been considered to be largely unaffected by microbial 
stimulations. However, expression of Asc is highly variable, and is often silenced, in 
context of cancers and tumors. Previously, p205 has been shown to regulate p21CIP/WAF 
expression in a p53-dependent manner (323). The tumor suppressor function of p205 may 
also be implemented through the action of Asc, which has been implicated in p53-
mediated Bax-dependent mitochondrial apoptosis (324). This is supported by the 
observation that CRISPR/Cas9 mediated knockout of p205 in melanoma cell line also 
affected Asc expression potently. Thus, it is possible that Asc deficiency in murine 
tumors can be correlated to a lack of p205 expression. Also, p205 is inducible by type II 
interferon that is involved in viral infection as well as in DNA damage response. Hence, 
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it would be interesting to study the role of p205 in tumorigenesis, cell proliferation and/or 
cell death. 
 
Humans have 4 PYHIN proteins including AIM2, IFI16, PYHIN1/IFIX 
and MNDA compared to 13 in mouse. The functional human ortholog of p205 is 
unknown. However, the convergence of genes in higher mammals signifies that their 
functions have converged as well. p205 shares high sequence homology with both 
PYHIN1/IFIX and human MNDA. Both PYHIN1/IFIX and MNDA contain a HIN200 
subtype A motif. However, the functions of these proteins have remained unsolved. One 
study has reported that during viral infection, PYHIN1/IFIX can associate with other 
regulatory transcription factors to inhibit viral replication. On the other hand, multiple 
reports have observed differential expression of MNDA in tumor and cancer cell lines 
similar to gene silencing of ASC in tumors, and cancer patients. It is also interesting to 
note that phylogenetic analysis shows that p204, p211, p205 and p207 form a clade with 
human IFI16 and PYHIN1/IFIX in the pyrin domain tree, rather than other mouse 
proteins (172). Hence, depending on the cell-type and immune responses, the functions of 
p205 is likely carried out by one or more PYHINs in humans. The straightforward 
approach would be to determine the expression of these PYHIN proteins in cancer cell 
lines known to down-regulate ASC expression. 
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Caspase 8 as a Regulator of Inflammasomes Activation in Fungal Infections  
   
  Regulation of inflammation and inflammasomes by caspase 8 is context-
dependent, and often contradictory. While caspase 8 itself can activate a non-canonical 
inflammasome, it is also involved in regulation of the canonical inflammasomes, 
inhibitory or activating. In BMDC infected with Paracoccidioides brasileinsis, NLRP3-
dependent caspase 1/11 activation of inflammasomes is the major pathway but in our 
study we show that there is a parallel pathway regulated by activated caspase 8 that is 
also responsible for IL-1β release (Figure 4.3). Future studies will delineate the subtle 
interplay that occurs between caspase 1 and caspase 8 in regulating infection. In the 
absence of caspase 8 activity, there is higher caspase 1 being produced whereas caspase 8 
induces higher IL-1β cleavage and secretion when caspase 1 is blocked. However, 
caspase 1 is activated primarily through the NLRP3 pathway and caspase 8 
inflammasome is dependent on the dectin-1/Syk pathway. It will be interesting to study 
the crosstalk between the two pathways and whether they cooperate or compete with each 
other. Using a Syk inhibitor showed an effect on IL-1β and caspase 8 processing as well 
as a partial effect on caspase 1 proteolysis during P. brasiliensis infection. However, in 
dectin-1 deficient mice (Clec7a-/-), P. brasiliensis infection caused reduction in IL-1β 
processing and release, but showed some amount of caspase 8 cleavage. Hence, further 
studies will be required to outline any other receptors that might activate the 
inflammasome as well as caspase 8 in fungal infection. The in vivo infection model of P. 
brasiliensis in Casp8-/-Rip3-/- mice clarified the critical involvement of caspase 8, but not 
Rip3, in controlling the fungal load in the lungs of animals that led to higher 
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inflammation in the lungs as well. At 30 days post-infection, P. brasiliensis infected 
Casp8-/-Rip3-/- mice were also in worse conditions than Rip3-/- or WT mice, with the 
DKO mice showing symptoms of shivering and acute weight loss. Hence, caspase 8 is 
crucial in controlling fungal infection, and may be regulating inflammation and immune 
responses through more than one signaling pathway.  
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Figure 4.3: Regulation and Activation of the Inflammasome by p205 and 
Caspase 8. p205 maintains the expression of the inflammasome adapter protein, Asc 
in a RNA Polymerase II-dependent manner. Upon stimulation with LPS or Interferons, 
p205 can collaborate with other transcription factors like c/EBPβ and p65 to enhance 
Asc expression. Asc is required for activation of the inflammasome (e.g. NLRP3, 
AIM2) to induce IL-1β secretion, cell death and other inflammatory responses. 
Infection with the fungal pathogen, Paracoccidioides brasiliensis stimulates caspase 
1- as well as caspase 8- dependent inflammasomes to activate IL-1β secretion. The 
caspase 8-dependent inflammasome requires dectin-1, Syk kinase and Asc. 
Caspase 8 also controls inflammasome activation by regulating the activity of mature 
caspase 1 (NLRP3 inflammasome).  
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